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Abstract 
Introduction 
HIV testing, linkage to HIV care and continuity of care are crucial for proper management of 
HIV/AIDS. There is increasing interest across sub-Saharan Africa, including in Tanzania, in 
accessing hard-to-reach populations and remote areas with HIV testing opportunities and linkage 
to HIV care. Despite the efforts being made by the Tanzanian government to address some of the 
challenges to improving HIV testing and subsequent linkage to HIV care and treatment services, 
such as increasing service outlets, linkage to care in Tanzania is still low: studies published in 2009 
and 2014 reported linkage rates of 14% at four months and 28% at one year. To our knowledge, 
there has not been any direct, prospective comparison between mobile and facility-based models 
of testing in countries like Tanzania, where treatment is only available in a minority of facilities. 
This study aimed to describe and compare rates and determinants of linkage to care in the first six 
months following an HIV-positive test result between mobile and facility-based models of HIV 
testing in Mbeya region, Tanzania. 
 
Methods 
An explanatory sequential mixed method study based on a prospective 2-armed cohort of 1,012 
newly HIV diagnosed individuals who tested either at facility-based or mobile/outreach HIV 
testing sites (n=16) in remote and border areas of Mbeya region, Tanzania, was conducted to 
describe and compare the rates and determinants of linkage to care. The cohort participants were 
interviewed using structured questionnaires at 0, 3 and 6 months after diagnosis, to gather 
information on HIV testing and linkage to care. Quantitative data to describe the populations 
testing in the two models were collected through register review for 11,733 clients who received 
HIV testing services in the study sites; the cohort was recruited from amongst these 11,733 clients. 
A subsample of the cohort also participated in qualitative individual interviews and focus group 
discussions. Additional qualitative data were collected through interviews with healthcare 
providers in the study sites, observation/field notes from the sites, and examination of guidelines 
and reports at the sites. Quantitative data were recorded, cleaned and analyzed using Stata Version 
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13 (College Station Texas. USA), while qualitative data were analyzed by thematic content 
analysis, supported by Atlas.ti Software.  
Findings 
At six months since diagnosis, 78% (793 out of 1012) of participants enrolled in the cohort had 
linked into care. Linkage to care was higher from facility-based than from mobile/outreach sites; 
84% (CI= 81% -87%, n= 512) of individuals tested at facility-based were linked to care, compared 
to 69% (CI= 65% -74%, n=281) of individuals tested at mobile/outreach in the same period. 
Individuals tested at facility-based sites entered HIV care sooner than the individuals tested at the 
mobile/outreach sites; the median time to linkage was 1 day (IQR: 1-7.5) for facility-based and 6 
days (IQR: 3-11) for mobile/outreach sites. Disclosure of HIV status was a significant factor 
associated with timely linkage to care: participants who disclosed their HIV status had a two and 
half times earlier rate of linkage to care compared to participants who did not disclose their HIV 
status (p<0.001). Clients who reported that they tested because they wanted to get treatment for 
HIV were 25% more likely to link to care (p=0.005). The study showed that more individuals 
tested at the mobile/outreach site compared to the facility based sites (56% vs 44%, p<0.001), 
however, HIV prevalence was higher in the facility testing group at 21.5% compared to 7.9% in 
the mobile/outreach group (p<0.001).   
The difference was seen in the HIV testing sites: the mobile sites were actively following people 
up in their homes, and HIV testing was experienced by study respondents as more friendly and 
more confidential, while at the facility-based sites testing was passive on the part of the staff, or 
routine through a PITC approach. Nevertheless, processes and procedures for linkage to HIV care 
section were similar for all clients, regardless of where they had tested, and all sites appeared to 
be adhering to national guidelines for testing and linkage to care. 
Qualitative findings of the study revealed that factors facilitating or impeding linkage to care 
occurred at all levels: patient, provider, health system and contextual. However, patient and health-
system related factors were most prominent. The factors that facilitated linkage to care at the 
individual level were: disclosure of HIV status to someone (spouse, family member, relative or 
friend), support from family/relatives, and having symptoms of disease at the time of diagnosis. 
On the other hand, fear of stigma, lack of disclosure, denial, being asymptomatic, and belief in 
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witchcraft were barriers identified at the level of individuals. At the provider level, support and 
good patient-staff relationships facilitated linkage, while negative provider attitudes and use of 
abusive language to patients were reported barriers to successful linkage. Clear referral procedures 
and well-organized clinic procedures were system-level facilitators of linkage, whereas poorly-
organized clinic procedures and visit schedules, overcrowding, long waiting times, and lack of 
resources (including human resources and equipment) were reported barriers. Distance and 
transport costs to HIV care centres were important contextual factors influencing linkage to care. 
 
Conclusion 
Timely linkage to care at six months after HIV diagnosis is much higher in Mbeya region in 2017 
than was reported in other rural regions only a short time ago. Findings from this study suggest 
that although mobile/outreach service delivery models bring HIV testing services closer to people 
in remote and resource-constrained areas, and do increase testing, there is still a significant gap in 
timely linkage to HIV care compared to sites within established health facilities. The more pro-
active and client-centred approaches observed at and reported by clients testing at mobile/outreach 
sites did not result in a comparable rate of linkage to care. In this setting, health system 
organizational factors, such as on-site services and well-functioning routine procedures, are of 
particular importance in facilitating linkage to care: these organizational factors, together with the 
individual-level factors related to reasons for testing and readiness or willingness to accept an HIV 
diagnosis and seek care, are powerful determinants of linkage. Even though the long waiting times 
at care and treatment centres could themselves be a significant barrier to the linkage, overcoming 
stigma, fear, and logistical barriers are of primary importance. Strategies that are more effective 
are needed to further improve linkage through the mobile/outreach model of service delivery, 
including increased attention to effectively communicating the importance of linkage to care and 
adherence to HIV treatment and providing additional support.  
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CHAPTER ONE 
INTRODUCTION 
1.0 Introduction 
HIV testing, linkage to HIV care, and continuity of care are crucial for proper management of 
HIV/AIDS (Hatcher et al., 2013; Wilton & Broeckaert, 2013). Thus, there is increasing interest 
across sub-Saharan Africa, including in Tanzania, in accessing hard-to-reach populations along 
major highways or trade corridors, in border areas, and in remote rural areas with HIV testing 
opportunities and linkages to HIV care and management (Staveteig et al., 2013; Bassett et al., 
2015; CDC, 2016). 
 
Mobile and outreach HIV testing can help to achieve universal HIV testing in sub-Saharan African 
countries. However, despite the efforts being made by the Tanzanian government to address some 
of the challenges to improving HIV testing and subsequent linkage to HIV care and treatment 
services, such as increasing service outlets, studies conducted in various regions of Tanzania show 
that linkage to care is still low. Many factors can interfere with or facilitate successful linkage to 
and continuity of care. This thesis describes and compares the populations accessing testing at 
mobile/outreach versus fixed/facility-based testing sites, and compares the processes, dynamics, 
and outcomes of linkage to care between these two models of HIV testing.  
 
This introductory chapter describes Tanzania’s HIV/AIDS response, particularly in relation to 
testing and linkage to care in the remote, hard-to-reach border region of Mbeya. It situates this 
response and the challenges of testing and linkage to care in the context of the changing and uneven 
patterns of the HIV pandemic in Africa and in Tanzania. This introduction sets the stage for the 
study rationale. The chapter concludes with an outline of the thesis. 
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1.1 HIV: an uneven and African pandemic 
HIV/AIDS is one of the world’s main public health problems, and it is estimated that about 36.7 
million people are living with HIV/AIDS worldwide (WHO, 2017). Sub-Saharan Africa carries 
the biggest burden of HIV infection, accounting for more than 70% of global infection, with nearly 
1 in every 25 adults (4.4%) living with HIV (UNAIDS, 2014; Kharsany & Karim, 2016). Women 
living with HIV in sub-Saharan Africa account for 58% of the total number of people living with 
HIV, with high rates of new HIV infections among young women aged 15-24 (Ramjee et al. 2013; 
UNAIDS, 2014; AVERT, 2016). Although the number of AIDS-related deaths fell by 39% 
between 2005 and 2013, Sub-Saharan Africa still accounted for 74% of all the people dying from 
AIDS-related causes in 2013 (UNAIDS, 2014; Kharsany & Karim, 2016).  
 
In the Sub Saharan Africa, ten countries (Ethiopia, Kenya, Malawi, Mozambique, Nigeria, South 
Africa, Uganda, Tanzania, Zambia and Zimbabwe) account for more than  80% of all people living 
with HIV in the region (UNAIDS, 2014b). South Africa and Nigeria account for 25% and 13% 
respectively, while the East African countries (Tanzania, Kenya, and Uganda) account for 6%,  
and Ethiopia 3% of all infections in SSA (UNAIDS, 2014; AVERT, 2016; Kharsany & Karim, 
2016). In South Africa, the overall HIV prevalence was estimated at 12.7% in 2016, with 
prevalence differing by provinces, with KwaZulu Natal leading at 16.9%, followed by 
Mpumalanga and Free State at 14.1% and 14.0 % respectively, while the Northern Cape and 
Western Cape had the minimum prevalence of 7.4% and 5.0 % respectively (Statistics South 
Africa, 2016). The Tanzania HIV/AIDS and Malaria Indicator Survey 2011/2012 (THMIS), 
reported HIV prevalence of 5.1%, with more females infected than males (TACAIDS, 2013; 
AVERT, 2016). In a similar manner to South Africa, the shape of the HIV epidemic in Tanzania 
also differs widely from one region to another, with HIV prevalence less than 2% in Manyara, and 
reaching 14.8% in Njombe region (NACP, 2014; AVERT, 2015).   
  
 
1.2. HIV/AIDS epidemic and national response to HIV/AIDS in Tanzania 
Tanzania has a population of 44.9 million with an average life expectancy of 58.2 years (NBS, 
2013; AVERT, 2015). Women are disproportionately represented among people living with HIV 
in Tanzania, with the Tanzania HIV and Malaria Indicator survey of 2012 (THMIS) showing that 
http://etd.uwc.ac.za/
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4.4%  of women aged 15-24 years were seropositive while the rate among men of the same age 
was 1.7%  (TACAIDS, 2013; NACP, 2014b). In Tanzania, HIV is one of the major underlying 
contributors to hospital admissions and deaths, and available data indicate that by December 2013, 
a total of 1,411,829 people were living with HIV/AIDS, and 78,843 people died in 2013 due to 
AIDS-related diseases (NACP, 2014). Recently, there has been a decline in the epidemic (Figure 
1), together with an increased commitment by the Government of Tanzania since the first reported 
case of HIV/AIDS in 1981 (NACP, 2012). 
 
The National AIDS Control Program (NACP) was established in 1987 as the first response to the 
HIV/AIDS epidemic. In December 2000, the Tanzania Commission of AIDS (TACAIDS) was 
established and assigned to coordinate multi-sectoral responses to HIV/AIDS (TACAIDS, 2008). 
Provision of HIV/AIDS-related counselling services in Tanzania started in 1988 through faith-
based organizations (FBOs) and Non-Governmental Organizations (NGOs). In 1989, the 
government established the first HIV testing sites in the public sector, with a vision of making this 
a routine practice (NACP, 2007; MOH, 2013; TACAIDS, 2013).  
 
Mobile HIV Testing and Counseling (HTC) was started in the early 2000s to complement existing 
approaches of HIV testing in the country, and to expand services to remote areas and hard-to-reach 
communities (NACP, 2012; MOH, 2013). In 2004, Tanzania launched the National HIV/AIDS 
care and treatment program and provision of care and treatment services for HIV in public health 
facilities (TACAIDS, 2013). Following on from this, in 2009 TACAIDS developed a National 
Multisectoral HIV Prevention Strategy (NMPS 2009-2012), which was a major milestone in 
response to the country’s HIV epidemic. Various prevention interventions were integrated to 
enhance compliance in implementation (TACAIDS, 2013; NACP, 2014). According to current 
policy guidelines, all testing sites are obliged to establish referral links to further HIV care and 
treatment centres, as “health care providers should give extra attention to linking the clients with 
follow up services” (NACP, 2012; MOH, 2013 page 8).   
 
Tanzania’s HIV epidemic is attributed largely to heterosexual transmission, with 80% of infections 
falling in this category (TACAIDS, 2013; NACP, 2014b). Since ART was made available in 2004, 
the government has strengthened efforts to scale up care and treatment services. It is estimated that 
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21%-30% of people living with HIV (PLHIV) in Tanzania have registered at the Care and 
Treatment Center CTC, and 69% of eligible adults were receiving ARVs by 2014 (NACP, 2014). 
HIV prevalence has decreased significantly from an overall prevalence of 7.0% in 2003/04 to 5.1% 
in 2011/12, due to increased education on HIV prevention and safe sex practices (NACP, 2014b; 
TACAIDS, 2013). Fig 1 below illustrates the decline in HIV prevalence in the adult population 
from 2003 to 2012. While an increase in HIV prevalence would be expected if incidence remains 
stable and mortality declines, the prevalence in 2016 is reported at 4.7% (AVERT, 2017). 
 
 
Fig 1: HIV prevalence among adults aged 15-49 years in Tanzania between 2003-2012 
Source: Tanzania-UNAIDS-Narrative report 2014 
 
1.3. HIV testing and linkage to care 
HIV testing in Tanzania is provided in both health facilities and out-of-facility sites (MOH, 2013). 
Facility-based approaches include client-initiated counseling and testing, or voluntary counseling 
and testing (VCT), and provider-initiated counseling and testing (PITC), as well as the Prevention 
of Mother to Child HIV transmission (PMTCT) program (Kapologwe et al., 2011; MOH, 2013; 
Layer et al., 2014). Out-of-facility modalities for HIV testing include home-based testing, stand-
alone VCTs, workplace or school-based testing, and community HIV testing through mobile vans 
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and organized HIV awareness campaigns (MOH, 2009; Njau et al., 2014; Cawley et al., 2015; 
Sharma et al., 2015). 
All individuals diagnosed as HIV positive must be linked to HIV care and treatment immediately 
(MOH, 2013; Suthar et al., 2013). According to Dombrowski (2013), successful linkage to care is 
defined as an individual completing a visit with an HIV medical provider within 90 days (three 
months) of initial HIV diagnosis. At this visit, the CD4 cell count, HIV staging, and an evaluation 
of the client’s need for ART initiation are done (NACP, 2012). Linkage to care is the bridge 
between HIV testing and HIV treatment care and support (Suthar et al., 2013; Gerdts et al., 2014). 
Timely HIV diagnosis and effective linkage into care and treatment are keys to improved outcomes 
(Kranzer et al., 2010; Rio, 2011; Sharma, 2015). Rosen and Fox (2011), defined linkage to care 
by stages, from registration at the Care and Treatment Center to ART initiation and full 
engagement in HIV care. Others defined linkage to care as the first visit to a primary health care 
or an HIV care provider authorized to prescribe ART after HIV diagnosis (Marks et al 2010; Rio, 
2011). In this study, linkage to care is defined as attending and completing the first step of 
registration at the HIV care clinic and receiving an HIV care and treatment card (Rosen & Fox, 
2011; Keller et al., 2013).  
 
1.4. HIV testing and linkage to care guidelines in Tanzania  
The Ministry of Health and Social Welfare in Tanzania developed the National Comprehensive 
HTC Guideline, which combines all aspects of HTC into one document. These include VCT, 
PITC, home-based counselling and testing, outreach HIV testing, and special organized testing 
events and campaigns, in order to facilitate smooth entry to care and treatment services (NACP, 
2014). This was expected to increase access to the care and treatment services through increased 
service outlets, although the literature demonstrates that referral and linkage remain problematic 
in Tanzania, with a number of studies showing a linkage of less than 28%  within  a year  (MRACP, 
2014; Nsigaye et al., 2009; Simmelink, 2014). The national HTC guidelines (2013) stipulate that 
after completion of HIV testing, all HIV positive clients should be linked to HIV care at designated 
centers known as care and treatment centers (CTCs), to assess their need of anti-retroviral therapy 
(ART), as well as to assess their immediate medical needs, and provide TB screening (NACP, 
2012). Depending on CD4 results and clinical staging, the client will either be started on ART or 
will be followed up regularly to monitor disease progression (NACP, 2012; MOH, 2013). At the 
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time of the current study, the cut-off point for ART initiation was a CD4 count of 350 cells/µL. 
Tanzania has since adopted the most recent WHO guidelines for “test-and-treat”, where someone 
who tests positive for HIV is immediately initiated on ART irrespective of their CD4 count (WHO, 
2016). 
 
1.5. Mobile/outreach HIV Testing Services in Tanzania 
In Tanzania, outreach and mobile testing sites have been implemented to improve on historically 
low rates of HIV testing (Ostermann et al., 2011; NACP, 2012; MOH, 2013). In response to these 
low rates, mobile and outreach testing sites have been introduced in Tanzania, reflecting an 
increased interest in providing early detection of HIV, and subsequent care and support for hard-
to-reach populations (NACP 2012; MOH, 2013). Although outreach and mobile testing have 
increased the rates of HIV testing uptake in Tanzania (Ostermann et al., 2011; Njau et al., 2014), 
linkage to care from outreach as opposed to from facility-based testing sites has not been evaluated. 
However, research from South Africa and Kenya suggests that linkage to care may be poorer from 
outreach testing sites compared to facilities (Bassett et al., 2014; Naik et al., 2015; Muhula et al., 
2016). Efforts are being made by the Tanzanian government to improve HIV testing and 
subsequent linkage to HIV care and treatment services, but studies conducted in various regions 
of Tanzania shows that linkage to care remains poor (Nsigaye et al., 2009; MRACP, 2014; 
Simmelink, 2014).   
 
1.6. Description of study setting: Mbeya Tanzania 
Tanzania is an East African country bordering Kenya, Uganda, Burundi, Rwanda, Congo, Zambia, 
and Malawi. Tanzania’s population of about 45 million lives in 30 regions and 125 districts, with 
more than 80% of people living in rural areas. Mbeya region is situated in the southern part of the 
country, more than 800 km from Dar-es-Salaam. It has a population of 2,707,410 people, with 
about 80% of these being self-employed in small-scale business and farming (NBS, 2013). Mbeya 
region has eight administrative districts divided into ten councils. It is on the highway to Malawi, 
Zambia and Congo, and has high population mobility which is associated with cross-border 
business and social interactions, thought to pose a high risk for HIV infection and challenges for 
continuity of care (MRHR, 2010; MRACP, 2012). The majority of people live in remote hard-to-
reach areas with infrastructure problems, including poor roads, and lack of electricity and water 
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(NBS, 2013; MRACP, 2014). About 23% of people in Mbeya live more than 5 km from a health 
facility, and 15% are more than 15 km from a health facility (TACAIDS, 2013). 
 
1.6.1. HIV/AIDS Status and health care services in Mbeya region 
HIV/AIDS is one of the major public health problems in Mbeya region, and Mbeya has remained 
among the three regions with the highest prevalence of HIV in the country for over a decade 
(TACAIDS, 2013; MRACP, 2014). HIV prevalence in Mbeya was found to be as high as 16.6% 
among adults in the early 2000s (Arroyo et al., 2005).  
The majority of health facilities in the rural areas do not offer CD4 testing or HIV treatment 
services. The region has a total of 430 health facilities in a distribution of 20 hospitals, 36 health 
centres, and 374 dispensaries. Out of these 430 facilities, 350 facilities provide Prevention of 
Mother to Child Transmission (PMTCT) services (MRACP, 2014). Mbeya has a total of 312 health 
facilities where clients can receive HTC services through recommended approaches; however, 
only 68 of these (21.7%) offer HTC services, posing a challenge to individuals who need to access 
HIV care services in the region (MRACP, 2014). Access to ART is a challenge for most HIV 
clients living in rural settings, with distance, poor infrastructure, and poverty being some of the 
constraints to successful referral of patients to facilities offering CTC services (MRHR, 2010). 
 
1.6.2. Addressing low rates of HIV testing: Mobile HIV Testing Services in Mbeya Region 
Despite near universal knowledge about HIV testing and increases in facilities offering HIV testing 
in Mbeya, rates of HIV testing remain low.  Reports up to 2010 showed that about 11.7% of people 
in the region had tested for HIV at least once in their lifetime (MRHR, 2010; NACP, 2012) , while 
the THMIS found that 67% of adult women and 50% of men  in Tanzania had been tested for HIV 
at least once in their lifetime. By 2013, Tanzania’s UNAIDS 2014 progress report found that only 
28.4% of people aged 15-49 had taken an HIV test in the past 12 months and knew their results 
(TACAIDS, 2013; AVERT, 2016).  
 
Among the first Non-Governmental Organizations (NGOs) to deliver stand-alone VCT, outreach 
HIV testing services, and home-based care services were ANGAZA, which was working with the 
African Medical and Research Foundation (AMREF), and KIHUMBE (Kikundi cha Huduma 
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Mbeya), meaning ‘home-based care services in Mbeya’, a local organization sponsored by 
USAID. (MRHR, 2010; AMREF, 2012).  
Mobile and outreach services, mostly operated by NGOs, usually offer only VCT services. These 
sites typically do not offer HIV care and treatment services, with the exception of the research 
mobile laboratory operating under the Mbeya Medical Research Centre (MMRC), which offers 
CD4-count testing at the point of care. All clients that test HIV-positive must be connected to the 
nearby facility-based sites for registration or linkage into HIV care and treatment services, for 
further care and necessary support (MRHR, 2010; MRACP, 2014). There are now several NGOs, 
working in collaboration with the Mbeya Region AIDS Control Program, that are offering 
mobile/outreach HIV testing and counseling services in Mbeya including: Walter Reed Program, 
Mbeya HIV Network, KIHUMBE Oaktree, SHDEPHA, Engender health, ANGAZA, Mango 
Tree, Lufingo Waviu (‘Waviu’ is a Swahili word for people living with HIV), PHEDEA, ST JOHN 
HUS and CARITAS. 
 
There are at least two organizations offering outreach HIV counselling and testing in each district 
of the Mbeya Region. The Mbeya Medical Research Centre (MMRC) mobile laboratory, also 
known as the Mobile Diagnostic and Training Centre (MDTC), has been offering CD4-count tests 
since 2009, covering between eight and twelve sites every three months (MMRC, unpublished 
data). Available statistics from the Mbeya Regional AIDS Control program annual reports 
(MRACP) suggest that more people undergo HIV testing at mobile/outreach HIV testing services 
(56%) compared to facility-based services (44%); however, only about 28% of all people tested 
were subsequently linked to HIV care (MRACP, 2012, 2014). In the next chapters, we will explore 
some of the elements influencing linkage to care in the two approaches to HIV testing services. 
 
Despite efforts to reach clients and offer HIV testing services, the main challenge is still the linkage 
and continuity of care for HIV positive clients, especially in the rural settings. This is because most 
facilities in remote areas do not have the capacity to offer HIV care services, including HIV 
staging, CD4-count testing, ART initiation, and other necessary laboratory services (MRHR, 2010; 
MRACP, 2014). Nevertheless, the annual Mbeya Region Hospital Report (MRHR) shows that 
there has been a substantial increase in facilities offering HTC services and HIV education 
campaigns since 2006. HIV testing has improved, and by 2014 about 53.8% of people have ever 
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tested for HIV and received their results in Mbeya (THMIS, 2011/12; MRHR, 2014). HIV testing 
accessibility and uptake has improved, but linkage to care remains a challenge.  
1.7. Rationale of study  
Tanzania has a high and uneven rate of HIV prevalence, with Mbeya region being among the three 
most-affected regions. There is increasing interest in accessing hard-to-reach populations along 
the highways and remote rural areas, and linking them to HIV care and management (Grabbe et 
al., 2010; van Schaik et al., 2010; Medley et al., 2013; MOH, 2013; Bassett et al., 2015). 
 
HIV testing is available through health facilities and community-based HIV testing sites, such as 
stand-alone VCT, mobile and home-based services, and other outreach testing services like 
campaigns, door-to-door testing etc. Mobile testing activities have been instituted to increase 
access and uptake, and available statistics suggest that more people prefer testing at mobile 
outreach services than at fixed health facilities (MRACP 2012; Meehan 2014). Despite increased 
HIV testing opportunities, linkage to care remains low, and a comparison of the rates and processes 
of linkage to care between these models has not been conducted. Moreover, there is little 
documentation regarding the kinds of the population and the reasons for using different models of 
HIV testing. Based on other healthcare access models, there are reasons to expect that factors 
facilitating or inhibiting effective linkage to care would differ between different models of services 
delivery (Medley et al., 2013; Gerdts et al., 2014; Naik et al., 2015).  
 
There has been little research on overall linkage to care in Tanzania, and to our knowledge, none 
on whether linkage to care differs between clients diagnosed at mobile/outreach sites compared to 
health facilities, nor on factors facilitating or inhibiting successful linkage to care between these 
two models of service delivery (Bassett et al., 2014; Labhardt et al., 2014). These differences may 
occur at the patient level, at service provider level, at the facility level, or at the level of the health 
system as a whole. For example, factors enhancing access to testing, such as dedicated outreach 
staff, may enhance linkage to care for those testing in mobile/outreach facilities, while factors such 
as geographic distance between patients’ homes and testing sites, weak referral systems, and lack 
of structural links between testing and treatment sites, may lead to disconnects between testing 
and care (Holzemer et al., 2007; Nsigaye et al., 2009; Leon et al., 2014).  
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Hence, this study sought to describe and compare the populations accessing testing at 
mobile/outreach and fixed/facility-based testing sites, and to compare the processes and outcomes 
of linkage to care between these two models of HIV testing, as well as to identify the factors 
influencing linkage to care after a positive HIV test result. This study aims to describe and compare 
rates of linkage to care and to identify and explore the determinants of linkage to care in the 6 
months following an HIV positive test result, in mobile and facility-based models of HIV testing 
in Mbeya region. The findings of this study will inform policy recommendations for HIV testing, 
linkage and continuity of care in the country.  
 
1.8 Outline of the thesis 
After this introductory background chapter, Chapter 2 reviews literature related to HIV testing, 
linkage to care, and factors influencing the uptake of testing and linkage to care in a conceptual 
framework, which includes individual, healthcare provider, health system, and contextual levels. 
Chapter 3 presents the objectives, design and methods of the study, as well as more detail on the 
study setting within Mbeya region. The findings of the research are reported in Chapters 4, 5 and 
6, in the form of manuscripts published in or submitted to peer-reviewed journals. Each manuscript 
addresses one or more specific study objectives. Chapter 4 presents the major quantitative 
outcomes of the study: the rates, timelines and determinants of linkage to care in the first six 
months after HIV diagnosis, between two arms of a cohort of over 1000 newly-diagnosed HIV 
positive clients who tested at mobile or outreach or facility-based sites. Chapter 5 reports 
quantitative and qualitative findings about the populations accessing the two models of testing, as 
well as the processes and dynamics of testing and linkage to care between the two models, while 
Chapter 6 explores the primary outcomes more deeply by reporting primarily qualitative findings 
about the facilitators and barriers to linkage to care. Chapter 7 summarizes and synthesizes the 
findings, and discusses them in relation to the literature, the study objectives, and the conceptual 
framework. Finally, Chapter 8 offers the conclusions of the study, and recommendations arising 
from this research. 
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CHAPTER TWO 
LITERATURE REVIEW and CONCEPTUAL 
FRAMEWORK 
2.0. Introduction 
This chapter reviews the literature about the uptake and modalities of HIV testing and linkage to 
HIV care after testing HIV positive. The first section reviews different approaches and models of 
HIV testing, in relation to the Tanzanian national guidelines for HIV testing and HIV management. 
This section also covers factors that influence uptake of HIV testing. The second section of the 
literature review concerns the processes for linkage to care in HIV treatment programs. In this 
section, the factors that influence successful linkage to care are reviewed. In the final section, a 
conceptual framework that proposes to investigate linkage to care at the individual level, 
healthcare provider level, health system level, and contextual levels is presented.   
 
2.1. Approaches and guidelines for HIV testing and counselling  
HIV testing is an important step for HIV-diagnosed individuals to seek and receive treatment and 
care, thus contributing to preventing further HIV transmission. As medications and treatment for 
HIV become widely available, HIV testing and efforts to link HIV-positive individuals to available 
treatment and care have become important policy priorities in African countries (Staveteig et al., 
2013; Gerdts et al., 2014). Despite the fact that more than 90% of people in Africa are aware of 
HIV and know where to get HIV counselling at testing services, HIV testing uptake is still not 
optimal (Musheke et al., 2013; Mabuto et al., 2014). Literature shows multiple factors influencing 
peoples' decision to go for HIV testing, including deterioration of physical health, the death of a 
sexual partner or child, and availability of treatment (Musheke et al., 2013; Layer et al., 2014). On 
the other hand, fear of HIV-related stigma, perceived inability of health workers’ to maintain 
confidentiality, long distances to VCT sites, and the psychological burden of living with HIV 
inhibit uptake of HIV testing, and hence generate the need for expansion and use of alternative 
models for HIV testing services to improve uptake (Matovu & Makumbi, 2007; Musheke et al., 
2013; Mabuto et al., 2014). The World Health Organization (WHO, 2012) underlines that no single 
HIV testing delivery model will suit different types of epidemics and different intended 
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beneficiaries, and thus suggests that countries should use a combination of approaches to expand 
HIV testing services, improve access for hard-to-reach populations, and serve people who are 
unlikely to seek HIV testing on their own (WHO, 2012; Staveteig et al., 2013).  Improving access 
to tests can help identify people in the acute stage of HIV infection and timely initiation of ART 
leads to better outcome of HIV management (Hatcher et al., 2013; Wilton & Broeckaert, 2013). 
 
2.1.1. HIV testing and available approaches 
HIV tests became available in 1985, some years after the HI virus was discovered to cause AIDS. 
HIV testing services were initially only available in clinic settings, offered to patients presenting 
with AIDS-related symptoms. Before treatment for HIV was available, many people questioned 
the benefit of HIV testing, and the potential harms that might arise following a positive HIV 
diagnosis (WHO, 2012; Staveteig et al., 2013). With the availability of ART in developing 
countries, Provider-initiated testing and counselling (PITC)  began to be considered and promoted 
(Staveteig et al., 2013; Kok et al., 2015).  
 
PITC is a strategy where healthcare personnel recommend HIV testing, usually to individuals 
whose symptoms suggest HIV infection, or whose presumed behaviour suggests exposure (WHO, 
2012; MOH, 2013) though as discussed below it is sometimes offered routinely to all clients in 
health facilities. It was begun in the Antenatal care (ANC) clinics following the finding that ARVs 
could reduce mother-to-child transmission (MTCT), however, PITC implementation was limited 
(WHO, 2012). The WHO suggested that PITC should also be prioritized in other clinical settings, 
like TB, STI and key population clinics (WHO, 2012).  
In Tanzania, HIV testing and counselling was introduced for the first time in 1989, but initially 
offered in the clinic setting only. During the roll-out and scale-up of this service package, and 
evolution of other testing and counselling approaches including mobile and outreach testing in 
2004, VCT services were offered outside clinic settings (WHO, 2012; MOH 2013). The use of 
different approaches and models of HIV testing service delivery, from health facility-based to 
mobile/outreach services, have been explored to reduce stigma and discrimination around 
HIV/AIDS, thus helping people to know their HIV status and access treatment that improves 
quality of life (WHO, 2012; AVERT 2013).  
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HIV testing through mobile and outreach services, including but not limited to stand-alone VCTs, 
workplace testing, door-to-door campaigns, and other outreach testing, was introduced as an 
alternative model to service delivery in remote areas (NACP, 2012; MOH, 2013). Available 
evidence shows that a significant percentage of people prefer to test for HIV in the mobile or other 
outreach services, rather than at facility-based sites (Ostermann et al., 2011; MRACP, 2012). 
Receiving results immediately after testing was reported to reduce people’s anxiety, hence making 
the initial approach to testing and returning for results a few days later obsolete (USAID, 2009; 
MOH, 2013).  
2.2. HIV testing at facility-based or clinic setting 
Facility-based HIV testing is a component of specific health care services offered in clinical 
settings that could be a place of addressing other health problems as well (Staveteig et al., 2013). 
The first HIV tests became available in 1985 and it was initially performed only in hospitals or 
clinic settings.  In the public healthcare facilities, HIV testing and counselling (HTC) was made 
available as part of an integrated clinical service (Meehan et al., 2015; Staveteig et al., 2013). 
Multiple factors, including poor access to health facilities, failure of risk-based assessments as the 
basis for testing, stigma, fear, and practical obstacles, such as transportation and cost were noted 
to affect uptake for HIV testing (Bassett & Walensky, 2010).  Also in Meehan et al., (2015) 
instances of poor staff attitude and long waiting times were reported as obstacles to HIV testing at 
public health facilities. Literature shows that uptake of HIV testing has been increasing in the Sub 
Saharan African countries, due to availability of ART and technology for instance, availability of 
rapid tests and less invasive testing reduced the burden to the client and care providers and the 
necessity of returning to the clinic to receive results  was removed and thus increasing uptake for 
HIV testing (Rizza et al., 2012; Staveteig et al., 2013; WHO, 2012). 
In health facility settings, Provider-initiated counselling and testing (PITC) or routine HIV 
testing— refers to HIV testing and counselling recommended at health care facilities as a standard 
component of medical care. Routine HIV testing in clinic setting was recommended in 2007 by 
World Health Organization to increase HIV testing uptake and to avoid missed HIV testing 
opportunities in health care facilities so that more people can be diagnosed, linked to HIV care, 
and provided ART. This has shown improvement in antenatal care, STIs and Tuberculosis 
departments (Bassett & Walensky, 2010; Rizza et al., 2012; WHO, 2012). 
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2.3. Addressing barriers to HIV testing through mobile/outreach and 
community testing programs 
Among other advantages of mobile and outreach testing, it was reported that the approach 
decreased transport costs and other social barriers to HTC access common at the facility-based 
services (UNAIDS, 2010; WHO, 2012; Medley, 2013).  Meehan et al. (2014) reported that Mobile 
HTC provides an opportunity to target specific populations and settings like the workplace, 
transport hubs, and communities. Thus, mobile and outreach HIV testing approaches play a major 
role in reaching groups of people who do not typically access HIV testing services at a clinic. 
These approaches were also expected to remove structural, logistic and social barriers to HTC, 
including—in the case of home-based and mobile or outreach HTC—costs associated with 
transportation to facility-based services (WHO, 2012; Meehan et al, 2014). UNAIDS (2010) 
reported that such community-based programs have improved HIV testing and linkage to care, as 
well as strengthening community mobilization and attitudes towards HIV/AIDS in general. In a 
randomized comparison of home and clinic HIV testing in Uganda, Lugada et al. (2010) found 
that more people preferred home-based testing than clinic testing; this was also reported in 
Tanzania and South Africa by MRACP (2012) and Meehan et al. (2014). Studies conducted in 
South Africa and Tanzania on characteristics and choices of people for different HIV testing 
approaches showed more men access mobile HIV testing services than clinic testing (Meehan et 
al, 2014; Njau et al., 2014). This finding emphasizes the importance of taking HIV testing services 
to the people to enable them to utilize the opportunity (Grabbe et al., 2010; Bassett et al., 2015) 
A systematic review of home-based voluntary HIV testing in Sub-Saharan Africa showed high 
acceptability of outreach and home-based HIV testing models: more than 70% of people tested at 
HIV testing campaigns and home-based testing services (Sharma et al., 2015). In a study 
conducted in Cape Town on characteristics of clients accessing mobile compared to clinic testing 
sites, the clients tested at the mobile HTC reported that they were passing by and took advantage 
of the opportunity to test, while those who accessed care at the clinic-based site reported that it 
was because the clinic was closer to home or workplace (Bassett et al., 2015). Distance and travel 
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cost to the testing site was not statistically significant, although time spent was less in the mobile 
than the clinic testing sites (Meehan et al., 2014; Naik et al., 2015). 
 
2.4. Linkage to HIV Care and treatment 
Effective linkage to HIV treatment care and support is a critical step in the HIV treatment and care 
cascade (WHO, 2012; Gerdts et al., 2014). All individuals diagnosed as HIV positive at any HIV 
testing site have to be properly linked to HIV care and treatment for assessment of immediate 
medical needs (WHO, 2012; MOH 2013). Immediate linkage to HIV treatment, care and timely 
initiation of ART leads to a better prognosis of the disease, and prevention of transmission of HIV 
to others (WHO, 2012; Hatcher et al., 2013). There was limited literature on HIV linkage to care 
at the time of this study, with most literature becoming available in 2014-2017.  
 
A range of factors may facilitate or mitigate the process of linkage in the trajectory of HIV care 
from the point of diagnosis to initiation of ART. These influences may occur at the level of the 
patient/individual, the healthcare provider, or the health system, or may be influenced by other 
factors acting at the structural or contextual level. Interruptions may occur at the level of the 
individual, such as choosing not to go for a repeat visit (Macpherson et al., 2012; Layer et al., 
2014). However, this interruption may reflect a problem in communication or relationship with 
the care provider, or with the organization of the program or the health system, as well as factors 
intrinsic to the patient’s context, such as family or work commitments, lack of money for transport 
costs, and long distances to the clinic (Nakigozi et al., 2013; Wachira et al., 2014).  
 
2.4.1. Poor linkage to care  
Low or delayed linkage to care leads to HIV positive individuals not benefiting from HIV care. 
Hence, efforts to improve coverage for HIV care and treatment services are hampered, resulting 
in increased risk of HIV transmission to others (Hayes et al., 2011; Mugavero et al., 2011; Gerdts 
et al., 2014)  A study conducted in KwaZulu-Natal, South Africa, reported that about 82% of 
people knew their HIV status, but only 45% had been linked to HIV care and treatment services 
(Haber et al., 2016). In a study conducted in Los Angeles on testing and linkage to care for 717 
http://etd.uwc.ac.za/
16 
 
HIV positive clients, it was found that about 60% entered into care within 3 - 6 months after HIV 
results, but 34% of clients had still not entered into care after one year (Oruga et al., 2012). It was 
also pointed out that people testing in sites with no HIV care facility were more likely to be 
unlinked to care compared to those testing in sites with HIV care services, and more males were 
not linked to care than females (Oruga et al., 2012; Wachira et al., 2014). A study conducted in 
Lesotho pointed out that a community-based HIV testing and counselling approach is widely used 
in Africa as part of scaling up HIV testing access, but the rates of linkage to care and ART initiation 
are still low (Labhardt et al., 2016). In another recent study, conducted in Umlazi township, in 
Durban, South Africa, on linkage to HIV care, it was found that individuals testing at the mobile 
services were 33% less likely to undergo CD4-count tests than individuals testing at the clinic 
services (Bassett et al., 2014). The evidence from the literature shows that linkage to care is still a 
problem in many SSA countries. 
 
2.4.2. Barriers to successful linkage to HIV care 
Literature shows that multiple factors may be responsible for delay or failure for linkage to HIV 
care at different levels (Figure 2: Conceptual framework). Studies conducted in  South Africa, 
Kenya and Tanzania found that fear of stigma, lack of disclosure of HIV status to relatives or other 
individuals, and being reluctant to enter into HIV care if asymptomatic at the time of diagnosis 
were the key factors reported as barriers to successful linkage to care at the individual level (Layer 
et al., 2014; Ostermann et al., 2015; Sharma et al., 2015; Fatoki, 2016;) The authors argued that 
delay in seeking care after testing HIV positive was more likely to happen in clients who did not 
expect to get HIV positive results and those who had difficulties in disclosing their status (Medley 
et al., 2013; Naik et al., 2015). 
 
At the provider level, negative healthcare provider attitudes and limited support were reported to 
hinder linkage and engagement into care (Govindasamy et al., 2012; Layer et al., 2014). At the 
program and health system level, the published literature shows a number of factors influencing 
linkage to care. A study conducted in Mwanza, Tanzania by Nsigaye et al. (2009) on linkage to 
care and referral systems to HIV care and treatment, showed a very low linkage (14%) at four 
months after HIV diagnosis. The study pointed out that the 86% of clients diagnosed with HIV 
who were not linked to care and treatment services had missed opportunities for timely initiation 
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of antiretroviral therapy, resulting in poor prognosis of the disease (Nsigaye et al., 2009). 
Respondents in this study expressed a desire for HIV treatment services to be in close proximity 
to their homes, rather than being referred to the city for further HIV care (Nsigaye et al., 2009). 
Another study on barriers for linkage conducted in Iringa, Tanzania reported multiple 
compounding barriers to linkage and progression in the continuum of HIV care, including rigid 
clinic organizations or practicalities of care at the clinic, congested clinics, poor service, and clinics 
being out of stock of supplies (Layer et al., 2014). 
 
Availability of alternate healing systems (like spiritual or traditional treatment), long distances to 
the facility offering HIV care services, and costs related to transport were among the contextual 
factors associated with delay or failure to linkage into HIV care services (Nsigaye et al., 2009; 
MacPherson et al., 2012; Mutasa-apollo, 2013; Layer et al., 2014; Genberg et al., 2015). 
 
2.4.3. Facilitators of successful linkage to care 
Studies conducted in Kenya, Tanzania, Uganda, Malawi and South Africa on factors facilitating 
linkage to care indicate that these factors can be grouped at the individual or patient, health 
provider, health system, and contextual levels (MacPherson et al., 2012; Hatcher et al., 2013; Layer 
et al., 2014). It has been shown that the disclosure of HIV positive sero-status to the spouse or 
family members, and social support from significant others, increased the likelihood of enrolling 
into care at the individual level (Hatcher et al., 2013; Hodgson et al., 2014; Layer et al., 2014). A 
good relationship between patients and healthcare providers, proper education, and availability of 
equipment were mentioned as enhancing linkage to care at healthcare provider level 
(Govindasamy 2012; Nakigozi et al., 2013). Integration of HIV testing and HIV care services, 
good patient-staff relationships, and short clinic waiting times were some of the factors identified 
to enhance linkage to HIV care at health system level (Genberg et al., 2015; Naik et al., 2015).   
At contextual level, short distances to the care and treatment centres, availability of home-based 
care providers, and community mobilization activities facilitated linkage and engagement into HIV 
care (Hatcher et al., 2013). Some studies on linkage to care pointed out that enhanced or facilitated 
linkage to care achieved higher percentage of linkage and timely ART initiation, and ultimately 
suppression of viral load in individuals diagnosed with HIV (Kapp et al., 2014; Sharma et al., 
2015; Ware et al., 2016; Kiene et al., 2017). 
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2.5. Guidelines for HIV testing and HIV management 
Development of global guidelines that ensure the appropriate use of evidence is one of the core 
functions of the WHO (WHO, 2012). The WHO has been developing and updating HIV 
prevention, care, and treatment guidelines as the need arises, based on the research and 
development of antiretroviral treatment of HIV/AIDS (WHO, 2016). The WHO (2012) 
recommended the use of a combination of strategies for HIV testing and counselling because it 
was realized that the modalities for HIV testing at the health facility premises will not be able to 
reach most people, especially those in remote areas. It was recommended that countries should 
choose a combination of approaches to increase HIV testing uptake, and link HIV positive patients 
into care for timely initiation of ART (WHO, 2012). 
 
2.5.1. HIV testing guidelines in relation to different HIV testing approaches in Tanzania 
Like most African countries, Tanzania follows WHO recommendations for the management of 
HIV/AIDS (MOH, 2015). For smooth implementation of HIV testing with different approaches, 
the Ministry of Health and Social Welfare in Tanzania recently drafted the National 
Comprehensive HIV Testing and Counseling (HTC) guideline, which combines all approaches to 
HTC into one document. The aim of this guideline is to improve HIV testing, prevention, linkage 
and enrolment into care, retention and adherence in general HIV care and treatment, and 
management of comorbidities in HIV/AIDS (NACP, 2014). Home-based and other outreach HIV 
testing programs have been put in place to improve the low uptake by community members of 
HIV testing and subsequently linking those individuals to HIV CTCs. Since most of the 
outreach/mobile HIV testing sites do not have the ability to offer HIV treatment and care services, 
the National comprehensive guideline for HIV testing and counselling (2013) emphasizes the 
importance of connecting all HIV positive diagnosed clients into HIV care for the proper 
management of HIV/AIDS. According to the guidelines, “It is the responsibility of HTC program 
and providers to ensure that HTC clients and patients are connected with appropriate services 
following HTC” (MOH, 2013, p-8). 
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During the time of this study (2014), Tanzania’s HIV/AIDS management was still following the 
previous WHO clinical staging recommendations, that require CD4 counts to complement the 
clinical stage classification system, with a cutoff point for ART initiation of a CD4 count of 350 
(NACP, 2012). The National guideline on management of HIV/AIDS indicates that provision of 
HTC, including ARVs, should take place at assessed and registered healthcare facilities, which 
have trained personnel (MOH, 2015). These CTC facilities should also be integrated with other 
services, such as TB clinics, Sexual and Reproductive Health, Family Planning, PMTCT, social 
welfare and spiritual support, legal support, and home-based care services (National AIDS Control 
Program, 2015). 
 
2.5.2. Guidelines for managing newly-diagnosed HIV clients 
The 2013 National Standard Operating Procedures for HIV Care and Treatment - Tanzania 
(NACP, 2013) recommended the following steps for managing HIV diagnosed clients: 
 Initial clinic visit:  
• Assess patient’s needs, record demographic information and patient contact details, 
issue relevant forms, and direct patient to appropriate point of care.  
• Do a confirmatory HIV test if there is doubt of their status, and CD4 cell count or 
sputum smear if indicated before the patient meets a counsellor and a clinician.  
• Specimen/samples (like blood, urine, sputum) for baseline investigation should be 
done within the facility or sent to a referral laboratory on the same day. 
 
 
 Follow-up visit:  
• Patients recommended for therapy will meet a counsellor/clinician to discuss 
adherence, dosing, and adverse reaction management.  
• Patients will be scheduled for follow-up monthly for the first six months depending 
on an assessment by the clinician. After the patient is clinically stable with good 
adherence for at least six months or more and no history of drug toxicity or recurrent 
OI he/she may see at two-monthly intervals or more as agreed between clinicians and 
the patient.  
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• During the visits, patients will see a clinician, pick up medication, and meet a 
counsellor.  
• At six months intervals, CD4 counts, and other blood tests will be performed. Patients 
will be evaluated to assess response to therapy. 
• Patients not yet eligible for ART require regular clinical and laboratory assessment 
(clinical staging and CD4 count) every 6 months.  
• All patients should report to CTC if their condition deteriorates even if it is before 
their next scheduled visit. 
 
2.6. Loss of patients between HIV Testing and HIV Care and Treatment 
Center 
A recent and growing body of literature on retention in HIV care between testing and treatment in 
sub-Saharan Africa reveals a significant loss of patients in every step of the process, from HIV 
testing to registration at the CTC (Losina et al., 2010; van Schaik et al., 2010; Mugglin et al., 2012; 
Evangeli, Newell, & McGrath, 2016; Haber et al., 2015). A systematic review for sub-Saharan 
African countries showed that about one-quarter of HIV positive individuals are lost to care 
between testing HIV-positive and having a CD4 count done (Sharma et al., 2015). Some clients 
do not register at any healthcare facility at all, and this is especially true for those who are 
asymptomatic (Layer et al., 2014; Wynberg et al., 2014). From the initial visit to the healthcare 
facility to receipt of CD4 count results or clinical staging, about 41% of patients who provide 
samples for CD4 never return for their results (Elul et al., 2014).  
 
In a systematic review and meta-analysis for sub-Saharan Africa on loss to follow-up between 
HIV diagnosis and ART initiation, it was found that individuals who were not eligible for ART 
were more likely to be lost to follow-up compared to clients who were eligible for ART (Mugglin 
et al., 2012). Elsewhere it was reported that some loss to follow-up occurs in early stages of the 
care cascade before the clients’ ART treatment eligibility is known. It was argued that patients 
have to complete several visits to the facility before it is decided whether they need immediate 
care or not, resulting in loss of clients between HTC and HIV care (McGrath et al., 2010; Haber 
et al., 2015). HIV positive clients living more than 10 kilometres from an HIV care facility are 
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more prone to drop out of the cascade compared to those living closer to the HIV care facility  
(Losina et al., 2010; Govindasamy et al., 2011; MacPherson et al., 2012).  
 
2.7. Conceptual Framework for factors influencing successful linkage to care  
As shown above, interruptions in successful linkage to and subsequent continuity of care among 
HIV positive patients may occur at different levels, and a range of factors may enhance or inhibit 
the process from the point of diagnosis to initiation of ART (Nsigaye et al., 2009; Hatcher 2012). 
The interruptions or barriers may occur at the level of the patient, due to stigma, being 
asymptomatic at the time of diagnosis, denial, lack of support from family or friends, or failure to 
disclose to the spouse and significant others. (Medley et al., 2013; Cummings et al., 2014; Dima, 
Stutterheim, Lyimo & de Bruin, 2014; Layer et al., 2014). At the healthcare provider level, a poor 
patient-staff relationship, lack of privacy, and confidentiality concerns may influence a client’s 
decision to enter HIV care (Govindasamy et al., 2012; Nakigozi et al., 2013; Sharma et al., 2015). 
At the health system level, over-crowded or congested clinics, long waiting hours, poorly 
organized clinic procedures, and lack of laboratory services, machines and reagents were some of 
the reported factors negatively influencing linkage and continuation in HIV care (MacPherson et 
al., 2012; Hatcher at el, 2013; Nakigozi et al., 2013; Wachira at al., 2014; Sharma et al., 2015). 
Sometimes the wider socio-economic and cultural context may influence a client’s decision to 
enter HIV care, such as long distances to the clinic offering HIV care service, high costs related to 
transport and work commitments.  
Thus, people may be influenced by factors acting at one or more of these levels (Rosen & Fox, 
2011; Gerdts et al., 2014; Hodgson et al., 2014; Layer et al., 2014). For example, all HIV positive 
clients should be given a referral letter or memo for the nearby CTC. However, at the CTC, the 
clients may require a number of visits before a decision is made regarding whether s/he needs to 
start treatment or not. An interruption in linkage and continuity may occur at the level of the patient 
if the client does not to go to a repeat visit, although this interruption may reflect a problem with 
the organization of the system, or communication from the provider, as well as factors intrinsic to 
the patient and his/her context, such as family or work commitments, or lack of money for transport 
costs (Rosen & Fox, 2011; Hatcher at el., 2013; Naik et al., 2015; Sharma et al., 2015). All of these 
factors and processes may interfere with linkage and continuity of care, therefore efforts must be 
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made to ensure successful linkage into care by addressing the factors influencing linkage to care 
at all levels (Gerdts et al., 2014;  Maulsby et al., 2015; Katz et al., 2017). 
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CHAPTER 3 
AIMS AND OBJECTIVES, METHODOLOGY AND 
ETHICAL CONSIDERATIONS 
 
3.0. Aims of the study 
This study aims to describe and compare rates and determinants of linkage to care in the first six 
months following an HIV positive test result, between mobile and facility-based models of HIV 
testing, in Mbeya region, Tanzania.  
 
3.1. Specific Objectives: 
1. To describe and compare the populations accessing testing at mobile/outreach versus 
fixed/facility-based testing sites in rural settings of Mbeya. 
2. To measure and compare time to linkage to care of HIV positive individuals tested at the 
mobile versus facility services, over the first six months after diagnosis in rural settings 
of Mbeya. 
3. To describe and compare the processes and dynamics of linkage to care between mobile 
and facility-based models.  
4. To identify factors (patient, provider, health system, and contextual barriers and 
facilitators) associated with linkage to HIV care services among newly diagnosed HIV 
positive individuals in the mobile services and facility-based services. 
 
3.2 Study design and overview of the project 
This study used an explanatory sequential mixed method design, where qualitative methods were 
applied to explain the results obtained by the quantitative study (Creswell, 2015). Mixed methods 
study designs have been viewed as a useful alternative to either quantitative or qualitative method 
alone, as the strengths of one method mitigate the limitations of the other, yielding more 
informative and useful results (Leech & Ownuegbuzie 2007; Creswell, 2015).  
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3.2.1. Quantitative study 
Quantitative data were collected through a cohort study, in which 1012 newly HIV diagnosed 
individuals, who tested in either facility-based or mobile/outreach site were enrolled and followed 
up for a period of six months. Data were collected through documents, guidelines, and records 
(register books and reports) to gather information related to individuals attending HIV testing 
services in both mobile and facility-based testing sites. The cohort participants were interviewed 
using structured questionnaires at different points over the first six months after diagnosis, to 
gather information on HIV testing and linkage to care. The design allows measuring of the 
outcomes and determinants of linkage to care over time in the two models of HIV testing service 
delivery (described in detail in Chapter 4).  In addition, the clinic registers for all clients (n=11,733) 
testing at the study sites over the study period were reviewed, as described in Chapter 5. 
 
3.2.2. Qualitative study 
Qualitative data were collected by conducting focus group discussions and in-depth interviews 
with the individuals enrolled in the cohort study. Additional data were collected through interviews 
with healthcare providers in the study sites, and observation/field notes from the sites. A 
descriptive and explanatory qualitative approach was used to describe the processes and dynamics 
of linkage to HIV care and treatment. Focus group discussions and in-depth interviews were used 
to collect information from the cohort participants, focusing on what happened from the time of 
diagnoses to the time of the interview, discussing their experiences of the procedures and timelines 
of registration, sample provision, and receiving their CD4 results, along with initiation of ART. 
We also interviewed one or two healthcare providers in each study site to gather information on 
linkage to care. A qualitative approach was also used to collect information on barriers and 
facilitators to linkage to HIV care and treatment (refer to Chapter 5).  
A qualitative approach captures the voice of respondents and allows participants’ experiences, 
feelings, or concerns to be well understood (Creswell, 2015). This approach was chosen to allow 
the gathering of information on participant’s experiences on HIV testing and linkage to care.  
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3.2.3. Phases of the study 
 
This study was conducted in two phases: 
 
Phase I 
The first phase comprised a review of documents, guidelines, register books, and records or 
reports at each site to gather information on individuals testing, referrals, and linkage to care, as 
documented in the routine records of the 16 study facilities during the study period. In this phase, 
the study looked at: 
 The number and proportions of individuals testing for HIV in the two models of services 
during the study period. 
 Demographic characteristics of people attending facility-based testing versus mobile 
testing for HIV. 
 Documentation, records, reports and availability of guidelines at the selected study sites. 
 
Phase II 
The second phase involved enrolling 1012 adult individuals who had recently tested HIV positive 
into a cohort study and following them for six months to gather information on linkage to care 
(from diagnosis to registration at a CTC for HIV care). Participants were enrolled in groups based 
on where they had gotten tested: 1) those tested at fixed public-sector facilities (facility-based), 
and 2) those tested at mobile, stand-alone VCTs, or any other outreach HIV testing services. In 
addition, a subsample of the cohort and a sample of healthcare providers were recruited for further 
interviews. Both quantitative and qualitative data collection methods were used in this phase. 
In this phase, the study looked at: 
 Demographic characteristics of participants in the cohort.  
 The proportion of individuals in each group who linked to HIV Care in the study period. 
 The time between HIV positive diagnosis to registration at an HIV care unit. 
 Referral systems/procedures in place, and processes of linkage to care. 
 Documentation, processes and dynamics of linkage from healthcare providers’ and 
clients’ perspectives.  
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 Timelines from one step to another in the cascade of HIV care (e.g. the time from 
registration to the provision of blood for CD4, time of results availability, ART initiation 
etc.) 
 Factors (facilitators and barriers) influencing linkage to HIV care. 
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Figure 3.1: The framework of study phases and research activities 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phase I 
Quantitative and Qualitative 
Document review (n=11733 patient records; guidelines; 
registers) 
Phase II 
 
Quantitative 
At enrollment visit:  
Administration of baseline structured 
questionnaire. 
Questions focused on client’s profile, 
reasons for testing and willingness or 
plans to enter HIV care (n= 1012). 
At 3 and 6 months: 
Administration of second structured 
questionnaire at 3 months (n= 885) and 
third questionnaire at six months 
(n=840), focusing on the process of 
linkage to care and determining their 
stage in HIV care.  
 
Qualitative 
Individual interviews with health care providers 
(n= 1-2 per site, total N=   20) to elicit information 
on process and procedures of linkage to care. 
Individual interviews with newly HIV diagnosed 
clients at the end of six months (n=10). 
Focus group discussions (n= 8 - FGDs) with HIV 
positive individuals (total N= 68) enrolled in the 
cohort to discuss:  
 Experiences and challenges in HIV care 
 Their feelings and opinions about HIV 
care services in their respective sites. 
 Setbacks for successful linkage and 
continuation in care 
 
http://etd.uwc.ac.za/
29 
 
 
3.4. Study setting 
 
The study was conducted in four districts of Mbeya Region in 2014. In 2012, the Mbeya region 
had a population of 2,707,410, consisting of 52% women and 48% men (NBS, 2013). The four 
study districts were selected to include high HIV-prevalence areas and hard-to-reach populations. 
Two districts (Kyela and Mbozi) are along the highways and have borders with Zambia and/or 
Malawi. The population in Kyela district was 221,495 in 2012, while Mbozi had 446,339 residents. 
High population mobility associated with cross-border business and social interactions is thought 
to pose challenges to linkage to and continuity of care in these districts. The other two districts 
(Mbeya Rural and Chunya) have a larger proportion of residents who live 10 km or more from a 
health facility. The population in these remote districts was 305,319 and 290,478 respectively 
(NBS, 2013). The HIV prevalence among people tested for HIV in 2014 in the selected districts 
was Mbeya Rural - 13.0%, Chunya - 9.2%, Kyela - 9.2%, and Mbozi - 8.7%.  
 
The study was conducted at 16 sites (eight facility-based and eight mobile/outreach sites), offering 
HIV testing and care services. Facility-based sites included hospitals, health centres or 
dispensaries, while mobile sites coordinated by NGOs used mobile vans or trucks, fixed tents, or 
offering services at stand-alone HIV testing sites. The eight facility-based sites selected in this 
study offered HIV testing services, as well as HIV care services (i.e. had a CTC within the same 
location). Sites had different arrangements for the first step of linkage to care, which is registration. 
In some facilities, registration was possible on the same day as testing, while other facilities had 
chosen a single day or two days per week for newly-diagnosed clients to register for HIV care. 
None of the mobile/outreach sites offered CTC services and had to refer their clients to the closest 
CTC for further management (HIV staging, laboratory test, and ART initiation). The mobile site 
from MMRC offered CD4 tests at the point of care but still had to refer newly-diagnosed clients 
with their CD4 results to nearby HIV care clinics or CTCs for registration and continuation of 
care. The study followed all study participants enrolled into the cohort for six months including 
those who did not link into HIV care, with the exception of the 17% of participants who were lost 
to follow up or died during the study.  
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Figure 3.2: Map of the study selected districts in Mbeya region 
 Source- Tanzania Census General Report - 29 March 2013 
 
Table 1: Names of sites participating in the study 
 
 
Districts Facility-based Mobile/outreach 
Kyela district Kyela Hospital 
 
Ipinda Health Center 
St John Hus (NGO) 
 
Research mobile lab 
Mbeya Rural Ifisi Hospital 
 
Inyala Health Center 
Kihumbe – Mbalizi 
 
Research mobile lab 
Mbozi Vwawa Hospital 
 
Tunduma Health 
Center 
SHDEPHA 
 
Research mobile lab 
Chunya Chunya Hospital 
 
Makongolosi 
Dispensary 
Kihumbe-Chunya 
 
Research mobile lab 
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3.5 Quantitative study 
3.5.1. Study population and sampling 
The study population comprised adults above 18 years receiving HIV testing at the facility-based 
and mobile/outreach sites in the four study districts of Mbeya region, all adults registering in CTCs 
in Mbeya region, and staff working at the mobile and facility-based testing sites and CTCs in 
Mbeya region. 
 
Four sites in each district (two facility-based and two mobile services) were randomly selected, 
for a total of sixteen sites to be included in the study. For the quantitative part of the study, all 
public or mission (faith-based) based, and outreach/mobile sites offering HIV testing services in 
the selected districts were listed. A total of 27 health facility and four mobile/outreach sites were 
listed in Mbeya rural, 20 health facility-based and four mobile/outreach sites in Chunya district, 
14 facility-based and five mobile/outreach sites in Kyela district, and 29 health facility-based and 
five mobile/outreach sites in Mbozi district. Four sites in each district (two facility-based and two 
mobile/outreach) were randomly selected from the list in each district using a table of random 
numbers. (I.e. a total of 90 facility-based sited and 18 mobile sites from the four study districts 
were the sampling frame from which a random sample of eight facility-based sites and eight 
mobile/outreach sites was selected for this study). 
 
3.5.2. Sample size 
The sample size was calculated using Epi Info software, with a confidence interval of 95% and 
power of 90%, assuming that the two study groups would have the same number of subjects. We 
estimated that 30% of individuals tested through mobile/outreach services and 41% of individuals 
tested at facility-based services were expected to link into HIV care. The estimated sample size 
was 828; we adjusted this sample size to account for possible dropouts and non-responders (10%) 
resulting in a total estimated sample size of 900 participants.  
 
3.5.3. Data collection and data analysis 
Data collection tools/instruments 
The data collection tools in this study included a structured questionnaire that was administered to 
the participants at three different times (during enrollment at day 0, at three months, and again at 
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six months after diagnosis). Along with this, register books, guidelines, and monthly and annual 
reports, were used to collect quantitative data. Qualitative data were collected through focus group 
discussions and individual interviews with the cohort study participants, and an additional 20 
individual interviews with healthcare providers in the study sites. All data collection tools (baseline 
and follow up questionnaires, site records/registers, FGD and in-depth interview guides) are 
included in Annexure 3. 
 
Participant recruitment and enrollment into the study 
Recruitment of participants to be enrolled in the study was done at the sites during morning health 
education sessions on HIV testing and results (normally provided by HIV nurse counsellors). After 
finishing the session, the nurse counselor introduced the research team to the attendees, then the 
researcher or research assistant explained the study in brief, and interested individuals were asked 
to meet with the research assistants in another room for further explanation of the study procedures, 
including asking for permission to get their test results and follow-up for possible questionnaire 
administration. Those potentially willing to participate in the study were invited for the enrollment 
and informed consent discussion and initial questionnaire administration (which occurred either at 
that time or at another time and place convenient to the participant, within seven days of the testing 
visit). On the day of enrolment, the participants were provided with an information sheet and 
informed consent to read, discuss and sign before undertaking any study procedure. The 
information sheet, consent form, and questionnaires were pretested, reviewed and refined in 
consultations with clients and healthcare providers at the sites which were not part of the study. 
These documents (information sheet and informed consent) are included in Annexure 2. 
 
Data collection 
Data collection was done between August 2014 and July 2015 at the 16 selected study sites (details 
in chapter 4, 5 and 6). The key outcome variables for the quantitative study were rates of linkage 
and time variance in the two models of HIV testing. The explanatory variables were factors 
associated with time variance in the linkage. 
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Data Analysis 
Quantitative data were recorded, cleaned and analyzed using Stata Version 13 (College Station 
Texas. USA). Descriptive analysis methods were used to present the characteristics of participants. 
Categorical data were analyzed and presented using frequencies and percentage, while numerical 
was analyzed using the measure of central tendency and measure of dispersion. Normally-
distributed data were reported by mean and standard deviation, and skewed data were reported by 
median and interquartile range. The Chi-square test was used to measure the association between 
dependent variables and categorical independent variables (age, sex, education, distance etc.). Cox 
regression was used to measure predictors of time to linkage in HIV care for variables that are 
time-dependent. Logistic regression was used to identify factors associated with the site of testing 
(mobile/outreach or facility-based), a likelihood ratio test was used to decide whether to keep a 
variable in the model if the P-value was <0.05. We compared the ratios and time variance in 
successful linkage to care using the Kaplan Meier estimator and Log-rank tests. Hazard ratio and 
corresponding 95% Confidence intervals (CIs) were used to identify factors associated with time-
dependent variables. For the entire analysis, the significance level was 0.05.   
   
 
3.5.4 Validity and Reliability 
Validity describes the extent to which a study captures what it is supposed to measure (Roberts, 
et al., 2006). To ensure validity, the study had a large sample size (1012 participants) and power 
(90%) sufficient to detect the outcome of interest. The study design used both quantitative and 
qualitative methods, allowing for substantiation and triangulation of information. The sampling 
methods used to select the districts and sites, as well as including both sexes of different age groups 
into the study, minimizes bias and increases the validity of the study. Selection bias was likely to 
occur because of the voluntary nature of the study. However, recruitment procedures encouraged 
and invited as broad a range of participants as possible to join the study. Comparison of the study 
participants’ demographic characteristics with those of the general population accessing that 
testing site helped to indicate whether selection bias was significant. The instruments are 
questionnaires which are adapted from similar studies conducted in Tanzania by Nsigaye et al. 
(2009), and in South Africa by Naik (2013). The tools for data collection were pre-tested prior to 
the study, and the first 15 enrollments and interviews were used as a pilot to offer an opportunity 
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to discuss the clarity of the questionnaires and procedures with research assistants and enhance 
validity by allowing the researcher to further improve the data collection tools. Furthermore, the 
subjects for this study were followed up for six months, and the questionnaire was administered 
three times at different points (0 months, 3 months and 6 months) to increase the validity of data 
collected as a reflection of the processes and dynamics of linkage to care. An extensive literature 
review relevant to the topic was done to interpret the study findings. The data were analyzed using 
a trusted statistical package, thus increasing the validity of study findings. 
 
Reliability describes how well a test will produce similar results in different circumstances 
(Roberts et al., 2006). To ensure reliability in this study, the research assistants and field assistants 
who collected data in the field underwent two days training on the study protocol and questionnaire 
administration. The researcher ensured that the questionnaire was clear, properly translated, and 
simple to understand, with most of the questions being closed-ended. The number of interviewers 
was limited to two trained interviewers per site to ensure consistency. The team regularly debriefed 
in the field to allow concerns/problems to be shared and addressed consistently. Standard operating 
procedures (SOPs) were designed for recruitment/enrollment procedures and questionnaire 
administration, and these were observed and supervised during data collection in the field to 
enhance reliability. Checking a random sample of 10% of questionnaires for completeness and 
accuracy and double entry of data after cleaning also increased reliability. The researcher was in 
the field continuously, visited the sites for questionnaire checking, supervision, and collection of 
questionnaires in the study sites. In cases of incompleteness of information or misunderstanding, 
the participant was traced and the data filled in accordingly.  
 
3.6. Qualitative study 
Study population and sampling 
For the qualitative part of the study, the study population consisted of the newly-diagnosed HIV 
positive individuals enrolled into the cohort, and the healthcare providers working at the HIV 
testing section or at the care and treatment centre in the selected study sites. Purposive sampling 
was used for selection of HIV positive clients from the cohort to take part in the individual 
interviews and focus group discussions. Selection considered the diversity of characteristics of 
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patients i.e. gender, age, education level, distance from the HIV care centre, and participants who 
had already registered at the care and treatment centre.  
 
3.6.1. Data collection and data analysis 
 
A total of eight focus group discussions, with 6- 12 participants in each group, were conducted 
with participants from the cohort for triangulation of information gathered from the quantitative 
part of the data. For individual interviews, ten participants from the main cohort were purposively 
selected to gather in-depth information about HIV testing and linkage to care, and their personal 
experience in HIV care services. One to two health care providers were interviewed and 
observations were done in each site in order to understand the processes/procedures and operations 
of the site with regard to HIV testing and linkage to care. The key variables or factors of interest 
were the factors influencing linkage to care at different levels (individual/patient, healthcare 
provider, health system, and contextual level). The interview guides are included with other study 
instruments in Annex 3. 
 
Qualitative data were analyzed by thematic-content analysis (Miles & Huberman, 1994), 
supported by Atlas.ti Software v7 (Friese, 2013). Data transcripts and interview notes were 
transcribed and translated into English, categorized and coded according to factors influencing 
successful linkage to care at different levels, and themes of the study that were formulated in 
advance. Data from focus group discussions (FGDs) were analyzed and interpreted based on the 
themes established in advance, as well as emerging themes. The findings from the two arms of the 
cohort were compared and interpreted and triangulated with the quantitative findings. Data from 
both FGDs and individual interviews were analyzed by the researcher, and cross-checked by the 
supervisors. 
 
3.6.2. Rigour  
Rigour is being thorough and credible in collecting data. Guba (1981) developed a model of four 
criteria of Trustworthiness (Credibility, generalizability, dependability, and confirmability) to 
ensure rigour in qualitative research. Credibility in this study was ensured by collecting 
information from people who have lived the experience and can provide rich information relevant 
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to study objectives. Triangulation of methods, data sources, and tools for data collection assisted 
with consistency and comprehensiveness of the data, thus enhancing credibility. Use of FGDs 
brought together a group of people who share experiences, which allows further triangulation of 
information. Study participants were followed up for six months, allowing for prolonged 
engagement between the subjects and research team; they spent sufficient time together for the 
subjects to be willing to open up.  
In this study, coding and categorization of factors were done according to themes prepared in 
advance arising from the study objectives, which increased credibility. The interviews and FGDs 
were conducted in private rooms to offer privacy and freedom of expression to respondents. The 
researcher determined accuracy and completeness of information by member-checking during 
individual interviews. The findings in this study are less likely to be transferable to broader 
populations. According to Krefting (1991), in qualitative research each situation is unique, 
therefore is less likely for findings to be generalized. However, the researcher provided data and 
descriptions that are rich enough for other researchers to be able to make a judgment about the 
transferability of findings to different settings. To ensure dependability, the researcher trained 
research assistants who collected data in the field, (training for protocol, data collection tools, and 
questionnaire administration). Questionnaire pre-testing was done before beginning the actual 
study. To ensure confirmability of this study, the researcher checked the internal coherence of the 
data/findings. All interviews were audio recorded to make sure that nothing mentioned by the 
respondent is overlooked.   
 
 
3.7 Overview of data collected against study objectives 
 
 
 
Table 2: Summary of data collected to achieve study objectives 
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Objective  
Data collected 
Objective 1:  To describe and 
compare the populations accessing 
testing at mobile/outreach versus 
fixed/facility-based testing sites in 
rural settings of Mbeya 
  
HIV testing models available at the particular site. 
Numbers of individuals testing for HIV in the two models of 
services. 
Demographic characteristics of people attending facility-based 
testing versus mobile testing for HIV. 
Proportions of people testing at fixed facilities compared to 
mobile services among all people tested. 
Objective 2: To measure and 
compare time to linkage to care 
and loss to follow up of HIV 
positive individuals tested at the 
mobile versus facility services 
three and six months after 
diagnosis. 
Demographic characteristics of participants in the cohort.  
Proportions of individuals who linked into HIV care in the study 
period for the two groups. 
Proportions of individuals lost to follow-up in the two groups. 
The time from HIV positive diagnosis to registration (link) at 
HIV care unit in the two groups. 
Objective 3: To describe and 
compare the processes and 
dynamics of linkage into HIV care 
in the mobile and facility-based 
models of HTC service delivery. 
Referral systems/procedures and processes of linkage. 
Documentation of patterns and procedures of linkage from 
healthcare providers’ and clients’ perspectives.  
Timelines in the cascade of HIV care (i.e. time between 
registration to the provision of blood for CD4, time of results 
availability, ART initiation etc. 
Objective 4: Identification and 
description of factors influencing 
linkage to care in a group of newly 
diagnosed HIV positive 
individuals.  
Identify and describe facilitators for linkage into HIV care. 
Identify and describe barriers for linkage into HIV care 
at the individual, provider, health system and contextual levels). 
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3.8. Ethical considerations 
 
The study was approved by the University of Western Cape (UWC) Senate Research committee, 
the Mbeya Medical Research Center, the Mbeya region Medical Research Ethics Committee 
(MMREC) and the Tanzanian National Institute for Medical Research (NIMR). The study took 
place within the routine schedule of volunteers, thus there were no extra visits for interviews. The 
risks involved were of emotional discomfort and inadvertent disclosure of HIV status. 
Respondents were well informed that participation in the study is completely voluntary. The aims 
of the study and methods were clearly explained to all potential study participants. All volunteers 
were given a study information sheet with details about the study which they read an informed 
consent form which they signed before any study procedure started. The volunteers were given an 
opportunity to ask any questions and were all answered before signing the informed consent form. 
Volunteers were ensured of confidentiality, and each participant enrolled in the cohort was 
assigned a study number that was used throughout the study. Respondents who participated in 
FGDs were asked to sign a confidentiality binding form and agreed to maintain confidentiality 
before the discussion. It was also explained that because the researchers could not guarantee that 
no one would disclose information from the discussion, it was important for people not to give any 
information that they feel is sensitive. It was furthermore explained that participants were free to 
withdraw from the study at any time without any negative consequences. If an interviewer came 
across an urgent health or other HIV-related problem during the course of the study, s/he was to 
refer the study participant to the nearest health facility. Otherwise, the study did not interfere with 
the natural course of activities and health-seeking behaviour of the study participants (Informed 
consent and information sheet –Annex 2).  
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SECTION II 
FINDINGS 
 
Introduction to study findings 
This section presents the findings of the study in the form of three manuscripts which have been 
published or submitted for publication. This introduction presents an outline of each paper, and 
the completed manuscripts follow as Chapters 4, 5 and 6. The references for each chapter have 
been included in the overall bibliography of the thesis, and are not separately included in these 
chapters. The manuscripts as published are included in the appendixes, with permission from the 
copyright holders.  
Chapter 4 aims to measure and compare time to linkage to care of HIV positive individuals tested 
at mobile versus facility services over the first six months after diagnosis, in rural settings of 
Mbeya. Along with this, Chapter 4 looks at factors (patient, provider, health system and contextual 
factors) associated with linkage to HIV care services among newly diagnosed HIV positive 
individuals in the mobile services and facility-based services. It addresses Objectives 2 and 4 of 
the study. Chapter 5 describes and compares the populations accessing testing at mobile/outreach 
versus fixed/facility-based testing sites, as well as comparing the processes and dynamics of 
linkage to care. It addresses Objectives 1 and 3.  Chapter 6 looks more deeply at Objective 4. It 
focuses specifically on facilitators and barriers to linkage to care at different levels, including 
patient, provider and health system levels.  
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ABSTRACT 
Objective: Linkage to care is the bridge between HIV testing and HIV treatment, care and support.  
In Tanzania, mobile testing aims to address historically low testing rates. Linkage to care was 
reported at 14% in 2009 and 28% in 2014. The study compares linkage to care of HIV positive 
individuals tested at mobile/outreach versus public health facility-based services within the first 
six months of HIV diagnosis.  
Setting: Rural communities in four districts of Mbeya region, Tanzania.  
Participants: A total of 1,012 newly diagnosed HIV positive adults from 16 testing facilities 
were enrolled into a two-armed cohort and followed for six months between August 2014 and 
July 2015. 840 (83%) participants completed the study. 
Main outcome measures: We compared the ratios and time variance in linkage to care using the 
Kaplan Meier estimator and Log-rank tests. Cox proportional hazards regression models to 
evaluate factors associated with time variance in linkage. 
Results: At the end of six months, 78% of all respondents had linked into care, with differences 
across testing models. 84% (95% CI= 81% -87%, n= 512) of individuals tested at facility-based 
were linked to care compared to 69% (CI= 65% -74%, n=281) of individuals tested at 
mobile/outreach. The median time to linkage was 1 day (IQR: 1-7.5) for facility-based and 6 days 
(IQR: 3-11) for mobile/outreach sites.  Participants tested at the facility-based site were 78% more 
likely to link than those tested at mobile/outreach when other variables were controlled 
(AHR=1.78; 95%CI: 1.52-2.07). HIV status disclosure to family/relatives was significantly 
associated with linkage to care (AHR=2.64; 95%CI: 2.05-3.39). 
Conclusions: Linkage to care after testing HIV positive in rural Tanzania has increased markedly 
since 2014, across testing models. Individuals tested at facility-based sites linked in significantly 
higher proportion and modestly sooner than mobile/outreach tested individuals. Mobile/outreach 
testing models bring HIV testing services closer to people.  Strategies to improve linkage from 
mobile/outreach models are needed.  
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Strengths and limitations of this study 
Strengths  
 Prospective adequately-powered cohort study  
 Participants from 16 sites 
 Participants followed up for six months, with good retention (83%). 
 
Limitations 
 Some participants may have moved elsewhere during the study and may have accessed 
care elsewhere; this warrants further investigation.  
 Retention was higher in facility-testing arm (87%) than in mobile-testing arm (76%)  
 Participant tracking might have enhanced linkage to care. 
 Despite a random selection process, all of the facility-based testing sites in our sample had 
care and treatment centres on site. 
Key words 
HIV, Linkage to care, Facility-based HIV testing, Mobile and outreach HIV testing, Mbeya, 
Tanzania. 
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INTRODUCTION 
HIV remains a major burden in Sub-Saharan Africa (SSA), with 790,000 deaths associated with 
HIV in 2014 (AmfAR, 2015). Despite the high prevalence and the increasing numbers of people 
living with HIV in need of highly active anti-retroviral therapy (HAART), timely linkage to care 
is generally poor across SSA (Elul et al., 2014; Naik et al., 2015). The Mbeya region is among the 
three regions in Tanzania with the highest HIV prevalence, with an average of 9% compared to 
the national average of 5.1%, (TACAIDS, 2013) and AIDS-related deaths are among the three 
leading causes of death in the area (MRACP, 2012; MRHR, 2010). 
Linkage to care is the bridge between HIV testing and HIV treatment, care and support (Gerdts et 
al. 2014). Timely HIV diagnosis and effective linkage into care and treatment are keys to improved 
outcomes (Kranzer et al. 2010; Rio 2011). All individuals diagnosed HIV positive must be linked 
to HIV care and treatment even if local treatment guidelines do not indicate that a person should 
be started on anti-retroviral therapy immediately (Suthar et al., 2013). CD4 cell count, HIV staging, 
and evaluation of the client’s need for ART initiation need to be done immediately. The Ministry 
of Health and Social Welfare in Tanzania guideline for initiation of ART is a CD4 count ≤ 500 
cells/µL(MOH 2015); however, during the period of this study, the actual cut-off point for ART 
initiation was a CD4 count of 350. The importance of linkage to care during HIV counselling and 
testing has been well-advocated in Tanzania; however, available literature indicates that linkage 
to care after testing HIV positive is still low, with only 14% linkage at 4 months reported in a 2009 
study, and only 23% in Ifakara and 28% in Mbeya region in 2014 (MRACP, 2014; Nsigaye et al., 
2009; Simmelink, 2014). Low or delayed linkage to care leads to failure of HIV positive 
individuals to benefit from HIV care. Hence, efforts are hampered to improve coverage for HIV 
care and treatment services, thus resulting in increased risk of HIV transmission to others 
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(Mugavero et al. 2011; Gerdts et al. 2014). Linkage to care remains at sub-optimal levels in the 
country due to barriers such as lack of understanding of the importance of care regardless of 
disease stage, distance from the clinic and transport costs (Nsigaye et al. 2009; Leon et al. 2014; 
Genberg et al. 2015). Fear of stigma related to HIV, failure to disclose HIV status, being 
asymptomatic at the time of diagnosis and negative attitudes of health care providers are other 
factors reported interfering with linkage to HIV care ( MacPherson et al. 2012; Govindasamy et 
al. 2012; Layer et al. 2014). 
Mobile and outreach testing sites have been introduced in Tanzania, reflecting an increasing 
interest in providing early detection of HIV and subsequent care and support in the hard to reach 
populations and remote areas (Leon et al., 2014; NACP, 2012). Most government health facilities 
in Mbeya region (the site of this study) offer provider-initiated testing and counselling (PITC) and 
voluntary counselling services, but only about 21% also offer HIV care and treatment services 
(MRACP, 2014). On the other hand mobile and outreach services, operated mostly by non-
governmental organizations (NGOs), usually offer only voluntary counselling and testing (VCT) 
services (MRACP, 2014). These sites do not offer HIV care services, with the exception of the 
research mobile laboratory operating under the Mbeya Medical Research Centre (MMRC) that 
offers CD4 testing on site. Clients who test HIV-positive must then go to facility-based sites for 
registration and other procedures for HIV care and treatment. (MRACP, 2012, 2014).  
There has been little research on overall linkage to care in Tanzania, and none to our knowledge 
on whether linkage to care differs between clients diagnosed at mobile/outreach sites compared to 
health facilities, nor on factors facilitating or inhibiting successful linkage to care between these 
two models of service delivery (Bassett et al., 2013; Labhardt et al., 2014). These differences may 
occur at the patient level, at service provider level, at the facility level or at the level of the health 
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system as a whole. For example, factors enhancing access to testing, such as dedicated outreach 
staff, may enhance linkage to care for those testing in mobile/outreach facilities, while other factors 
such as geographic distance between patients’ homes and testing sites and treatment sites, weak 
referral systems and lack of structural links between testing and treatment sites may lead to 
disconnects between testing and care (Holzemer et al., 2007; Leon et al., 2014; Nsigaye et al., 
2009).  
One South African study found that individuals testing at mobile services were 33% less likely to 
undergo CD4 testing than individuals testing at static clinic services, and only 10% of mobile 
testers were successfully linked into care versus 72% of clinic testers; (I V Bassett et al., 2013), 
however, in South Africa nearly all health facilities now offer treatment, care and support. Hence, 
findings about differences between mobile and facility-based testing and subsequent linkage to 
care may not be directly transferable to Tanzania, where testing and care are not always available 
as a ‘one stop shop’. Active referral or self-referrals are therefore more common in Tanzanian 
situations.  
Mbeya region has a total of 312 health facilities where clients can receive testing and counselling 
(HTC) services through recommended approaches; however, only 68 facilities (21.7%) offer HIV 
care and treatment service (MRACP, 2014).  At least two outreach partners or non-governmental 
organizations offer HIV counselling and testing in each district of the Mbeya Region. The Mbeya 
Medical Research Centre  MMRC mobile laboratory, also known as the Mobile Diagnostic and 
Training Centre (MDTC) has been offering CD4 count tests at the point of care (MRHR, 2010). 
Since 2009, the mobile laboratory has been covering between 8 to 12 sites every three months. 
Available statistics from the Mbeya regional AIDS control program (MRACP)  (MRACP, 2012) 
suggest that more people undergo HIV testing at mobile/outreach HIV testing services (56%) 
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compared to facility-based services (44%); however, only about 28% of all people tested were 
linked into HIV care (Bassett et al., 2014).  An earlier study conducted in Mwanza reported that 
despite increased testing opportunities only 14% of newly diagnosed patients had linked into care 
4 months after HIV diagnosis (Nsigaye et al., 2009). Another study on linkage to care conducted 
in Ifakara showed a linkage of about 23%, indicating that linkage to care is a challenge in Tanzania 
(Simmelink, 2014). 
This article reports new findings on linkage to care and compares the outcomes of linkage and 
time to linkage into care for individuals tested HIV positive at mobile/outreach sites, versus 
individuals tested HIV positive at facility-based services over the first six months after diagnosis 
in rural parts of the Mbeya region. The findings of this study are expected to inform policy makers 
and other stakeholders in the Tanzanian health care system on the optimization of HIV testing and 
immediate linkage to care, an issue of critical importance for timely initiation of antiretroviral 
therapy. 
 
STUDY DESIGN AND METHODS 
This was a prospective mixed-method cohort study of 1,012 adults who tested HIV positive 
recruited into a two-armed cohort (health facility-based vs. mobile/outreach HIV testing sites). 
The study participants were followed for six months to gather quantitative and qualitative 
information on linkage to care since diagnosis.  
Study Setting  
The study population comprises rural communities in four of the then eight districts of the Mbeya 
Region in 2014. In 2012, the Mbeya region had a population of 2,707,410 with 52% women and 
48% men (National Bureau of Statistics, 2013). The four study districts were selected to include 
high HIV prevalence areas and hard-to-reach populations. Two districts (Kyela and Mbozi) are 
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along the highways and have borders with Zambia and/or Malawi. The population in Kyela district 
was 221,495 in 2012, while Mbozi had 446,339 residents. High population mobility associated 
with cross-border business and social interactions is thought to pose challenges to linkage to and 
continuity of care in these districts. The other two districts (Mbeya Rural and Chunya) have a 
larger proportion of residents who live 10 km or more from a health facility. The population in 
these remote districts was 305,319 and 290,478 respectively (National Bureau of Statistics, 2013).  
The HIV prevalence among people tested for HIV in 2014 in the selected districts were Mbeya 
Rural -13.0%, Chunya- 9.2%, Kyela- 9.2%, and Mbozi - 8.7%. 
All public and mission health facility-based and outreach/mobile sites in the selected districts were 
listed. A total of 27 health facility and 4 mobile/outreach sites were listed in Mbeya rural, 20 health 
facility-based and 4 mobile/outreach sites in Chunya district, 14 facility-based and 5 
mobile/outreach sites in Kyela district and 29 health facility-based and 5 mobile/outreach sites in 
Mbozi district. Four sites in each district (2 facility-based and 2 mobile/outreach) were randomly 
selected from the list in each district using a table of random numbers. The eight facility-based 
sites selected had a care and treatment centre (CTC) within the facility. Sites had different 
arrangements for the first step of linkage to care, registration: in some facilities, registration was 
possible on the same day as testing, while other facilities had chosen a single day or two per week 
for newly diagnosed clients to register into HIV care. None of the mobile/outreach sites offered 
CTC services; they had to refer their clients to the closest CTC for further management (HIV 
staging, laboratory test, ART initiation etc.). The mobile site from MMRC was offering CD4 tests 
at the point of care, but still had to refer newly diagnosed clients, already with their CD4 results to 
nearby HIV care clinic or CTCs for registration and continuation of care. 
 
Sampling  
The sampling strategy for testing sites is described above. The sampling framework for the cohort 
comprised all adults above 18 years receiving HIV testing at facility based and mobile/outreach 
sites in the four study districts of Mbeya region. The sample size was calculated using Epi Info 
software with a confidence interval of 95% and power of 90%, assuming that the two study groups 
would have the same number of subjects. Thirty per cent of individuals tested through mobile 
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/outreach services and 41% of individuals tested at facility-based services were expected to link 
into HIV care. The estimated sample size was 828; we adjusted this sample size to account for 
possible dropouts and non-responders (10%) resulting in a total estimated sample size of 900 
participants. 
 
Data collection procedures 
Prior to data collection at the clinic, the research team briefed the nurse counsellors at study sites 
on the study objectives and procedures. In turn, these nurse counsellors introduced the research 
team to clients.  Interested individuals were invited to a private room for detailed explanation, 
informed consent process, and agreement on a convenient time and place for questionnaire 
administration. Initial data were collected between August and December 2014. Follow up 
questionnaire administration continued until June 2015. Eight out of 1,020 individuals who were 
approached for participating during data collection were not enrolled in the study because two of 
them were seriously sick and needed hospital admission, three were planning to move out of 
Mbeya to their home villages after receiving the results and the other three did not come back for 
enrolment and interviews within seven days of testing and we were unable to track them. Research 
assistants who underwent two days of training on informed consent and data collection procedures 
did data collection.  
Outcome measures 
The key outcome was the proportion of participants successfully linked to HIV Care and Treatment 
Centre across the sample and in each arm of the cohort. In this study, “facility-based sites” refers 
to fixed or static facilities such as hospitals, health centres and dispensaries while “mobile/outreach 
sites” means all outreach HIV testing services, including campaigns, mobile testing clinics, home 
visits or special event testing services. 
The operational definition for linkage to care in this study is that a newly diagnosed individual has 
reported to a care and treatment centre, completed the registration process and has been provided 
with a Care and Treatment Centre (CTC) registration number and clinic card.  This definition of 
linkage to care is based on Rosen and Fox (Rosen & Fox, 2011)  and the National AIDS Control 
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Program in Tanzania(NACP, 2012); it was chosen to allow comparison with earlier studies of 
linkage to care. 
This paper reports on preliminary outcomes for which a structured questionnaire was administered 
to respondents at enrolment, at 3 months and at 6 months to ascertain time to linkage into HIV 
care and to explore factors related to linkage to care.  Information collected at enrolment included 
demographic data, date of HIV testing, reasons for testing, plans for linkage into care and plans 
for disclosure of HIV status to any family member, other relative or friend.  All baseline 
information was self-reported by participants.  In follow up interviews at three and six months, we 
asked about registration/linkage into care, CD4 count testing, ART status and results disclosure 
status. At these follow-up interviews we also we also reviewed the participants’ clinic card to 
verify the reported dates of linkage, ART initiation and CD4 count results.  
Data Analysis 
Quantitative data from sites were recorded, cleaned and analysed using Stata Version 13 (College 
Station Texas. USA). Descriptive analysis methods were used to present the characteristics of 
participants. Categorical data were presented using frequencies and percentage, while quantitative 
data were presented using the measure of central tendency and measure of dispersion. Cross-
tabulation was used to show the distribution of study subject by testing site. We compared the 
ratios and time variance in linkage to care using the Kaplan Meier estimator and Log-rank tests. 
Cox proportional hazards regression models were used to evaluate the factors associated with time 
variance in linkage to care. Statistical significance was declared at p-values less than 0.05 for the 
entire analysis. 
Ethical considerations 
The study was approved by the University of Western Cape (UWC) Senate Research Committee, 
the Mbeya Medical Research Centre, the Mbeya Medical Research Ethics Committee (MMREC) 
and the National Health Research Ethics Sub-Committee (NatHREC) under the Tanzanian 
National Institute of Medical Research (NIMR). Participation was voluntary and it was explained 
to participants that they were free to withdraw from the study at any time without negative 
consequences. Volunteers were provided with an information sheet containing all details about the 
study. They signed an informed consent and confidentiality procedures were observed. 
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RESULTS 
3.1. Participant characteristics and comparison between facility-based and 
mobile-based testing models 
The cohort of 1,012 HIV positive individuals included 58.5% female participants (56% facility; 
61% mobile), with a mean age of 35.8 years (SD 10.5) for facility-based and 35.3 years (SD 
10.0) for mobile/outreach participants. By the end of six months follow up overall 83% of 
participants were still active in the study, 87% in the facility-based arm and 76% in the 
mobile/outreach arm (p<0.0001). In both testing models, about 60% of participants were married 
and more than 80% of participants were self-employed with small-scale farming or petty 
businesses. A detailed listing of the patient characteristics is presented in Table 1. Age, sex, level 
of education and occupation were not statistically different between the two testing models, 
while statistical differences in marital status, means of transport, time to reach clinic, income and 
time to linkage were observed after Chi-square analysis. 
 
3.2. Linkage to care at six months  
At six months, 78% of enrolled participants were linked to care across both arms. Eighty-four 
percent (95%CI: 0.81-0.87) of participants tested at the facility-based sites were linked into care 
within the first six months of HIV diagnosis, compared to 69% (95%CI: 0.65-0.74) from the 
mobile/outreach-tested group. Figure 1. The interval from the day of HIV testing to the day of 
registration at a CTC was compared between participants who tested at a health facility and those 
tested through a mobile/outreach model. The median time to linkage was 1 day (IQR 1-7.5 days) 
for those who tested at a health facility and 6 days (IQR 3-11 days) for those who tested through 
any mobile/outreach model.  
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3.3. CD4 cell counts facility-based sites and Mobile sites 
Of the 793 clients linked into care, 512 (64.5%) tested in facility-based sites and 281 (35.4%) 
tested in mobile/outreach sites.  Most of the clients (n=774, 97.6%) had a recorded CD4 count. 
The mean CD4 count among participants who tested in facility-based sites was 279.6 cells/µL 
(SD, 211.8), whilst among those tested in mobile/outreach sites the mean CD4 count was 288.9 
cells/µL (SD,168.8) Student t-test showed no statistical difference in CD4 count at the point of 
linkage to care between the two testing models (p=0.49).  
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Table1: Background characteristics of study subjects by site 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Variable Facility-based Mobile N p-value 
Gender 
Male 
Female 
 
265(43.66) 
342(56.34) 
 
157(38.77) 
248(61.23) 
 
422(41.70) 
590(58.30) 
 
0.122 
Age ,mean (SD) 35.8(10.5) 35.3(10)  0.901 
Marital status 
Single 
Married 
Separated 
Divorced 
Widower 
 
78(12.85) 
361(59.47) 
82(13.51) 
13(2.14) 
73(12.03) 
 
48(11.85) 
252(62.22) 
37(9.14) 
26(6.42) 
42(10.37) 
 
126(12.45) 
613(60.57) 
119(11.76) 
39(3.85) 
115(11.36) 
 
 
 
0.002 
Level of education 
None 
Primary 
Secondary 
Vocational 
 
104(17.13) 
470(77.43) 
29(4.78) 
4(0.66) 
 
81(20.00) 
299(73.83) 
24(5.93) 
1(0.25) 
 
185(18.28) 
769(75.99) 
53(5.24) 
5(0.49) 
 
 
0.399 
Main occupation 
Unemployed 
Student 
Driver 
Employed 
Self employed 
Other 
 
28(4.61) 
18(2.97) 
9(1.48) 
18(2.97) 
530(87.31) 
4(0.66) 
 
15(3.70) 
3(0.74) 
5(1.23) 
11(2.72) 
369(91.11) 
2(0.49) 
 
43(4.25) 
21(2.08) 
14(1.38) 
29(2.87) 
899(88.83) 
6(0.59) 
 
 
0.226 
Means of transport 
Walking 
Bicycle 
Motor cycle 
Public Transport 
Private car 
 
163(26.85) 
93(15.32) 
143(23.56) 
201(33.11) 
7(1.15) 
 
200(49.38) 
77(19.01) 
71(17.53) 
55(13.58) 
2(0.49) 
 
363(35.87) 
170(16.80) 
214(21.15) 
256(25.30) 
9(0.89) 
 
 
0.0001 
Time to reach clinic 
<1 hour 
1-2 hours 
2-5 hours 
>5 hours 
 
 
397(65.40) 
157(25.86) 
50(8.24) 
3(0.49) 
 
295(72.84) 
76(18.77) 
26(6.42) 
8(1.98) 
 
692(68.38) 
233(23.02) 
76(7.51) 
11(1.09) 
 
 
0.004 
Time to linkage, (days) 
Median(IQR) 
1(1-7.5) 6(3-11)   
0.0001 
Income(Tsh)-per month 
<100,000 
100,000-500,000 
500,000-1,000,000 
>,1000,000 
NA 
Refused to answer 
 
497(81.88) 
39(6.43) 
3(0.49) 
0(0.00) 
52(8.57) 
16(2.64) 
 
320(79.01) 
56(13.83) 
2(0.49) 
1(0.25) 
21(5.19) 
5(1.23) 
 
817(80.73) 
95(9.39) 
5(0.49) 
1(0.1) 
73(7.21) 
21(2.08) 
 
 
 
0.0006 
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Figure 1: Linkage status for facility-based vs mobile /outreach sites 
 
3.4. Time to linkage facility-based and Mobile sites 
The time to linkage (registration) was significantly shorter in the facility tested group, compared 
to the mobile/outreach tested group (p <0.001), Figure 2. Log-rank test showed that there was a 
significant difference between the two groups (p <0.001). Sensitivity analysis was carried out on 
the 840 participants who were successfully followed for six months.  Cox regression analysis 
revealed that a person tested at a facility-based site increased the -likelihood of linkage by 61% 
(AHR=1.61; 95%CI: 1.39-1.85) compared to persons tested at mobile sites.  Log-rank test found 
a significant difference between the two groups   (p <0.001). 
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Figure 2: Survival analysis for time to linkage (KPM) 
 
 
 
3.5. Linkage from mobile sites with point of care CD4 test versus no CD4 test 
Of 405 participants testing at mobile/outreach sites, 182 (44.94%) individuals had tested for HIV 
at the MMRC mobile site, where CD4 testing was offered at the point of HIV testing, but no 
registration or ART was provided. 223 (55.06%) individuals tested for HIV at mobile/outreach 
sites without the availability of CD4 tests, registration and ART. A total of 66.5% of study 
subjects testing for HIV with an immediate CD4 test and 72% of those testing at a site without 
CD4 test were linked into care within the first six months; however, this difference was not 
statistically significant.  
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3.6. Factors associated with time to linkage 
Bivariate Cox regression showed that there were several factors associated with likelihood to 
linkage, and multivariate Cox regression analysis revealed that a person tested at facility-based 
increases the likelihood of linkage by 78% (AHR=1.78; 95%CI: 1.52-2.07) compared to persons 
tested at mobile centre when other variables were controlled. Disclosure of HIV status to partners, 
family, a relative or a friend was found to be a significant factor associated with two and a half 
times increased the likelihood of linkage to care (AHR=2.64; 95%CI: 2.05-3.39).  Participants 
whose main reported reason for testing was an intention to receive treatment were 25% more likely 
to link to care (AHR=1.25; 95%CI: 1.06-1.46), Table 2.  
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Table 2: Factors associated with time to linkage at bivariate and Multivariate Cox regression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
**Significant at p-value <0.05 
 
Variable Crude HR 95% CI Adjusted 
HR 
95% CI 
Gender 
Male 
Female 
 
Ref 
0.97 
 
 
0.84-1.12 
 
Ref 
0.98 
 
 
 
0.84-1.14 
Age 
18-30 
30-45 
45-60 
>60 
 
Ref 
0.95 
1.18 
1.06 
 
 
0.81-1.11 
0.95-1.47 
0.65-1.73 
 
Ref 
0.98 
1.12 
1.11 
 
 
0.83-1.17 
0.87-1.44 
0.66-1.88 
Marital status 
Single 
Married 
Separated 
Divorced 
Widower 
 
Ref 
1.24 
1.14 
1.27 
1.37 
 
 
 
0.98-1.56 
0.85-1.53 
0.84-1.91 
1.02-1.83 
 
Ref 
1.06 
0.87 
1.19 
1.15 
 
 
 
0.83-1.35 
0.64-1.18 
0.78-1.83 
0.82-1.61 
Time to reach clinic 
 
<1 hour 
1-2 hours 
2-5 hours 
>5 hours 
 
 
Ref 
1.06 
0.97 
0.75 
 
 
 
0.89-1.25 
0.74-1.28 
0.37-1.52 
 
 
 
Ref 
1.03 
1.17 
1.09 
 
 
 
0.86-1.22 
0.88-1.55 
0.54-2.22 
Testing site 
Mobile based 
Facility based 
 
Ref 
1.73 
 
 
 
1.49-
2.003** 
 
Ref 
1.78 
 
 
 
1.53-2.07** 
Health improved because of 
ARV 
  No 
 Yes 
 
 
Ref 
1.46 
 
 
 
1.22-1.74** 
 
 
Ref 
1.01 
 
 
 
0.82-1.24 
Any friend/Family taking 
ARVs 
  No 
 Yes 
 
 
Ref 
1.35 
 
 
 
1.16-1.58** 
 
 
Ref 
1.01 
 
 
 
0.85-1.203 
I want to receive treatment 
 
  No 
 Yes 
 
 
Ref 
1.25 
 
 
1.07-1.45** 
 
 
Ref 
1.25 
 
 
1.06-1.45** 
Disclosure of HIV Status 
  No 
 Yes 
 
 
Ref 
2.82 
 
 
 
0.25-3.54** 
 
 
Ref 
2.64 
 
 
 
2.05-3.39** 
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DISCUSSION 
 
This study prospectively measured linkage to care in remote and hard-to-reach areas and 
populations, and compared successful linkage and time to linkage into HIV care between two HIV 
testing service delivery models in rural settings of the Mbeya region in Tanzania.  
The study was designed and implemented against the background of historically low rates of 
linkage to care, recent widespread implementation of mobile testing to address low population 
rates of HIV testing, and evidence from other settings of significantly poorer linkage to care after 
HIV diagnosis at the mobile/outreach-based testing sites compared to facility-based testing sites.  
Our study found that 78% (n=793) of individuals of the overall cohort had registered at care and 
treatment centres within the first six months after diagnosis, representing a dramatic improvement 
in linkage to care after HIV diagnosis compared to the recent past in Tanzania (MRACP, 2014; 
Nsigaye et al., 2009; Simmelink, 2014).  
A number of studies on HIV testing and linkage to care in other SSA countries have reported 
linkage rates of more than 60% (Bassett et al. 2014; Hatcher et al. 2013; Rasschaert et al. 2014; 
Genberg et al. 2015; Sharma et al. 2015; Muhula et al. 2016). Our encouraging findings likely 
reflect a combination of the health system and social changes, including reduction in stigma. Our 
study itself may also have increased linkage to care through regularly contacting and following up 
HIV positive individuals.  
Linkage to care in the group of people tested through the facility-based model was significantly 
higher compared to the group tested through the mobile/outreach services. More people were 
linked to care, and they linked modestly sooner in the health facility than mobile clinic arm. This 
aligns with earlier studies in Kenya, South Africa and systematic review and meta-analysis of 
community and facility-based HIV testing ( Bassett et al. 2014; Genberg et al. 2015; Sharma et al. 
2015). 
 Likewise, a meta-analysis conducted in the United States on entry into medical care after HIV 
positive diagnosis reported high entry by people testing at clinics and hospitals compared to other 
community testing settings (Marks, Gardner, Craw, & Crepaz, 2010).  
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While the improvement in linkage across the overall cohort and the early linkage to the first step 
of care are encouraging findings, the continued gap in linkage to care between mobile and facility-
based testing is important to address. It is possible that some of the respondents lost to follow up 
in the mobile/outreach arm sought and were linked to care in other sites; however, we believe that 
significant health system-level barriers must be addressed to ensure timely linkage and, ultimately, 
retention in care.  
Some of the outreach testing activities are done very far from the clinics that offer CD4 testing 
and HIV care. For example, some clients in Chunya district must travel more than 100 kilometres 
on a rough road to reach a facility that offers CD4 test services and ART. We suggest an expansion 
of mobile staging and ART services in remote areas. Furthermore, health care providers should 
ensure that education and emphasis on the importance of being in HIV care, even if the client does 
not yet require ART according to local guidelines, are emphasized during counselling.  
 Disclosure of  HIV sero-status to partners  and/or  family members was strongly associated with 
earlier linkage to care compared to those who did not disclose to partners, and/or family 
members/relatives, again corresponding with findings elsewhere ( Hodgson et al. 2014; Dima et 
al. 2014; Ostermann et al. 2015), and highlighting the continued importance of facilitating 
disclosure  and social support. 
We found that the majority of participants who reported, “Wanting to receive treatment in case 
they are infected with HIV” as one of the reason for testing for HIV, tested at facility-based sites. 
This may suggest that they perceived themselves to be at higher risk, or that they already intended 
to seek care for their symptoms and that individuals testing at facilities were more willing to link 
immediately into care because they needed treatment (Layer et al., 2014). This would align with 
studies elsewhere that have reported higher CD4 counts at mobile sites than at facility-based sites 
(Bassett et al., 2014); however, while we found slightly higher CD4 counts in the mobile testing 
arm, this difference was not statistically significant. We therefore think it is important to explore 
and address health system facilitators and barriers, such as the availability of integrated HIV 
testing, care and treatment services within the same facility/site. 
This interpretation is supported by other findings from our study: a total of 265 individuals, 51.7%, 
who tested at facility-based sites were able to link on the same day of HIV testing, while only 12% 
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of those testing through the mobile/outreach model were able to link on the same day. This is likely 
associated with the availability of HIV testing and HIV care and treatment services within the 
same compound at facility sites. Not surprisingly, some studies report that CD4 testing at the point 
of care reduces time for linkage, eligibility assessment and ART initiation, (Hyle et al., 2014; 
Wynberg et al., 2014), and having HIV testing services and HIV care (CTC) at the same location 
improves rates of linkage to care and ART coverage (Layer et al., 2014; J Wachira et al., 2014). 
While Tanzania has made significant progress in increasing testing and linkage to care, our study 
strongly supports arguments for increasing the proportion of health facilities with care and 
treatment services from the current low level of 21.7% (MRACP, 2014). 
Further analysis of our qualitative and quantitative data will help elucidate these findings. 
Nevertheless, studies on HIV testing indicate that outreach testing services increase access in 
remote areas, but linkage to care remains a problem (Kranzer et al., 2010; Labhardt et al., 2014). 
Our study supports these findings, whilst reporting significant improvements in overall linkage to 
care since 2009 and 2014. 
The strength of this study is that we had a large sample of newly HIV positive diagnosed 
individuals in the cohort, enrolled from 16 different sites who were followed up for six months 
from the time of diagnosis. The project team used telephone calls to follow clients on their dates 
of next visit to the clinic. Use of phone calls may have been one of the factors that facilitated or 
enhanced linkage to care among the study participants.  
The study has some limitations: We were not able to see all clients during the study period, despite 
efforts to track them through telephone calls by the study team, CTC and community-based health 
care providers in their respective areas. It may be assumed that the clients might have moved to 
other places due to prevailing trade routes with extensive cross-border migration; however, our 
study was not able to ascertain the exact name of linkage site and linkage beyond the study sites. 
This warrants further investigation.  An additional limitation of our study is that the random 
selection of facility-based sites yielded a sample where all facilities had on-site care and treatment 
centres.  
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CONCLUSION 
Linkage to care is the bridge between HIV testing and treatment/care services for HIV positive 
individuals. In comparison with previous studies conducted in 2009, 2012, and 2014 in Tanzania, 
this study shows that significantly more newly diagnosed HIV positive individuals had linked to 
care within a short time of testing. We also found that linkage to care within 6 months of HIV 
testing was significantly higher from health facility-based HIV-testing sites compared to 
mobile/outreach sites. Finally, though of more modest clinical and population health significance, 
these individuals were linked into care significantly sooner, particularly at sites where same-day 
registration for care and treatment was possible. Individuals who had disclosed their HIV status to 
their partner and/or family members were more likely to link into care earlier than those who did 
not disclose to anyone.  Findings from this study suggest that although mobile/outreach service 
delivery models bring HIV testing services closer to people in remote and resource restrained 
areas, there is still a significant gap in timely linkage to HIV care compared to sites within 
established health facilities. Thus, strategies that are more effective are needed to further improve 
linkage through this model of service delivery, including increased attention to effectively 
communicating the importance of linkage to care even for people who do not feel sick. In addition, 
the availability of care and treatment at facility-based testing sites should be significantly increased 
from the current low levels of less than 21.7% of public facility-based testing sites offering 
treatment and care.   
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Abstract 
Background 
Like other countries, Tanzania instituted mobile and outreach testing approaches to address low 
HIV testing rates at health facilities. Our recently published cohort study found that clients testing 
at facility-based sites were more likely to link to care than those testing at mobile sites. This paper 
1) describes the populations accessing HIV testing at mobile/outreach and facility-based testing 
sites in hard-to-reach rural settings of Mbeya region, Tanzania, and 2) compares processes and 
dynamics from testing to linkage to care between these two testing models.  
 
Methods 
An explanatory sequential mixed-method study a) reviewed records of all clients (n=11,773) 
testing at 8 mobile and 8 facility-based testing sites over 6 months; b) reviewed guidelines; c) 
applied questionnaires at 0, 3 and 6 months to a cohort of 1,012 HIV newly-diagnosed clients from 
the 16 sites;  d) conducted focus group discussions (n=8) and in-depth qualitative interviews with 
cohort members (n=10) and health care providers (n=20);  e) observed HIV testing sites (n=10) 
and Care and Treatment Centers (CTCs) (n=8). 
 
Results 
More clients tested at mobile/outreach than facility-based sites (56% vs 44% of 11,733, p<0.001) 
and were more likely to be younger and male (p<0.001), but more tested HIV-positive at facility 
sites (21.5 % vs. 7.9% of 11,733, p<0.001). All sites in both testing models adhered to national 
HIV testing and care guidelines. Staff at mobile sites showed more proactive efforts to support 
linkage to care, and clients report favouring the confidentiality of mobile sites to avoid stigma. 
Clients testing at mobile/outreach sites faced longer delays and waiting times at treatment sites 
(CTCs).  
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Conclusions 
Rural mobile/outreach HIV testing sites reach more and different clients. However, despite more 
proactive care and confidentiality at mobile sites, clients who tested at facility-based sites were 
more likely to link to care sooner than those from mobile sites.  Our findings highlight a 
combination of a) patient-level factors, including stigma; and b) well-established procedures and 
routines for each step between testing and initiation of treatment in facility-based sites. Long 
waiting times at treatment sites are a further barrier that must be addressed. 
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Background 
In Tanzania, an estimated 1.5 million people were living with HIV in 2013, a 5.1% prevalence 
amongst the adult population (MOHsw, 2014; UNAIDS, 2014b). HIV testing and successful 
linkage of people with HIV into HIV care constitute important first steps in effective management 
of HIV/AIDS, and in reaching the 90-90-90 goal set by the WHO: 90% of people with HIV 
infection are diagnosed, 90% of those diagnosed start ART, and 90% of those taking ART achieve 
viral load suppression by 2020, and the goal of an AIDS-free world by 2030 (Haber et al., 2017; 
UNAIDS, 2014a) In the context of low levels of HIV testing in Tanzania (MOH, 2013; NACP, 
2012; Ostermann et al., 2011)   the government promoted out-of-facility-based testing services to 
complement health facility-based voluntary counselling and testing (VCT), which predominantly 
existed alone until the early 1990s (Kapologwe et al., 2011; Layer et al., 2014; Njau et al., 2014).  
The out-of-facility-based testing (referred to as the  “mobile/outreach testing model” in this study) 
currently recommended in the country includes home-based testing, workplace or school-based 
testing, and testing through mobile vans (Cawley et al., 2015; MOH, 2013; Njau et al., 2014). 
  
Linkage to care 
Regardless of how people get to know their HIV status, what is of primary importance is that those 
who test HIV-positive be successfully linked to HIV treatment and care for further medical care, 
psychological and social support (Hatcher et al., 2013; MOH, 2013). Linkage to care has been 
described as the process of assisting individuals with an HIV positive diagnosis to enter into HIV 
medical care, or the process of engaging newly-diagnosed HIV-infected persons into HIV primary 
care (Dombrowski, 2013; Philbin et al., 2015; Rio, 2011). It is a crucial step along the HIV 
continuum of care for better management and prognosis for HIV-positive individuals (S. Gerdts 
et al., 2014; Haber et al., 2015; Ulett et al., 2009). Linkage to care has been defined as attending 
at least one clinic appointment within 90 days following diagnosis (Bhatia & Giordano, 2011; 
Dombrowski, 2013). 
 
Other studies defined linkage to care as attending one or more clinic visit for HIV care within one 
to six months of diagnosis, or more than two visits within six to twelve months of diagnosis (Keller 
et al, 2013; Rio, 2011).In this study, we operationalized linkage to care as attending and completing 
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the first step of registration at the HIV care clinic and receiving an HIV care and treatment card 
within the first six months after diagnosis (Keller et al., 2013; Rosen & Fox, 2011). Studies 
conducted in South Africa reported 52.5% and 62.1% clients being linked to care within three 
months of diagnosis  (Govindasamy et al., 2011; Naik et al., 2015) respectively. In Tanzania, a 
study conducted in Kisesa, a rural area in Mwanza region, showed a linkage of 14% at four months 
after HIV diagnosis (Nsigaye et al., 2009).  
 
Tanzania’s national HIV testing and counselling guidelines (2013) stipulate that after completion 
of HIV testing, all HIV-positive individuals should be linked to receive appropriate care and 
treatment care services at designated care and treatment centres (CTCs)(MOH, 2013; NACP, 
2012). To this end, all HIV testing sites in Tanzania are expected to establish referral links to these 
centres (MOH, 2013; NACP, 2012). However, it has been reported that while mobile/outreach 
HIV testing and counselling (HTC) models are now widely used in Africa, the rates of linkage to 
care and initiation of antiretroviral therapy (ART) are often low (Bassett et al., 2014; Hatcher et 
al., 2013; Labhardt et al., 2016). In Tanzania, like other sub-Saharan African countries, poor 
referral systems, distance and transport costs, poor clinic organization, and inadequate resources 
pose continuing challenges to linkage to care (Layer et al., 2014; Nsigaye et al., 2009; Simmelink, 
2014). In addition, the clients receiving testing at mobile sites may differ from those testing at 
facilities. We recently reported a two-armed cohort study which found that clients testing at 
facility-based sites were more likely to link to care than those testing at mobile/outreach sites (E.S. 
Sanga et al., 2017) This paper seeks to understand this outcome.  
 
This paper’s two objectives are 1) to describe the populations accessing HIV testing at 
mobile/outreach and fixed/facility-based testing sites in hard-to-reach rural settings of Mbeya 
region, Tanzania, and 2) to compare processes and dynamics from testing to linkage to care 
between these two testing models. 
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Methods 
This was an explanatory sequential mixed-method study, where qualitative methods were used to 
complement the quantitative results (Creswell, 2015) in a process evaluation approach (Hulscher 
et al., 2003), which helped us to (1) compare the populations accessing the two models of testing; 
(2) describe the linkage to care models; and (2) explore and compare the actual practices by staff 
and intended users (Hulscher et al., 2003), in order to shed light on the primary outcomes of the 
cohort study (rates and timelines of linkage to care between the two models) (Sanga et al., 2017). 
The study reviewed guidelines and records (register books and reports) at 16 mobile and fixed 
facilities (8+8), to complement a two-armed cohort study of 1,012 newly-diagnosed HIV-positive 
individuals recruited from these same sites and interviewed with structured questionnaires on HIV 
testing and linkage to care at 0, 3 and 6 months after diagnosis. We also observed selected sites 
and conducted eight focus group discussions and ten in-depth interviews with newly HIV 
diagnosed individuals enrolled in the cohort study, and individual interviews with health care 
providers (n=20) working at either HIV testing units or CTCs. This paper reports on analyses of 
additional data from the cohort study to interpret findings previously reported (Sanga et al., 2017)  
and adds new data on populations accessing the two models of HIV testing and on processes and 
dynamics of linkage to care. Figure 1 outlines the methods for the objectives reported here.  
 
Sampling 
Multiple sampling techniques were applied to select the study sites and respondents from four 
districts in Mbeya region, Southern Tanzania.  Districts were purposively selected to represent 
hard-to-reach populations, including two districts on the highway to Malawi and Zambia, and two 
remote districts. A total of 16 study sites were randomly selected out of 108 sites offering HIV 
testing services in the four study districts using a random table. These included two facility-based 
and two mobile/outreach testing sites in each district. Though only a minority of health facilities 
in the region offer Care and Treatment services, all facility-based sites randomly selected for this 
study were in facilities which also had CTCs.    
 
We reviewed records for all individuals receiving HIV testing services at the study sites between 
August 2014 and July 2015 (n=11,733). Respondents for qualitative interviews were purposively 
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selected from the main cohort of adults above 18 years receiving HIV positive testing at the 
selected facility-based and mobile/outreach sites. Details of cohort construction and recruitment 
have been reported elsewhere (Sanga et al., 2017). 
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Figure 1: Methods framework 
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against conceptual framework of client, provider, 
health system and contextual levels 
Quantitative 
Data from prospective 2-
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the study sites over the 
study period)  
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Qualitative 
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health care providers (n= 1-2 
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The study enrolled 1012 participants evenly divided across the two arms of the study (testing at 
mobile/outreach vs facility-based HIV testing sites). Cohort retention at 6 months was 83% 
overall, 87% in the facility-based testing arm and 76% in the mobile/outreach-testing arm.  Health 
workers were purposively selected to include nurse counsellors at HIV testing sites, nurse 
counsellors and doctors at the care and treatment centre, and in three sites we interviewed the site 
managers. One day of structured non-participant observation was done by the lead investigator 
(ESS) at each of the study sites indicated in Table 1, with an assistant at some sites, taking notes 
of all ongoing activities related to either HIV testing or HIV care. In addition, about 32 hours were 
spent at eight care and treatment centres observing actual registration and linkage to care activities. 
The researcher and the assistant compared and compiled their respective notes and observation 
guides after each day of observation. 
 
Data Collection Procedures 
We recruited cohort participants between August and December 2014, and follow-up 
questionnaire administration continued until July 2015. Participant enrollment was done at the 
selected study sites with the assistance of the nurse counsellors who introduced the research team 
to clients during health education sessions. The research team explained the study briefly, and 
interested individuals were invited to a private room for detailed explanation, informed consent 
and agreement at a convenient time for questionnaire administration. Data were collected by 
research assistants who underwent a two-day training on protocol, informed consent, and data 
collection procedures. Data collection tools were pretested in two sites not selected for this study. 
 
We administered questionnaires  and reviewed documents records or registers in all 16 selected 
study sites, while site observation/field notes, health care providers in-depth individual interviews 
(IDI), client in-depth individual interviews, and focus group discussions (FGDs) were conducted 
in some of the sites, as shown in the table below (Table 1). Qualitative interviews and FGDs were 
conducted in Swahili by the lead investigator (ESS), assisted by four trained research assistants.  
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Table 4: Research sites and data collection methods  
Districts Type of Site IDI-HCP Observation/ 
Field- Notes 
IDI-Client FGDs 
Facility-based sites   
Kyela Kyela Hospital x x X  
 Ipinda Health Centre x x X X 
Mbozi Vwawa Hospital x x   
 Tunduma health 
Centre 
x x X X 
Mbeya Rural Ifisi Hospital x x X X 
 Inyala health centre x x   
Chunya Chunya hospital x x X X 
- Makongolosi 
Dispensary 
x x   
Mobile/outreach sites   
Kyela ST JOHN HUS-Kyela x x X X 
 MMRC mobile- Kyela x x X  
Mbozi SHDEPHA - Mpemba x x X  
 MMRC Mobile-Mbozi x   X 
Mbeya Rural KIHUMBE- Mbalizi x x X X 
 MMRC mobile- Mbeya 
Rural 
x    
Chunya KIHUMBE- Chunya x x X X 
 MMRC- Mobile- 
Chunya 
x x X X 
 
 
Data Analysis 
Quantitative data from sites were recorded, cleaned and analyzed using Stata Version 13 (College 
Station Texas, USA). Descriptive analysis methods were used to present the characteristics of 
participants (frequencies and percentage for categorical data, measures of central tendency, and 
dispersion). Cross-tabulation was used to show the distribution of study subjects by the testing site 
where we had multiple possible categories. Statistical significance was declared at p-values less 
than 0.05. 
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Qualitative data were audio recorded and transcribed verbatim in Swahili. The transcripts were 
translated by two professional translators to English, and each transcript was checked by the first 
author. The transcripts were analyzed using Atlas.ti version 7, a qualitative data management 
software (Friese, 2013). The data were analyzed by ESS and FCM using the thematic content 
analysis approach (Miles & Huberman, 1994). We employed the following steps: (1) free coded 
the data; (2) identified themes and subthemes; and (3) selected themes that are important for this 
study. 
 
Our conceptual framework was developed on the basis of existing frameworks and literature on 
access to care, the conceptual framework included individual, provider, health system and 
contextual factors (Govindasamy et al., 2012; Hatcher et al., 2013; Hodgson et al., 2014; Rosen & 
Fox, 2011). We also compared the observed and reported HIV testing and linkage to care processes 
against the Tanzanian national guidelines (MOH, 2013; MOHsw, 2015).  
 
Rigour and Trustworthiness 
To enhance rigour and trustworthiness, we used multiple HIV testing sites and triangulated three 
different data collectionn methods with a variety of respondents after piloting, as described above. 
Research assistants underwent an intensive training for quality assurance. Data analysis was 
conducted by two of the authors and crosschecked by the last author. Finally,  we followed 
guidelines for reporting qualitative research (Tong et al., 2007).  
  
Ethical considerations 
The study received ethical clearance from The University of Western Cape (UWC) Senate 
Research Committee, the Mbeya Medical Research Centre, the Mbeya Medical Research Ethics 
Committee (MMREC), the National Health Research Ethics Sub-Committee (NatHREC), under 
the Tanzanian National Institute for Medical Research (NIMR). Prior to data collection at each 
clinic, the research team briefed the nurse counsellors about the study objectives and procedures. 
Interested individuals were invited to a private room for detailed explanation, informed consent 
process, and agreement on a convenient time and place for the questionnaire to take place. 
Participation in the study was voluntary, and it was explained to participants that they were free to 
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withdraw from the study at any time without negative consequences. Volunteers were provided 
with an information sheet containing all details about the study. They signed an informed consent 
form, and confidentiality procedures and anonymity were observed. 
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Results 
We first compare the overall client base of the sites comprising the two testing models (Table 2). 
Next, we compare the two models in terms of the processes and dynamics from HIV testing to 
linkage into care, subsequently analyzing each approach with regard to the individual, healthcare 
provider, health system, and contextual levels.  
 
 
I  Description of individuals tested for HIV at the facility-based and mobile/outreach 
sites during the study period 
We reviewed registers from the 16 study sites to collect information related to individuals 
attending the sites for HIV testing services, and a total of 11733 individuals received HIV testing 
services during the study period out of 166,556 individuals who received HIV testing services in 
the Mbeya region. More people tested at the mobile/outreach sites than facility-based sites (56% 
vs 44%, p<0.001). The report for Mbeya regional AIDS program reported a proportion of 66.4% 
testing at the mobile/outreach sites and 33.6% testing at the facility based in 2014.  More women 
(55%) attended HIV testing services than men; and mean age was 33 years, with most clients being 
married and self-employed in small-scale businesses. Table 2 describes the characteristics of the 
clients testing in the two models. Chi-Square test showed statistically significant differences in 
patients’ characteristics between facility-based and mobile testing sites, notably that clients testing 
at mobile/outreach sites were slightly younger (p<0.001) and more likely to be male (p<0.001). 
We were unable to determine how many clients were linked into care because the registers are 
filled in immediately after testing and counselling and contained no information on linkage status. 
However, site staff at all sites reported verbally that all clients tested positive were provided with 
a referral form to bring to the CTC of their choice. It was also noted that the referral form has a 
section at the end of the form that was supposed to be cut off by the nurse at the CTC and brought 
back to the HIV testing section for feedback to the counsellor, but in most sites there was no 
evidence that these had been brought back to the HIV testing section. It was from this group of 
11,733 individuals who came for HIV testing that the cohort of 1,012 newly HIV diagnosed 
participants were recruited. 
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Table 2: Characteristics of clients tested at facility vs. mobile/outreach sites over the period 
of six months (N=11733) 
Variable Facility-based  
(n = 5 234) 
Mobile 
(n= 6 539) 
p value 
 
Age 
    <25 yrs. 
    25-39 yrs. 
    40-59 yrs. 
   >60yrs 
 
1395 (26.7) 
2389 (45.6) 
1147 (21.9) 
303 (5.8) 
 
2045 (31.3) 
2756 (42.2) 
1360 (20.8) 
378 (5.7) 
 
P<0.001 
Gender 
     Male 
     Female 
 
2261 (43.2) 
2973 (56.8) 
 
3066 (46.9) 
3473 (53.1) 
 
P<0.001 
Marital Status 
Single 
Married 
Separated 
Divorced 
Widow 
 
1363(26.1) 
3107(59.6) 
379(7.3) 
34(0.7) 
331(6.4) 
 
2063(31.6) 
3787(57.9) 
289(4.4) 
87(1.3) 
308(4.7) 
 
P<0.001 
Education 
None 
Primary 
Secondary 
Post-Secondary 
 
160(3.7) 
3784(88.1) 
304(7.1) 
45(1.1) 
 
561(8.8) 
4944(77.6) 
700(10.9) 
165(2.6) 
 
P<0.001 
Occupation 
Unemployed 
Employed 
Self Employed 
Student 
 
 
125(2.9) 
78(1.8) 
3946(92.1) 
138(3.2) 
 
 
91(1.4) 
173(2.7) 
5882(92.3) 
228(3.6) 
 
 
P<0.001 
Ever tested HIV 
No 
Yes 
 
 
3064(58.5) 
2170(41.5) 
 
3236(49.5) 
3303(50.5) 
 
P<0.001 
Results 
Negative 
Positive 
 
4111(78.5) 
1123(21.5) 
 
6023(92.1) 
516(7.9) 
 
P<0.001 
To whom planned to disclose 
Spouse/Partner 
Relatives 
Others 
No Plan to Disclose 
 
2758(52.7) 
2291(43.8) 
153(2.9) 
32(0.6) 
 
3540(54.1) 
2572(39.3) 
411(6.3) 
16(0.3) 
 
P<0.001 
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II. Mobile (Outreach) HIV testing model 
Mobile sites refer to HIV testing services outside of regular health facilities. In this study, they 
included stand-alone single-purpose, HIV testing sites operating under different NGOs such as 
Walter Reed Program, Mbeya Medical Research centre, USAID, PACT Tanzania, SHDEPHA 
Mbeya HIV network, KIHUMBE, and Faith-Based Organization such as the Anglican and 
Moravian missions. The mobile/outreach teams move from one place to another in the community 
or work in venues outside of public sector healthcare facilities. 
 
The mobile or outreach HIV testing services include but are not limited to: campaigns; mobile 
testing clinics using cars or tents; home visits; and workplace, school or special event testing 
services like World AIDS Day. Most of the mobile/outreach testing sites are coordinated by Non-
Governmental Organizations that work in collaboration with the Mbeya Regional Medical Office 
and the Ministry of Health. All mobile/outreach sites included in the study were working under 
NGOs and were funded by different organizations, such as the Henry Jackson Foundation through 
Walter Reed program, USAID, the European & Developing Countries Clinical Trials Partnership 
(EDCTP) and church organizations. All eight mobile sites had register books for individuals 
coming for HIV testing, as well as monthly and annual reports in place. The mobile/outreach 
testing sites had more complete records of the clients attending care in their sites compared to 
public facility based sites.  
 
Processes and procedures at the mobile/outreach sites 
Our observations and respondent reports revealed that all mobile/outreach sites offer HIV testing, 
and then refer HIV-positive clients (with a referral letter) to the nearby CTCs for further care. One 
mobile site from the Mbeya Medical Research Centre offers CD4 testing and HIV staging in 
addition to HIV testing, then refers the HIV-positive individuals to the nearest CTC. In some of 
the mobile sites, we observed the care providers assisting the newly-diagnosed client’s link into 
care by escorting them to the CTCs, or by visiting them at home to encourage them to seek HIV 
care services. 
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We observed larger numbers of individuals waiting for HIV testing before opening hours in the 
outreach services compared to the number of clients at the facility-based services. During focus 
group discussions and individual interviews, when asked the reason for choosing the outreach site 
for HIV testing, a significant number of respondents reported that they heard announcements when 
passing by, or they saw the HIV testing truck parking and, seeing many people around, they came 
and decided to test. Ten clients said they feel more comfortable testing at the mobile site for 
confidentiality reasons because the service providers in the mobile teams do not come from their 
community:  
I have always been scared to test for HIV for a long time, when I heard that there are 
specialists from Mbeya town offering free HIV test and other tests. I said let me go and test 
because no one knows me in that team so even if I am positive nobody in this community will 
know that I have this [HIV] problem [Female 30 yrs.]. 
Some participants responded that the entertainment taking place during outreach services and 
campaigns are what motivated them to come closer, and then they decided to test for HIV.  
In the focus group discussions about processes of linkage to care, some clients who tested at the 
mobile sites expressed their wish that the mobile/outreach site could also offer ART, instead of 
referring them to the facility-based sites: 
The nurse gave me a letter, she said I should come to ... hospital for CD4 test probably I will 
need ART since I was very weak, the day we went to the hospital there were so many people 
and the queue was long, I said if KIHUMBE (the site where she tested) was also providing 
medication (ART) it would have saved me from this distress [FGD5]. 
In the mobile/outreach testing sites, the number of clients would vary depending on the type of 
activity. For example, at an HIV testing campaign or special events like World AIDS Day, where 
normally there are advertisements and car announcements and posters inviting people to come to 
receive free HIV testing, up to 200 people are testing for HIV daily. At these events, there are 2-6 
nurse-counsellors, 1-2 doctors and 2-4 other support staff, including recorders, HIV health 
educators, and drivers. However, when these sites conduct HIV testing at their office (stand-alone 
VCT site) or on home visits, the number of clients was 20-60 per day, with 2-4 staff on duty. Of 
the 405 study participants who tested at the mobile sites, 69% (95%CI 0.65% to 0.74%) 
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successfully linked to HIV treatment and care in a qualified CTC within 6 months (Sanga et al., 
2017).  
 
III. Facility-based HIV testing model 
In this study “facility-based sites” refers to fixed or static facilities within the public or mission 
health sector, like hospitals, health centres, or dispensaries where individuals walk in for HIV 
testing, or where they came for other illnesses but the care providers advise them to take an HIV 
test as well. Although only 21% of facilities in Mbeya qualify as CTC’s, all eight randomly 
selected facility-based sites had HIV testing services and CTCs within the campus. 
 
Processes and procedures at the facility-based site 
The eight facility-based sites in this study had an HIV testing section/unit, and a physically 
separate HIV care section (CTC) within the same campus. Therefore, clients testing HIV positive 
in these sites also had to be linked to a care and treatment centre for further HIV care services, 
with a referral letter that had to be taken to the nurse at the CTC section, where the client will 
register into care. Normally the clients go to the CTC on their own unless there is a situation that 
needs to be explained to the CTC care provider. For example, if the person is not from the area 
(was visiting family or friend), they should enter care in their home area, but if they currently have 
a medical condition that needs doctor’s attention, the HIV testing nurse can escort the client to the 
CTC. At that point, s/he will be given a card with their CTC number that can be linked to the 
client’s file that is stored at the clinic. 
 
The sites had register books for individuals coming for HIV testing or/and coming for entry into 
HIV care (registration at CTC). However, some sites had incomplete documentation, with missing 
information about individuals attending HIV testing and HIV care in the register books. 
 
Qualitative interviews revealed that some of the individuals who tested at the facilities did not plan 
in advance to be tested. For instance, they went to the clinics because they felt unwell and as part 
of the screening and diagnosis, the health care providers suggested an HIV test. Other clients had 
been referred from lower-level facilities, like dispensaries, for further management at the higher-
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level facilities, and through PITC they were advised to take an HIV test. Similarly, clients who 
were admitted to the facility for other illnesses got an HIV test as part of management. PITC is 
done at the outpatient department as well as in the patient’s wards, although nurses in the ward 
may refer the patient to the HIV testing section if the ward does not have a qualified HIV 
counsellor. 
 
Linkage to care 
With regard to linking HIV positive individuals to care, when an individual tests HIV positive, 
s/he is provided with a referral letter/form. At the designated CTC, generally in another part of 
the facility, the client hands the referral letters obtained from the testing sites to the nurse 
responsible for registering newly-diagnosed HIV-positive individuals. The individuals’ details 
are recorded in a register, and the individuals are provided with a clinic card (CTC-card) 
detailing their personal information and clinic appointment visits. They have to bring this card 
every time they attend their clinic or go to any HIV care clinic in the country. The whole 
procedure of registration takes between 1- 3 hours including waiting time. When this process is 
complete, the individual is considered to have entered or linked to HIV care. By the end of the 
study, linkage to care analysis showed that 84% (95% CI 81% to 87%) of participants tested at 
the facility-based testing sites were linked into care within the first 6 months of HIV diagnosis, 
significantly higher than the 69% linked from the mobile sites (p<0.001) (Sanga et al., 2017). 
 
With the individual successfully linked to care, they are sent to a clinician for HIV staging, a 
prescription for CD4 count test, and TB screening (clinicians include medical doctors, assistant 
medical officers, and clinical officers, all of whom can prescribe or write laboratory requisition in 
Tanzania). In some sites, the client goes straight to CD4 testing if the services are available on the 
same day. However, most clinics only do a CD4 test on selected days of the week, meaning that if 
their doctor consultations fall on a day that the CD4 testing services are unavailable, the clients 
are told to return on a day the services are available. Clients who had tested at the research mobile 
laboratory which included CD4 count testing did not have to repeat a CD4 count; the doctors 
would make care decisions based on the result the client brought from the testing site. In most 
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cases, CD4 results were available within 3-7 days and clients had to return to the CTC for these 
results and proceed to the next step: the decision over whether to be started on ART or not. 
 
Every HIV-positive individual is required to attend treatment adherence sessions for at least three 
days. In some of the sites, the individual could have the adherence sessions while awaiting their 
lab results. At certain sites, these adherence-counselling sessions are organized for three 
consecutive days, while at other treatment centres, the adherence counselling sessions are done on 
the same day each week for three consecutive weeks.   
 
When the CD4 test results are received from the laboratory, the clinician makes the decision of 
whether or not to start the individual on ART.  If the individual has a CD4 count of less than 350 
cells, they are initiated on ART. 350 was the cut-off point during the time of data collection; 
however, recently there has been a circular from the Ministry of Health on HIV treatment, 
implementing the ‘Test and treat’ approach, regardless of the CD4 count. The process for the ART-
eligible clients to be initiated from the day of registration takes between one and three weeks. By 
the end of the study, 793 (78%) of the participants were enrolled in CTCs. Among those who were 
linked into care, 77% were initiated on ART. Participants tested in the facility-based sites were 
initiated on ART faster than those tested in the mobile site. In the first week since registration, 27 
(39%) of those tested in a facility were on ART, compared to 19 (37%) tested in mobile sites. The 
majority of participants (92%) attended between 3-5 clinic visits/appointments before starting 
ART (Table 3).   
 
With a CD4 count above 350, individuals were not eligible for ART at the time of this study, 
unless they had other conditions like TB, or were in HIV stage III and IV. Non-eligible individuals 
were given an appointment to return after three months, for continuous follow-up and checking of 
ART eligibility. In some facilities, it is highly recommended that each individual should share 
their status with a significant other (relative or a friend) to have them as a treatment supporter 
(accompagnateur). In other sites, this recommendation was not strongly emphasized. Finally, the 
individual is sent to the pharmacy for their medication to be dispensed. After receiving the 
medication, the individual returns to the nurse at the registration desk to get the date of their next 
appointment (Figure 2).  
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Figure 2: A diagrammatic illustration of the linkage to care process  
 
Estimated number of clients and staff at the CTC per day 
The number of clients at the CTC was high in all sites that offered HIV care and treatment services: 
between 60 - 120 clients per day in most sites, and more in some sites on some days. In the facility-
based sites, the HIV testing sections did not have long queues of people waiting for services. Most 
of the facilities tested about 10-30 clients per day. In most facility-based testing sites, there were 
one or two nurse counsellors at the HIV testing station. In all facilities, the section of care and 
treatment services had 2-6 Nurses, 1-3 Doctors and 2-5 other cadres like lab technicians, 
pharmacist, recorder etc. Some sites also had Home Based Carers (HBCs) or stable patients in 
ART known as treatment experts, who were assisting with giving health education on treatment 
adherence or organizing patients’ files. In the health centres and dispensaries, we observed 50-100 
clients in the waiting area. These clients are expected to be seen by 2-3 nurses and 1-2 doctors. For 
this reason, the waiting times at the waiting areas could extend to six hours. This was also reported 
by health care providers and clients during the in-depth interviews.   
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Whilst the actual services provided at CTCs are the same regardless of where the client tested, 
clients coming from mobile/outreach sites experienced more delays at several stages, reflecting 
the additional challenges of travelling to a new facility with unfamiliar schedules. Table 3 
summarizes the processes and timelines at CTCs, comparing clients diagnosed at facility-based 
and mobile sites, whilst Table 4 summarizes the similarities and differences between the two 
models of testing.  
 
Table: 3. Process/procedures and timelines for a newly diagnosed client at the CTC 
Variables Total Facility-based Mobile Chi-square 
P value 
 N (%) N (%) N (%)  
Time to complete Registration and other procedure on the first day 
< 1 hour 
1-3 hours 
3-5 hours 
> 5 hours 
NA 
 
5(0.6) 
388(48.9) 
334(42.12) 
54(6.8) 
12(1.5) 
 
3(0.59) 
291(56.8) 
201(39.26) 
12(2.34) 
5(0.98) 
 
2(0.71) 
97(34.5) 
133(47.33) 
42(14.95) 
7 (2.49) 
 
P<0.001 
Give Blood for CD4 count on same day as registration 
Yes 
No 
NA 
 
455(57.4) 
326(41.1) 
12(1.5) 
 
278(54.3) 
229(44.7 
5(0.98) 
 
177(62.9) 
97(34.5) 
7(2.49) 
 
0.006 
Time takes to receive CD4 results 
Same day 
2-7 days 
8-14 days 
NA 
 
13(1.6) 
742(93.6) 
26(3.28) 
12(1.5) 
 
11(2.2) 
479(93.55) 
17(3.32) 
5(0.98) 
 
2(0.7) 
263(93.59) 
9(3.2) 
7(2.49) 
 
0.18 
Started ART 
Yes 
No 
 
613(77.3) 
180(22.7) 
 
402(78.5) 
110(21.5) 
 
211(75.1) 
70(24.9) 
 
0.28 
How regularly do you check CD4 
Every 3 months 
Every 6 months 
 
495(69.4) 
298(32.6) 
 
345(67.4) 
167(32.6) 
 
150(53.4) 
131(46.6) 
 
P<0.001 
Time it takes to start ART from registration 
1-7 Days 
8-14 Days 
15-30 Days 
30-90 Days 
>90 Days 
 
234(38.2) 
234(38.2) 
93(15.2) 
39(6.4) 
13(2.1) 
 
157(39.1) 
174(43.3) 
43(10.7) 
23(5.7) 
5(1.2) 
 
77(36.5) 
60(28.4) 
50(23.7) 
16(7.6) 
8(3.8) 
 
P<0.001 
Visit before starting ART 
1-2 visits 
3-5 visits 
6-10 visits 
 
38(6.8) 
519(92.4) 
5(0.9) 
 
13(3.5) 
363(96.3) 
1(0.3) 
 
25(13.5) 
156(84.3) 
4(2.2) 
 
P<0.001 
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Table 4: Summary of Similarities and differences in facility-based and mobile/outreach 
sites 
 Facility-based site Mobile/outreach sites 
General  
Study working definitions  Facility-based testing sites: fixed or static facilities within 
the public or mission health sector (e.g. hospitals, health 
centres or dispensaries) where individuals walk in for HIV 
testing or other health care services. 
Outreach HIV testing sites include but are not limited to 
mobile testing clinics using cars or tents, home visits, 
workplaces, schools, campaigns or special event testing 
services like World AIDS Day.  
Most mobile /outreach testing sites are operating under 
Non-Governmental Organizations.  
Funders Government facilities Non-Governmental organizations/sponsors 
Client/individual level 
 
Reason for testing at a particular 
site 
 Coming voluntarily for HIV test, or 
 
 Coming for medical care and HIV test 
suggested by staff (PITC), or 
 
 referred from lower level facilities, or 
 
 admitted to the ward and then advised to take 
a test. 
 
 People come for HIV testing because they were 
passing by and saw the tents of track and decide 
to test, or 
 
 Heard the public announcement for free 
services in their area, or  
 
 Coming voluntarily for HIV test because HIV 
testing services were brought closer to where 
they live. 
  
Number of clients tested  during 
the study period 
5234 with 21.5% diagnosed HIV positive. 6539 with 7.9% diagnosed HIV positive. 
 
Health care provider level 
 
Human resource or types of staff 
available 
Nurses: 1-2 in VCT  
Nurses 2-5 at CTC 
Doctors 1-2 doctors at CTC 
 
Other staff- lab technician, pharmacy, and recorders 1-4 
 
Nurse counsellors 3-6 
 
Home-based carers 1-2 
Doctors only at the research mobile 
 
Mobile sites normally have more counsellors, home-
based care (HBCs), and peer health educators; they only 
have doctors in special events 
Client Follow up  PITC actively implemented but no active post-
test follow-up of clients.  
 Some minimal follow-up for clients who are 
initiated on ART by treatment experts (in 
facilities where they exist) to ensure that they 
do not stop treatment. 
 KIHUMBE, SHDEPHA, and St John Hus sites 
follow up their HIV positive clients through 
the Home-based care workers who are paid 
by the organization.  
 
 HBCs sometimes assist clients with the 
linkage to care process and conduct home 
visits for support and follow up.  
 
 HBC provides the numbers of the clients who 
are lost to follow-up to the site manager who 
compiles and writes an annual report for loss 
to follow-up and sends reports to the regional 
office 
System level 
 
HIV testing and HIV care activities  The sites offer HIV testing and HIV care services 
 
Clients come from home following services at the health 
facility. 
 
Clients may come to the site for another sickness, and the 
healthcare provider may advise the person to test for HIV  
The sites offer HIV testing and refer the clients to facility-
based CTCs for HIV care services 
 
Conducts mobile/outreach HIV testing, moves from one 
place to another following people in the community or 
their homes  
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Some of the mobile sites (e.g. KIHUMBE) also conduct HIV 
test in some of their offices in fixed buildings 
 
During special events and campaigns, music and dancing 
groups entertaining people are standard 
HIV testing place/venue 
 
Fixed buildings like hospitals, health centres or 
dispensaries (at the HIV testing and CTC section) 
 
In one facility, there was a television set at the CTC clinic 
clients were watching while waiting for services 
Mobile cars/vans,  
Fixed buildings/clinics 
Open areas/grounds 
Tents 
 
Functioning tools/equipment and 
guidelines 
Register books 
Reports 
Referral form/letter 
Patient files 
Laboratory services available 
 
Guidelines - HIV testing guidelines were not available at 
the site, but most staff reported being trained on the 
current guidelines 
Register books 
Reports 
Referral forms 
Clients tracing forms for HBCs 
No laboratory services except for the research mobile 
HIV testing guidelines were not available at the site, but 
most staff reported being trained on the current guidelines 
Record keeping Register books and monthly reports in some sites were 
incomplete 
All register books and monthly reports were well kept 
and complete 
Information available  Health education on HIV and HIV treatment adherence 
sessions 
 
Posters related to HIV diseases fixed in waiting areas 
 
Advertisements of services by local radio stations. 
Car announcement/public announcements 
Campaigns 
Flyers with HIV information distributed to community 
members 
Community mobilization and invitation for free HIV 
testing 
Testing algorithms Use of Determine TM as primary test if reactive Uni-gold 
is used for confirmation,  
However, Elisa test can be done  if necessity arises 
 
Use of Determine TM as a primary test if reactive Uni-
gold is used for confirmation. 
 
If necessary, they refer clients for Elisa at the nearby 
hospital or ask the participants to come again after two 
weeks for re-testing 
Referral procedure for HIV 
positive clients. 
 
Same referral forms are used at 
the facility-based and mobile sites 
Provide referral form to the CTC within the facility. Provide the referral letter/form and advise the client to 
link at the facility of their choice. 
Contextual level 
Availability of HIV testing and 
HIV care services 
HIV testing services availability is better compared to 
availability of HIV care service.  
In most of the sites (including dispensaries) HIV testing is 
done, although the distance was still a challenge especially 
in Chunya and Mbeya rural districts.   
 
HIV testing services are brought closer to clients’ homes, 
however, the challenge was to get care and treatment 
services. 
In some cases, clients needed money for transport to 
reach a site where they can receive care. 
 
 
 
 
Discussion  
This study sought to describe and compare the processes and dynamics of HIV testing and linkage 
to care among newly-diagnosed individuals testing either at the facility-based or mobile/outreach 
sites in rural settings of Mbeya, Tanzania. We have described the procedures of linkage and the 
roles of various actors including patients, providers, and clinic organization in arriving at 
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successful linkage to care, in relation to national guidelines. The study also compared the 
populations accessing HIV testing at mobile/outreach versus fixed/facility-based testing sites in 
rural settings of Mbeya. Identification of characteristics of people, strengths and weaknesses in 
each model, and the capacities of the overall health system will help strengthen  provision of 
universal testing and linkage to care for HIV-positive individuals (Govindasamy et al., 2011; 
Hatcher et al., 2013; Njau et al., 2014; Ostermann et al., 2011). 
 
HIV testing and management guidelines 
Both mobile and facility-based HIV testing sites and HIV CTCs attended to the clients in 
accordance with the National guidelines for HIV testing and HIV management. Although most 
sites did not have the paper guidelines in place, the staff were trained in and understood their 
responsibilities with regard to HIV testing and HIV care services. After HIV-positive diagnosis 
and post-test counselling, the care providers explained the available options for further care and 
provided the clients with referral letters. The difference was seen in the HIV testing sites: the 
mobile sites were actively following people up in their homes, and HIV testing was done out of 
hospital premises, with some activities that attracted more people to come for testing, while at the 
facility-based sites testing was passive and sometimes by PITC approach. Processes and 
procedures in the HIV care section were similar for all clients regardless of where they had tested, 
although those tested at the MMRC mobile site did not have to re-check their CD4 count test. At 
the CTC, the processes and procedures corresponded to what is reported in other studies (Genberg 
et al., 2015; Gerdts et al., 2014; Haber et al., 2015). 
 
Shortage of healthcare workers in HIV care and treatment centres 
The improved linkage to care found in our study compared to earlier research in Tanzania are 
highly encouraging, but staff shortages pose a significant challenge. We noted overcrowding and 
long waiting periods at the CTC, representing a further barrier to linkage to care to those clients 
who did follow up after a positive HIV test result and tried to register at a CTC. In Tanzania, only 
52% of the government-identified required numbers of health workers are actually available in the 
health sector, a situation now considered a national crisis requiring continuous and collaborative 
attention (MOHsw, 2014). 
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Health worker density in Tanzania ranges from 4/10,000 population to 10/10,000 population 
(MOHsw, 2014). All of the HIV CTCs included in this study had many clients while the number 
of staff was low, causing HIV-positive individuals to spend a long time at the clinic waiting for 
services. This is likely to affect the engagement and retention of patients in HIV care, as reported 
in other studies (Labhardt et al., 2014; Layer et al., 2014; Wachira et al., 2014). This is particularly 
challenging for remote areas like the study site, as most of the staff prefer to work in urban areas 
rather than rural areas with poor working and living environments. Plans are underway to increase 
the number and capacity of health and social welfare workers at all levels and areas of the country 
by 2018, and to reduce the shortage of staff from 52% in 2014 to 30% in 2019 (MOHsw, 2014). 
 
Choosing where to test 
The study supports findings reported elsewhere that outreach testing methods are effective in 
improving the uptake of HIV testing, but linkage to care after testing positive is lower in the 
outreach testing approaches (Bassett et al., 2014; Hatcher et al., 2013). This study found that more 
people tested at the mobile/outreach sites compared to the facility-based sites. The significantly 
lower rates of positive HIV test results in this population suggests that most people may be hoping 
for and expecting confirmation that they are HIV negative. In contrast to both the higher HIV rates 
and the respondent reporting that they went for HIV testing at the facility based site because they 
were sick. In the mobile sites, services are provided by care providers who are not from within the 
community, meaning that people feel their results will remain confidential. This is likely 
particularly important for individuals who fear that they may learn that they have a positive test 
result. However, the problem for linkage to care occurs when the client is asked to go for HIV care 
at the same clinic they were initially avoiding for the testing, echoing similar findings  and reasons 
for choosing testing at outreach services reported in other studies conducted in sub-Saharan 
African countries (Bassett et al., 2015;Meehan et al., 2015; MRACP, 2012). 
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Dynamics of HIV testing and linkage to care 
The study revealed that different factors at the individual, provider, health system and contextual 
levels may influence the individual’s decision for testing, choices of testing site, and ultimately 
linkage to care and initiation of ART. More people tested at the mobile facilities than the facility-
based sites, but HIV-positive results were more likely in the facility-based testing group. This 
finding supports the results of our cohort study, where many participants said they went to the 
facility–based site because they were sick (Sanga et al., 2017). It also reflects the impact of well-
implemented PITC.  Of note is that nearly all records (over 99%) in both models of testing 
indicated that clients reported a specific intention to disclose their HIV status. In our cohort study, 
a markedly smaller proportion (83.5%) reported disclosing their status to someone and status 
disclosure was found to be a significant factor associated with increased likelihood of linkage to 
care (Sanga et al., 2017). 
At the system or program level, this study reveals some of the tradeoffs between policy objectives 
of maximizing testing versus maximizing linkage to care. Health systems research suggests that 
processes from HIV testing to linkage into HIV care may be different in health facility-based and 
outreach testing models, especially with respect to active referral to help individuals diagnosed 
with HIV to gain access to treatment and care services(Stuart, Harkins, & Wigley, 2005). This 
study found that while mobile and outreach sites do indeed reach more people and actively try to 
facilitate linkage to care after an HIV positive test result more than facility-based sites do, the rates 
and timeliness of actual linkage to care are longer than for those testing at facility-based sites. This 
is the case despite the additional access barrier posed by overcrowding and long waiting times 
once clients arrive at CTCs to attempt to link to care. The mobile/outreach sites were not offering 
HIV care services. The presence of services in a site, together with standard referral procedures 
and staff who are motivated to offer and facilitate PITC, appears to outweigh the inconvenience 
of having to return several times for different stages of the care process, at least for individuals 
who make it to a facility-based site for an HIV test. This echoes findings reported by other linkage 
to care studies (Bassett et al., 2014; Medley et al., 2013; Wachira et al., 2014), suggesting that 
while specific contextual factors must be addressed to remove barriers to both testing and linkage 
to care in any given site, cross-cutting systemic barriers and facilitators occur across settings. 
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The study revealed that mobile/outreach sites increased HIV awareness and uptake of voluntary 
HIV testing, particularly amongst younger and single adults, who are at greater risk of HIV 
infection. However, challenges remain with linking HIV-positive clients to care. The current 
referral processes in Tanzania needs to be revisited to allow more active follow-up and assisted 
linkage to care, as this has been shown to enhance linkage in other areas (Kiene et al., 2017; Ware 
et al., 2016). 
 
Improvements and streamlining in clinic organization (such as not requiring patients to return 
multiple times to give a blood sample for a CD4 count, obtain the CD4 count result, be staged and 
assessed for ART and treatment adherence sessions) would probably further enhance linkage to 
care. Our study highlights the importance of the system-level factors of availability of services and 
standard referral and care management procedures. Combined with provider-level adherence to 
PITC guidelines even in the absence of “going the extra mile” to support patients, these system-
level factors facilitate high rates of timely linkage to care for most patients. What has not yet been 
addressed, however, is what it would take to reach the patients who do not come to HIV care 
facilities, and who face barriers of stigma, shock at a positive HIV test result, and distance to link 
to care. Our findings here and in previously published work (Sanga et al., 2017) show that this is 
a much smaller proportion of the population living with HIV than just some years ago in rural 
Tanzania (where linkage to care within four months was only 14% (Nsigaye et al., 2009), but there 
is still a long way to go to reach the 90-90-90 goal and ending AIDS by 2030. 
 
 
 
Strengths and limitations  
Process evaluation of this nature determines whether program activities have been implemented 
as intended. The strength of this study is that it tracks in a stepwise manner the various actions or 
procedures from HIV testing to linkage into HIV care for newly HIV diagnosed clients, using 
multiple data sources and methods to triangulate data. Limitations of this study are that because 
all of the randomly selected facility-based sites in our sample also had CTC facilities within the 
campus, we were not able to assess how linkage to care from facility-based sites without CTCs 
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compares to linkage from mobile sites or from facilities offering comprehensive services within a 
single facility. A further limitation of the study is that, while collecting information on the process 
and procedure of linkage to care, we did not have access to those individuals who tested HIV-
positive but were lost to follow-up, and we were unable to know if they had linked or not.  
 
Conclusion 
In this study, understanding the populations accessing HIV testing at mobile or outreach and 
fixed/facility-based testing sites in hard-to-reach rural settings of Mbeya region, Tanzania, and 
comparing processes and dynamics from testing to linkage to care between these two testing 
models in a two-armed cohort followed for 6 months after receiving a positive HIV test result 
helped to generate useful program-relevant information. The national guidelines for HIV testing 
and HIV management were observed by the healthcare providers in both models. Despite the more 
proactive care and clients’ appreciation of confidentiality at the mobile sites, clients who tested at 
facility-based sites were more likely to link to care and to do so sooner because of integration of 
HIV testing and HIV care services in the same location/spot, as well as that the clients sought HIV 
testing services because they were sick, and therefore had the desire to start treatment.  
This suggests the importance of considering a combination of patient-level factors, notably 
different reasons for testing and stigma, and well-established procedures and routines for each step 
between testing and initiation of treatment at all types of HIV counselling, testing and care 
facilities. Drawing on and further developing existing frameworks and approaches to access to 
care, this study’s findings may inform the development and adaptation of strategies that can 
respond to the challenges of newly HIV diagnosed individuals and be responsive to the health 
system realities.  
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Abstract 
Background: In Mbeya region of Tanzania, the rate of linkage into HIV care was estimated at 
28% in 2014. This study explored the facilitators and barriers to linkage to HIV care at 
individual/patient, healthcare provider, health system, and contextual levels to inform the design 
of interventions to improve linkage to HIV care. 
Methods: A descriptive qualitative study was conducted between August 2014 and July 2015, 
nested in a cohort study following 1,012 newly-diagnosed HIV positive individuals for 6 months. 
Eight focus group discussions and ten in-depth interviews were conducted with recently-diagnosed 
HIV-positive individuals from the cohort, and a further 20 individual interviews were conducted 
with healthcare providers. Transcripts were transcribed verbatim in Swahili, translated into 
English, and analyzed through thematic content analysis supported by Atlas.ti qualitative analysis 
software. In the discussion, the qualitative findings are interpreted in relation to the quantitative 
findings of the parent cohort study. 
Results: The study identified multiple factors influencing linkage to care. Status disclosure, 
support from family/relatives, and being symptomatic were reported to facilitate linkage at the 
individual level. Fear of stigma, lack of disclosure, denial, being asymptomatic, belief in 
witchcraft, and spiritual beliefs were barriers identified at the individual level. At the healthcare 
provider level, support and good patient-staff relationships facilitated linkage, while negative 
attitudes and use of abusive language by healthcare providers to patients were reported as barriers 
to successful linkage. Referral procedures and well-organized clinic procedures were system-level 
facilitators of linkage, whereas poorly organized clinic procedures and visit schedules, 
overcrowding, long waiting times, as well as the lack of resources (including human resources and 
equipment) were reported barriers. Distance and transport costs to HIV care centres were important 
contextual factors influencing linkage to care. For most of the factors identified, there was an 
agreement between the HIV-positive individuals and the healthcare provider respondents.  
Conclusion: Linkage to HIV care is an important step towards proper management of HIV/AIDS 
infection. This study found that access and linkage to care are influenced positively and negatively 
at all levels, but the individual-level and health system-levels barriers were most prominent. 
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Interventions must address issues around stigma, and improve the capacity of HIV treatment/care 
clinics to provide a better quality of care, particularly in light of adopting the ‘Test and Treat’ 
model of HIV treatment and care recommended by the World Health Organization (WHO). 
 
 
Introduction 
Sub-Saharan Africa (SSA) bears the highest HIV/AIDS burden in the world, having an estimated 
71% (25.8 million) of all the people living with HIV/AIDS in 2014 (UNAIDS, 2014b). In 
Tanzania, an estimated 1.5 million people are living with HIV, representing a prevalence rate of 
5.1% (NACP, 2014; UNAIDS, 2014). Rates of HIV testing is low, particularly in rural areas 
(Nsigaye et al., 2009; Simmelink, 2014). In 2015, the Ministry of Health and Social Welfare in 
Tanzania, in collaboration with other stakeholders, drafted the National Comprehensive HIV 
Testing and Counseling (HTC) guideline, which combines all approaches of HTC into one 
document. The aim of this guideline was to improve HIV testing, HIV prevention, linkage and 
enrolment into care, retention and adherence in general HIV care and treatment, and management 
of comorbidities in HIV/AIDS. In Tanzania, home-based and other outreach HIV testing programs 
have been put in place to improve the low uptake by community members of HIV testing, and 
subsequently linking those individuals who test positive to HIV care and treatment centres (CTCs). 
By increasing the types and number of HIV/AIDS treatment and care service outlets, it was 
expected that successful linkage to HIV treatment and care among people living with HIV in 
Tanzania would improve (NACP, 2014b). 
Despite an increase in the rates of HIV testing following the expansion of outreach HIV testing 
approaches (Labhardt et al., 2016), studies conducted in various regions of Tanzania have reported 
low linkage to care for individuals who test HIV positive (Mayer, 2011). A study conducted in 
Mwanza (Northern Tanzania) reported a linkage as low as 14% in the first four months after 
diagnosis (Nsigaye et al., 2009). While improvements are occurring, linkage to care remains poor. 
According to Simmelink (2014), Ifakara, Tanzania has a linkage rate of 23.1%. Similarly, findings 
from the Mbeya Regional AIDS control program 2014 report show a linkage rate of 28%. These 
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rates of linkage to HIV care from various regions in Tanzania are indicative of a generalized 
problem faced by the Tanzanian HIV and AIDS treatment program. 
 
Linkage to care: a crucial step in HIV control 
Timely and effective linkage to HIV treatment, care and support are crucial for a better prognosis. 
Hence, the most recent WHO “test-and-treat” guidelines for HIV treatment and care recommend 
that treatment should be immediately initiated once someone has tested positive for HIV, 
irrespective of their CD4 count (WHO, 2016). However, treatment initiation can only be achieved 
if the HIV-positive individual is successfully linked to care and initiated on treatment. 
Linkage to care is described as the process put in place to ensure that  HIV-positive individuals 
are successfully entered into HIV medical treatment and care ( Rio, 2011; Dombrowski, 2013). 
The process of linkage to care includes educating patients about the benefits of being in care and 
providing facilitating services such as referral letters and guidance in selecting a treatment centre 
(PwP, 2013).  
A range of factors may facilitate or hamper the process of linkage in the trajectory of HIV care, 
from the point of diagnosis to initiation of ART. These influences may occur at the level of the 
patient/individual, the healthcare provider, the healthcare system, or the system or contextual level. 
Several studies have explored the barriers and facilitating factors to linkage to care in Kenya, 
Uganda, Malawi and South Africa ( Losina et al., 2010; MacPherson et al., 2012; Govindasamy et 
al., 2012; Nakigozi et al., 2013; Bassett et al., 2014; Naik et al., 2015). Fear of stigma, lack of 
disclosure of HIV status to relatives or other individuals, being asymptomatic at the time of 
diagnosis, and negative healthcare provider attitudes are some of the factors reported as barriers 
to timely linkage into HIV care ( Govindasamy et al., 2012; Layer et al., 2014; Genberg et al., 
2015). Factors identified as facilitating linkage were the integration of HIV testing and HIV care 
services, good patient-staff relationships, and short clinic waiting times (Genberg et al., 2015; Naik 
et al., 2015). In Tanzania, Layer et al. (2014) explored and classified the facilitating factors and 
barriers to linkage to HIV care and treatment services. However, the authors of this paper did not 
find any studies in Mbeya region, a transient and hard-to-reach region of Tanzania where linkage 
into HIV care is a particular challenge (MRACP, 2014). How these general factors play out in 
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specific contexts is at the heart of improving practice and outcomes for this highly variable 
pandemic.  
This study sought to explore the barriers and facilitators to linkage into HIV care after testing HIV 
positive in the hard-to-reach rural settings of Mbeya region, at the individual, provider, system and 
contextual levels in order to contribute to a deeper, intervention-oriented understanding of the 
dynamics of linkage to care in Mbeya region, in the southern highlands of Tanzania. 
 
Study setting 
The study was conducted in rural communities within Mbeya region of southern Tanzania. This 
remote and transient region is characterized by higher HIV prevalence than the national average 
(9% vs. 5.1%). A high proportion of the population lives more than 10 km from a health facility 
(higher than the WHO-recommended 5km), and the area is characterized by high rates of 
population mobility for cross-border trade between Tanzania, Zambia and Malawi. Both testing 
and linkage to care are particularly challenging in these circumstances. 
The study was undertaken in four purposively selected districts among the eight administrative 
districts of Mbeya region: Mbeya Rural, Kyela, Mbozi and Chunya (Figure 1). The selected 
districts included areas of high HIV prevalence and hard-to-reach populations. Two districts 
(Kyela and Mbozi) are along major highways and have borders with Zambia and/or Malawi, while 
Mbeya Rural and Chunya districts have a larger proportion of residents who live 10 km or more 
from a health facility. 
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Figure 1: Map of the selected districts in Mbeya region 
 
Characteristics of healthcare provision in relation to HIV care in Mbeya 
Region 
In Mbeya region, about 23% of the inhabitants live within 5 km of a health facility, and 15% are 
more than 15 km away from a network of health facilities that includes 20 hospitals, 36 health 
centres, and 374 dispensaries (TACAIDS, 2013). Out of these 490 health facilities, 350 facilities 
provide Prevention of Mother to Child Transmission (PMTCT) services, 312 provide HIV 
Counseling and Testing services, while only 68 health provide Antiretroviral therapy (ART) 
services (MRACP, 2014). The majority of health facilities in the rural areas do not offer CD4 
testing or HIV treatment services, although there has been a substantial increase in health facilities 
offering HIV testing and ART services in this region since 2010 (MRACP, 2014). 
 
Design and methods 
The qualitative study reported here is nested within a larger study that aims to document and 
compare rates, patterns and determinants of linkage to care in the 6 months following an HIV 
positive test result, between mobile and facility-based models of HIV testing in Mbeya region, 
Tanzania. To achieve the aim, we adopted a prospective mixed-method cohort design. 1, 012 adults 
who tested HIV positive were recruited into a two-armed cohort (facility-based vs. 
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mobile/outreach HIV testing sites) and followed up for six months to gather quantitative and 
qualitative information on linkage to care since diagnosis. 16 study sites were identified for the 
study; eight facility-based sites that were offering HIV counselling and testing as well as HIV care 
and treatment services, and eight mobile/outreach sites which offered HIV counselling and testing, 
with one (the Research Mobile lab) offering on-site CD4 count test.  
In the first phase of the project, we quantitatively compared the outcomes of linkage and time to 
linkage into care for individuals who tested HIV-positive at mobile/outreach sites, versus 
individuals tested HIV positive at facility-based services, over the first six months after diagnosis 
in rural parts of the Mbeya region (Sanga et al., 2017). In the second phase, reported here, we 
aimed to describe the factors influencing linkage to HIV care services among newly diagnosed 
HIV-positive individuals in the mobile services and facility-based services, focusing on 
patient/individual, provider, health system and contextual levels. To this end, we adopted a 
sequential explanatory mixed methods design (Creswell,2015) based on the prospective cohort 
study. 
We conducted a descriptive qualitative study, which allows a summarisation of specific events 
experienced by individuals or groups of individuals (Lambert & Lambert, 2013). Ninety-eight 
study participants were purposively selected from HIV-positive individuals who have been in the 
HIV care umbrella between 0-6 months, 68 HIV-positive individuals participated in eight focus 
group discussions (FGDs), each with six to 12 respondents, and in-depth interviews (IDIs) were 
conducted with another ten HIV-positive individuals. We also conducted 20 in-depth interviews 
with healthcare providers in the study sites. The respondents for FGDs and IDIs were drawn from 
a cohort of recently-diagnosed HIV-positive individuals, of whom about 78% reported being 
linked to care within the first six months of diagnosis (Sanga et al., 2017). The lead investigator 
(ES), assisted by four trained research assistants, conducted the interviews.  
A two-day training session on the data collection methods was held with the research assistants 
before testing the data collection tools. We piloted the interviews and FGD guides in two sites 
(health facilities), which were not among the included districts research sites, and adjusted the 
instruments based on these pilots. The interviews with patients focused on their experiences of 
being HIV positive, the circumstances around their registration into a treatment/care program, and 
any challenges or enablers with regard to registration usually considered the first step to linkage 
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in care. The interviews with healthcare providers asked about the availability of HIV testing and 
linkage to care guidelines, along with whether these guidelines are being followed, and explored 
the healthcare providers’ perspectives about what inhibits or enables individuals to link into care 
immediately after testing HIV positive. 
Interviews and discussions were audio-recorded and transcribed verbatim in Swahili, and 
transcripts were then translated into English. Thematic content analysis (Miles & Huberman, 1994) 
of the translated transcripts was supported by Atlas.ti v7 (Friese, 2013). The analysis involved the 
following steps: (1) looking for barriers and facilitators at each of the 4 levels; (2) developing 
themes and subthemes; and (3) selecting relevant themes for the study (Ryan & Bernard, 2003). 
Finally, in the discussion, the qualitative findings are interpreted, together with the earlier 
quantitative findings of the parent cohort study (Sanga et al., 2017) to enrich the understanding of 
both quantitative and qualitative findings.  
 
 
Rigour and Trustworthiness 
Following Lincoln and Guba (1985) and Shenton (2004), several strategies were employed to 
enhance credibility, transferability, dependability and confirmability. We adopted a qualitative 
method with three methods of data collection to explore and complement the findings of a 
quantitative study. Member checking, by recapping the discussions with validation by the 
respondents, was done during the focus group discussions. We applied different data collection 
techniques with a variety of respondents who were selected from multiple HIV testing sites. 
Dependability was addressed by training and supervision of a small number of field workers, and 
by ensuring that interviews and focus group transcripts were translated from Swahili to English 
by two professional translators, and checked by the first author who is fluent in both languages. 
Data analysis was conducted by two authors, and cross-verified by the last author. For 
confirmability, we kept an audit trail during the course of the study. Finally, we adopted the 
relevant guidelines of the 32-item checklist for reporting qualitative research (COREQ) as 
prescribed by Tong, Sainsbury, & Craig, (2007) to report important aspects of the research team, 
study methods, context of the study, findings, analysis and interpretations. 
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Ethical Considerations 
The study received ethical clearance from the following Ethics review boards: University of 
Western Cape (UWC) Senate Research Committee, Mbeya Medical Research Center, Mbeya 
Regional Medical Research Ethics Committee (MMREC), and the National Ethical Committee/ 
Medical Research Coordinating Committee at the National Institute for Medical Research in 
Tanzania. Willing participants were provided with an information sheet detailing the nature, aim, 
and significance of the study. Participation was voluntary, and participants were advised that they 
were free to withdraw from the study at any time without negative consequences. Willingness to 
participate was confirmed by signing an informed consent form. Confidentiality and anonymity 
were ensured by using pseudonyms and numbers to represent participants. 
 
 
Results 
Study sites and characteristics of respondents 
Ninety-eight participants, including 78 recently-diagnosed HIV-positive individuals and 20 
healthcare providers, took part in the study in FGDs and IDIs.We conducted the eight focus group 
discussions with both male and female 18 years and above. The FGDs included both women and 
men since previous qualitative interviews and community discussions in the area suggested that 
experiences with health care including for HIV can be discussed openly in mixed-sex groups. The 
FGDs transcripts as well as observation during the FGDs confirmed that men and women 
participated approximately equally. We interviewed 30 males and 68 female respondents despite 
inviting equal numbers of males and females to participate in these interviews.  For the ten 
individual interviews, five male and five female HIV-positive individuals participated. The 
healthcare providers’ interviews included seven site managers or facility in-charge staff, and 13 
nurse counsellors. The sample of health care providers included six males and 14 females; in most 
of the sites, nurse-counselors were female, while we found more male clinicians or site managers. 
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Table 5.1: Research sites and data collection techniques applied 
Districts Type of Site No of FGDs No of IDI-Clients No of IDIs- HCP 
Facility-based sites 
Kyela 
Kyela Hospital 0 1 2 
Ipinda Health Centre 1 1 1 
Mbozi 
Vwawa Hospital 0 0 1 
Tunduma health Centre 1 1 2 
Mbeya Rural 
Ifisi Hospital 1 1 1 
Inyala health centre 0 0 2 
Chunya 
Chunya hospital 1 1 2 
Makongolosi Dispensary 0 0 1 
Mobile/outreach sites 
Kyela 
ST JOHN HUS-Kyela 1 1 2 
MMRC mobile- Kyela 0 1 1 
Mbozi 
SHDEPHA - Mpemba 0 0 1 
MMRC Mobile-Mbozi 1 0 0 
Mbeya Rural 
KIHUMBE- Mbalizi 1 1 1 
MMRC mobile- Mbeya Rural 0 0 1 
Chunya 
KIHUMBE- Chunya 0 1 2 
MMRC- Mobile- Chunya 1 0 1 
TOTAL  8 10 20 
 
 
Factors identified as influencing linkage to care 
Themes related to factors influencing linkage to care were categorized into four levels based on 
the conceptual framework used in the study proposal: individual, healthcare provider, health 
system, and contextual levels. Table 2 below illustrates the various categories into which the 
emerging themes and factors were classified. We present the identified factors at various levels 
first, reporting facilitators and then barriers, and then we report the most frequently mentioned 
factors from focus group discussions, individual patient interviews, and individual healthcare 
provider interviews.  
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Table 5.2: Facilitators and barriers to linkage in care by levels 
LEVEL CATEGORIES THEMES/Factors 
Individual Facilitators Perceived severity of illness 
Seropositive status disclosure 
Social support from family members/relatives and fellow HIV-positive individuals 
Barriers 
 
Fear of stigma 
Asymptomatic 
Denial  
Poor health literacy 
Lack or fear of disclosure 
Belief in witchcraft and traditional treatment 
Spiritual beliefs 
Health Care 
Provider 
Facilitators Good patient-healthcare provider relationship 
Supportive healthcare providers (encouragement) 
Barriers Negative attitude from healthcare provider  
Health System Facilitators Availability of referral procedures i.e. referral letter/Referral form 
Good service organization 
Barriers Poor clinic procedures and visit schedules 
Clinic over-crowding 
Long waiting times at the clinic 
Few care and treatment centres, and inadequate resources 
Shortage of staff 
Inadequate CD4 testing machines (malfunctioning) 
Contextual Facilitators Short distance  
Low transport  costs to clinic 
Barriers Long distance 
High transport cost 
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Results overview 
While we identified both barriers and facilitators at all levels and from all respondents, we found 
that individual-level and health system-level factors reported by both HIV-positive individuals and 
healthcare providers were particularly prominent. With regard to the individual-level factors, most 
of the HIV-positive individuals mentioned stigma as an important barrier. During the FGDs and 
IDIs with the HIV-positive individuals, the participants kept steering the discussions toward 
stigma-related issues. With regard to the health system factors, both the HIV-positive individuals 
and the healthcare providers emphasized over-crowding and long waiting times at the centres.  
All 98 participants invited to participate in the study agreed to do so, and the interviews and FGDs 
appeared open and free-flowing. During the discussions with the study participants, it was 
observed that both the HIV-positive individuals and the healthcare providers were very emotional 
when communicating their concerns, especially the health system-level barriers. We also noticed 
that in discussing the health system level in one of the sites, while the HIV-positive individuals 
mentioned that there were times when medication was out of stock, the healthcare providers did 
not agree that this happens. In spite of this difference in opinion on the issue of medication being 
out of stock, overall, there was no animosity or antagonism expressed between the HIV-positive 
individuals and the healthcare providers.  
 
Individual level  
The individual level includes issues related to the individual’s knowledge, attitudes, feelings, 
experiences and behaviours towards linkage to care or accessing healthcare services. 
 
Facilitators to linkage to care 
Three factors were identified as facilitators to linkage to care at the individual level: Individuals 
being sick or having symptoms at the time of diagnosis, seropositive status disclosure, and support 
from family members/relatives. 
  
Perceived severity of illness or threat: The individual’s perception of their health status, and 
specifically being sick, was felt to influence linkage to care positively. This is illustrated in the 
following excerpts: 
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Initially, I didn’t think it was necessary to go [to the hospital] but one day I had a fever. I 
felt my hands and legs not working at all. I thought I am going to die. I asked my sister to 
take me to the hospital for medication [IDI - Client3: Female - 35 years]. 
They stay at home until they are seriously sick is when they go to the hospital for 
registration [FGD7]. 
 
Seropositive status disclosure: Respondents cited disclosure of seropositive status as an 
important factor in facilitating linkage to HIV care in HIV-positive individuals. For example, one 
participant reported:  
Most of my relatives know my status after since I told them. They support me. Sometimes 
they escort me to the clinic [IDI - Client3: Female-35 years]. 
Social and moral support from family members/relatives and from other HIV-positive 
individuals: Social and moral support from family and relatives were reported to enhance linkage 
behaviours of HIV-positive individuals in a number of the FGDs and IDIs: 
I started suffering so I decided to ask my elder brother to escort me to do the test [HIV] 
and I was found HIV positive [FGD3]. 
My sister encouraged me, she said it not the end of the world, I will be okay when I start 
medication, and there are so many people who are in this [HIV] situation [IDI-Client8]. 
At our place Lusungo, we have formed the HIV support group which we meet every 15 of 
the month to discuss issues and encourage each other… we contribute little money for 
emergency …like if someone does not have transport fare we give [FGD2].    
 
Individual-level barriers to linkage to care 
Six factors were salient as barriers to linkage to care from this sub-theme: fear of stigma, denial 
and being asymptomatic at the time of diagnosis, lack of understanding of the importance of being 
in care, lack of disclosure, belief in witchcraft and traditional treatment, and spiritual belief. 
 
Fear of stigma: Stigma related to attending HIV care clinics or CTCs was the most frequent 
factor described by the participants as a barrier to being registered (linked) into HIV care and 
treatment. This was captured in statements such as the following: 
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They do not like going to the hospital; some fear that other people will see them at the 
clinic and know that they are infected [FGD1]. 
Most of them are because they fear that people will see them at CTC and start pointing 
fingers [IDI - HCP2].  
 
Denial and being asymptomatic: Disbelief of test results, especially when the individual shows 
no symptoms yet, was reported as a prominent barrier to linkage to care among individuals who 
had tested positive for HIV: 
I was pregnant and I went to the clinic for antenatal care. They [clinicians] tested my blood 
and told that I am infected with HIV. I did not believe it because I was not sick and had no 
other health problem apart from being pregnant [IDI - Client9: Female 30 years]. 
Some clients do not believe they are infected because they are healthy [IDI - HCP17]. 
 
Poor health literacy (lack of understanding of the importance of being in care): Poor health 
literacy in the form of lack of understanding of the importance of being in care was an important 
hindrance to linkage to care. The issue of poor health literacy was mostly reported by the 
healthcare providers. The patients did not particularly allude to issues related to poor health 
literacy. Two examples are shown in the following quotes:  
Maybe education is still low, they do not understand that is important to start ART care 
while you are still strong than when you are very weak [IDI - HCP9]. 
Also, some people are just ignorant especially those who do not have any symptoms, they 
do not see the importance of being in care if they are not sick. [IDI - HCP5]. 
 
Lack or fear of disclosure: The respondents, both patients and the healthcare providers, 
identified the lack or fear of disclosure as an important barrier to linkage to care. Participants 
revealed that HIV-positive individuals sometimes fail to disclose their HIV status to their 
significant others for fear of consequences, such as intimate partner violence and divorce. This is 
captured in the following statements: 
Many women are facing problems when disclosing HIV status to the men and some lead 
to divorce [FGD3]. 
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They do not tell their partners, so it becomes difficult for them to come to the clinic and 
they come secretively [IDI - HCP13]. 
 
Belief in witchcraft and traditional treatment: Based on the reports of some of the HIV-positive 
individuals, it was identified that belief in witchcraft is a challenge to linkage to care among 
some HIV-positive individuals in rural areas. These experiences were mostly shared by the 
patients.  
When I started getting sick, my in-law took me to a traditional healer, he said I am 
bewitched. He [traditional healer] started treating me with different herbs, some for 
drinking and others for bathing. I wasn’t getting any better so I told him; I want to go to 
the hospital [FGD 2]. 
He [traditional healer] said it was one of my neighbours in the market who is jealous of 
me. He [the neighbour] had put something in my store that is causing us to suffer from 
unknown diseases [IDI - Client 2: Male 42 years]. 
 
Spiritual belief: It was also reported by some respondents that spiritual belief had a negative 
impact on linkage to care behaviours of some HIV-positive individuals. This was captured in 
most focus group discussions with the patients, and some of the key informant interviews with 
the healthcare providers support this point of view: 
You know when there is a problem you become worried so you can come here [clinic] or 
try other places. They say they pray for you and you will be healed [FGD 4].  
Some patients go to the new churches. The pastors in those churches they pray for them 
and give them holy water to take and they tell them you will be healed [IDI - HCP 3]. 
 
 
Healthcare provider level 
These are factors related to the relationship between the care providers and the individual, as well 
as the behaviours of the healthcare providers.  
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Healthcare provider facilitators to linkage to care 
Two factors were identified as facilitators for linkage to care under this theme: Support or 
encouragement from healthcare providers, and good patient/staff relationship. 
 
Support or encouragement from healthcare providers: There were similar testimonies from 
both patients and healthcare providers that support and encouragement from care providers 
facilitated the registration (linkage) of HIV-positive individuals in the CTC. The role of support 
and encouragement is captured in these excerpts: 
Frankly speaking, the health providers here treat us nicely. They explained to me step-by-
step on how to use drugs. I thank them. It is two weeks now since I started the drugs. They 
are providing good services [FGD3]. 
They [the nurses] even gave me the drugs for preventing chest infection and another disease 
[IDI - Client6: Female 48 years]. 
 
Good patient-healthcare provider relationship: A patient who took part in the focus group 
discussions indicated that a good relationship and service delivery from the healthcare providers 
could encourage patients to link to care. A good relationship between the healthcare provider and 
the patient was reported to enhance linkage and continuity in HIV care, as reported in some 
focus group discussions: 
The nurses are very polite and helping us a lot [FGD1]. 
Generally, the service providers are treating us well; we do not have any complain [FGD4]. 
 
 
Healthcare provider barriers to linkage to care 
Negative healthcare provider attitude and use of abusive language were reported by the HIV-
positive individuals, particularly in one FGD and one IDI. However, on a follow-up visit, the 
healthcare provider in the site in question claimed that this is related to a shortage of staff at the 
site: sometimes staff are overwhelmed by responsibilities and work overload, so the patients feel 
neglected. 
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Poor healthcare provider attitude and use of abusive language: Some participants reported that 
negative healthcare provider attitudes and the use of disrespectful language and shouting by 
some of the healthcare providers was an important barrier to linkage to care. It was also reported 
that patients dropped out of care when mistreated at the clinic. Participants in two of the focus 
group discussions expressed this in the following statements: 
When we reach here [clinic], they look at us like we are not normal human beings, they 
discriminate against us. They tell us to come very early but you see they start attending to 
us at 01:00 in the afternoon and sometimes you end up not getting the drugs [FGD2]. 
Truly, shouting can contribute so much, it hurts. You think I am sick then doctor barks or 
shouts at me, so they decide to stop coming [FGD6]. 
 
 
Health system level 
These are the factors related to the health systems and HIV care program implementation in the 
facility and include the organization of the healthcare services, leadership, resource availability 
(including human resources), and access to health-promoting services like home-based care or 
HIV support groups at clinics.  
 
Health system facilitators for linkage to care 
Two factors were identified as facilitators to linkage to care under this theme: availability of 
referral procedures (i.e. provision of referral letter/referral form), and the existence of a well-
organized clinic system with HIV testing service and HIV care services, as well as possibilities of 
same-day registration. 
 
Availability of referral procedures: Most of the reports attesting to the availability of referral 
process were provided by the healthcare providers, although some of the patients provided 
narratives that support the reports of the healthcare providers. Providing a referral letter/form to 
enable the registration process of individuals at the CTCs was reported to facilitate linkage to 
HIV care and treatment. The referral letter is an important document given to HIV-positive 
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individuals to confirm their seropositive status and facilitate registration into a CTC. The role of 
the referral letter in the care linkage process is captured in these statements below: 
If the client is positive, I refer him/her to CTC with this form (referral form) we have to 
make sure they are registered in the book [IDI-HCP1]. 
We refer the client we give him/her a referral letter with CD4 results print out and we also 
do HIV staging so that the CTC clinician can decide on how to continue [IDI-HCP7]. 
 
It was also revealed that, in some of the sites, the peer health educator escorted the newly diagnosed 
individual to the clinic. 
I sometimes take the letter from here (St John hus site) and I accompany the person to the 
clinic at Kyela hospital, I take them through all steps [FGD 1].  
 
Service design or clinic services organization: Both the healthcare providers and the patients 
agreed that the availability of HIV testing, CD4, counts and HIV care and treatment services 
within the same facility, organized to provide a complementary service, enabled linkage to care. 
This provides the possibility for individuals who test positive to be registered and thus linked to 
care at the CTC, on the same day. 
Normally when I find a positive client, I go to the next room where we keep the documents 
for registration and the CTC cards, so I register him/her in the CTC register and give them 
a CTC clinic number with the treatment card [IDI-HCP12]. 
He [the care provider] gave me the letter and asked me to go to room number 10, show this 
[registration card] to the nurse. They gave me a card then I went into another room to give 
blood for CD4 [FGD 2].  
We have formed the HIV support group which we meet every 15 of the month to discuss 
issues and encourage each other… we contribute little money for emergency …like if 
someone does not have transport fare we give [FGD 2]. 
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Health system barriers to linkage to care 
Five factors were identified as barriers to linkage to care within the health system umbrella. These 
are Un-organized clinic procedures and visits schedules, clinic overcrowding, long waiting times 
at the clinic, inadequate CTCs, and shortage of staff. 
Disorganized clinic procedures and visit schedules: While it was reported by study participants 
that healthcare facilities can provide integrated services of testing and treatment/care, which 
facilitated linkage to care, narratives from patients and healthcare providers indicate that the 
services might not be available on the same day. Some of the healthcare facilities had a schedule 
of when testing takes place and when registration to treatment/care occurred. This required 
patients to make multiple visits to the facility. For example, an individual testing on Friday 
morning will be given a referral letter to come the next Tuesday for registration, and then they 
will be told to come on Wednesday or Friday for CD4 testing and then given another 
appointment to get their CD4 results.  
We do CD4 testing on Wednesdays and Fridays, the other days is for in-patients’ tests. So 
if it is Wednesday and the client comes early, they go directly to the CD4 testing section 
and they are given a date to come for results normally. This could be in about three or four 
days’ time [IDI - HCP10].  
He gave me some papers (referral form) to go with and show the nurse at the CTC. I went 
and the nurse said I should come on Tuesday for registration [IDI - Client2: Male 42 years]. 
 
Clinic overcrowding: Reports from both patients and healthcare providers indicated that clinic 
overcrowding could constitute a barrier to linkage to care. When patients found a huge crowd of 
people when they arrived at the clinic, they were tempted to return home. This could lead to the 
patient failing to become linked to care timeously. This was supported by the discussions among 
the patients in a focus group. 
So even when you tell a client to go and join the queue for registration, he says ‘there are 
too many people, I will come tomorrow’ and that is it. They disappear. We don’t know 
whether they go to other clinics or what happens to them [IDI-HCP9]. 
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For the matter of staying a long time it is because we are so many, therefore, we take a lot 
of time [FGD1]. 
Long waiting times at the clinic: This was another frequently mentioned issue from both the 
patients and healthcare providers. It was revealed that owing to the overcrowding in the CTC, it 
took a long time for the healthcare providers to consult everyone, leading to long waiting times 
for patients, and hence a potential barrier to linkage to care. 
Patients wait for services for a very long time because the same staff has to go in the wards 
to assist, and then come here again for HIV client. For example, on Wednesday when they 
come for adherence treatment classes we can only start with them after 12 noon, and they 
always complain [IDI - HCP6]. 
We wait for services for a very long time and the waiting place is open when it is raining, 
we suffer a lot [IDI - Client1: Female 33 years]. 
 
Inadequate resources and equipment: Shortage of resources, such as HIV care centres, staff and 
CD4 testing machines, were identified as possible barriers to linkage in care. Statements from 
both healthcare providers and HIV-positive individuals suggest how this resource shortage could 
interfere with linkage of HIV-positive individuals into HIV care.  
There is a severe shortage of staff here; clients wait for CTC services for hours before they 
are attended to. We are only two nurses and one doctor per shift if one of them is sick or 
on leave, patients wait up to 4 o'clock in the evening [IDI - HCP6]. 
The problem is, we depend on only this hospital for all people in Chunya, people from 
Lupa tingatinga and all other villages…and Chunya is big [FGD4]. 
 
In one district, the recurrent breakdown of the CD4 machine was mentioned as a strong barrier to 
their linkage with HIV care: 
Also, the recurrent problem is with the CD4 machine [breakdown]. Maybe the government 
can help us by buying a new machine, even two we are so many here who need the service 
[IDI - Client1].  
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Most of the patients there are delayed due to CD4. This is the only site with a working CD4 
machine. We receive patients from Sumbawanga even Nakonde from Zambia because this 
service is not available in their areas [IDI - HCP14].   
 
 
Contextual level 
Contextual factors refer to matters associated with access to, and affordability of, ART treatment 
and care services, and this may also include social and cultural factors concerning HIV infection. 
Depending on how far the individual lives from the clinic, the themes identified under this category 
could be either a facilitating factor or a barrier. Those who live close to the clinic did not identify 
access to the clinic facility as a possible barrier to linkage to care. Conversely, those who live 
further from the care facility saw distance and transport cost to the facility as a potential challenge 
to linkage to care.  
 
Contextual facilitators to Linkage to care 
Proximity and low travel cost to the clinic: Proximity and low travel costs was one of the factors 
that was reported to facilitate linkage to care in HIV-positive individuals, as reported by some of 
the participants; 
I do not live very far from here, I just get a boda-boda [hired motorbike] and I pay only 
one thousand [less than half a dollar] and I can even walk if I want to [IDI - Client6: Female 
48 years]. 
For me, distance is not a problem, I walk for about ten minutes and am here, sometimes I 
send my daughter to bring the card for me and put it in the box while am still at home, 
when I come here I just wait for my turn to take medication [FGD7]. 
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Contextual barriers for Linkage to care 
Long distance and high transport cost to CTCs: Long distances to the clinic and the high cost of 
transport were reported by the participants (especially in two districts Chunya and Mbozi) as a 
deterring factor to linkage to HIV care and treatment.  
We refer our clients to either … hospital [about 10-15 Km] to the …health centre also 
about same distance. They say ‘I do not have bus fare for now [IDI - HCP11]. 
Transport is very costly. Sometimes, I borrow money from friends and sometimes I come 
with my bicycle but I do not have the energy to ride for a long distance [IDI - Client2: Male 
42 years]. 
Binti-manyanga is far, it is about 100 kilometres from here and the cost of transport is very 
high about 28000 to 30000 [about $14] per trip [FGD4].   
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Discussion: integrating qualitative and quantitative findings 
in relation to published literature 
The study sought to explore the facilitators and barriers to linkage into HIV care after testing HIV 
positive in the rural settings of Mbeya region, from both facility-based and mobile/outreach sites. 
The literature on linkage to care indicates that while many studies have explored and described 
barriers to linkage to HIV treatment in various settings, fewer studies have looked at the facilitating 
factors, and even fewer have explored both together. In this study, multiple factors were identified 
as influencing linkage to care in newly-diagnosed HIV positive individuals, and we identified these 
factors under four levels i.e. individual, healthcare provider, health system, and contextual levels 
(Figure 2). 
          
Figure 2: Conceptualizing the factors influencing linkage to HIV care in Mbeya, Tanzania 
 
Based on the findings of this study, as indicated in Figure 2, access and linkage to care plays out 
at different levels, but the individual-level and health system-levels barriers were most prominent. 
At the individual level, HIV-positive individuals cited stigma as a very important barrier to linkage 
to care. This suggests the need for more population-level educational programs and community 
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HIV-support groups. At the health system level, clinic overcrowding and long waiting times came 
across strongly from both the HIV-positive individuals and the healthcare providers. 
Each of the identified levels of factors is discussed in the section below, with particular attention 
to integrating the qualitative findings of this study with the quantitative findings from the parent 
cohort study (Sanga et al., 2017). 
 
Individual level 
At the individual level, the study revealed that having symptoms of disease (being sick at the time 
of diagnosis), the disclosure of HIV status, and support from family/relatives were facilitators to 
linkage to care. The findings from the quantitative parent study revealed that disclosure of HIV 
status was a significant factor associated with timely linkage to care: participants who disclosed 
their HIV status had a 35% earlier rate of linkage to care compared to participants who did not 
disclose their HIV status (Sanga et al., 2017). This finding was supported by the HIV-positive 
individuals and the healthcare providers who participated in the qualitative study. Social and moral 
support from the HIV-positive individuals’ families and spouses, although not identified in the 
quantitative data as significant to linkage to care, were salient in the qualitative inquiry. This result 
corresponds to other similar studies on linkage to care (Medley et al., 2013;Cummings et al., 2014; 
Dima et al., 2014; Hodgson et al., 2014).  
In this study, the most frequently reported barriers to linkage into HIV care include fear of stigma 
related to HIV, lack of disclosure, being asymptomatic at the time of diagnosis, and denial. 
However, belief in witchcraft and belief in spiritual healing were also reported to hinder linkage 
into HIV care. Similar findings were identified in other studies on linkage to HIV care in sub-
Saharan countries (Hatcher et al., 2013; Hodgson et al., 2014; Layer et al., 2014; Nakigozi et al., 
2013; Sharma et al., 2015). 
 
Healthcare provider level 
We found that healthcare providers’ moral and practical support and good patient-staff 
relationships enhance linkage to HIV care. Conversely, the perceived experience of negative 
provider attitudes, lack of respect and/or use of abusive language from healthcare providers to 
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patients was reported by the study participants to impede successful linkage to HIV care. Other 
studies report corresponding results (Nakigozi et al., 2013; Wachira et al., 2014; Layer et al., 
2014). However, in this study, the healthcare providers in some instances suggested that negative 
relationships with clients are related to a shortage of staff at the site, and high workloads. Existing 
literature indicates that basic resources, effective management, and supportive supervision issues 
need to be addressed within a health system in order for patient-centered care of high interpersonal 
quality to become a priority for healthcare providers (Cowing et al., 2009; Lamarche et al., 2011). 
 
Health system level 
At the health system level, we found the availability of good referral procedures and well-
organized clinics services to be important facilitators for linkage to HIV care. Elul et al. (2014), in 
their study on enhancing linkage to care, reported that availability of CD4 testing at the point of 
care, and a short message service (SMS) reminder of appointment to patients, was a facilitator to 
linkage. We also found that in some clinic settings, testing and linkage to care were performed on 
the same day (same day registration), and sometime CD4 tests were also done on the same day. 
This helps to explain the finding in the quantitative parent study that those tested at facilities were 
significantly more likely to have linked to care sooner than those tested at the mobile sites (Sanga 
et al., 2017).  
 
Healthcare providers in the qualitative study indicated that the mobile clinic staff took measures 
to promote linkage to care. For instance, one of the healthcare providers running the mobile clinics 
reported that they situated their mobile laboratory near a health facility, such as a hospital, health 
centre or dispensary, to link their HIV and TB clients to the existing system for further care. It was 
also reported by the healthcare provider from mobile/outreach services that the peer educator 
escorts the newly-diagnosed individuals to the care centre after counselling and testing, to ensure 
linkage. The quantitative part of the study showed that individuals who tested in facilities had a 
78% higher rate of earlier linkage to care compared to those tested in mobile/outreach sites. By 
adopting the above-mentioned strategies, the linkage to care rates from the mobile testing 
individual could be improved, as these findings suggest that the disadvantages of testing outside 
of a multi-service facility are not overcome even by highly motivated and proactive staff action.  
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Barriers to linkage in care at the health system level included poorly-organized clinic procedures 
and visits schedules, overcrowding and long waiting time, and lack of resources including staff 
and equipment at the clinic. While some studies have indicated that having HIV testing services 
and HIV care available in the same facility improves rates of linkage to care and ART coverage 
(Layer et al., 2014; Genberg et al., 2015), the integration of these services, if not well coordinated 
and organized could also constitute a barrier to linkage to care. These factors were similar to some 
of the health system barriers reported in other HIV care linkage studies ( Mayer, 2011; MacPherson 
et al., 2012; Wachira et al., 2014; Sharma et al., 2015;). However, the qualitative findings reported 
here, particularly in light of the quantitative findings (Sanga et al., 2017) suggest that even poorly 
integrated “one-stop shops” are preferable to multiple visits to separate facilities. 
 
 
Contextual level 
The context level factors that were identified in this study were related to the distance to the 
healthcare facility, and the cost of transport. For respondents living in close proximity to the clinic, 
distance and cost were not a challenge. However, it was a significant challenge to respondents who 
lived further than 10 km from the clinic. Nevertheless, the multivariate Cox analysis of the 
quantitative part of our study indicated that there was no significant difference between the rates 
of linkage to care for HIV-positive individuals who lived less than 10kms from the healthcare 
facility compared to those who lived more than 10kms from the healthcare facility (Sanga et al., 
2017). This could be explained by the fact that other barriers at the individual, provider and 
institutional levels could have influenced the decisions not to register for HIV treatment and care 
more than the distance. In spite of this finding, long distances from the treatment facility, and cost 
of transportation were reported by a significant number of the HIV-positive individuals as barriers 
to linkage and remaining in HIV care. A number of studies have also reported the influence of 
long distances and transport costs on linkage to care behaviours of individuals diagnosed with HIV  
(Nsigaye et al., 2009; Govindasamy et al., 2012; Juddy Wachira et al., 2014). Furthermore, some 
of the HIV-positive individuals reported that short distances to the clinic and low transport cost 
improved the rate of linkage to care. This is seldom reported in the literature.  
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Social and moral support from family members, friends, neighbours and significant others were 
reported to facilitate linkage and retention in HIV care, echoing findings reported by Gerdts et al. 
(2014) and Genberg et al. (2015). A possible mediator between disclosure of HIV status and early 
linkage is the perceived social and moral support that the HIV-positive individuals receive from 
their significant others after disclosure. 
 
Strengths and limitations 
One of the strengths of this study is that various stakeholders (healthcare providers, and HIV-
positive individuals), different data collection methods (FGDs and IDIs) and multiple sites (16 
sites) were used to elicit relevant information. By triangulating the data source, collection methods 
and sites, we improved on the trustworthiness of the study. We had mixed-sex FGDs which yielded 
complementary results and showed that men and women can explore shared as well as divergent 
experiences. This is a contribution in a field which seldom offers men and women the opportunity 
to exchange views together. However, the study had some limitations for instance, while we 
explored the challenges and facilitators for linkage to care, we only interviewed individuals who 
were already under the care umbrella. We did not have access to those individuals who tested HIV 
positive but were not registered in care. In addition, we did not delineate the responses of those 
who tested in the mobile sites from those who tested at the facilities, because both groups were 
entering care at the health facility-based sites.  While we found that the mixed FGDs were rich and 
gender-specific complementary themes emerged from the individual interviews, we did not 
conduct separate men’s and women’s FGDs which may have yielded additional themes. 
During this study, it was identified that poor leadership and management at some of the facilities 
were responsible for poor linkage to care behaviours. Although this study focused on the factors 
influencing linkage to care, it did not focus in particular on the broader health system issues like 
health management and leadership. This may require further investigation to address the issues 
around leadership and health systems management. 
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Conclusion  
The importance of HIV-positive individuals being linked to HIV care has been demonstrated in 
the literature. The findings of this study indicate that, while there are many barriers to linkage to 
care, there also exist some facilitating factors. The study showed that individual, healthcare 
provider, health system and contextual factors might all influence linkage into care, but that 
individual-level factors (such as stigma), and health system factors (under-resourced and poorly 
coordinated facilities), are particularly important from the perspective of both patients and 
providers.  
 
This study was undertaken in part to inform future interventions. Among interventions that could 
be implemented to address some of the challenges of linkage to care are improved counselling 
strategies, and the establishment of HIV support groups and community interaction programs to 
discuss and address HIV stigma-related matters in the community. At the health system level, 
improvement of inadequate human and other resources, and of HIV care clinic procedures to 
allow the provision of better quality of care and treatment services to HIV-positive individuals, 
are urgently needed. Low rates of testing and linkage to care in hard-to-reach and vulnerable 
populations, such as those, living in Mbeya region, Tanzania, may thus improve to acceptable 
levels. 
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CHAPTER 7 
SUMMARY OF FINDINGS AND DISCUSSION 
 
7.1 Contributions of this thesis 
In Chapter 1, we introduced the problem which guided this research: 
HIV testing, linkage to HIV care and continuity of care are crucial for proper management of 
HIV/AIDS. There is increasing interest across sub-Saharan Africa, including in Tanzania, in 
accessing hard-to-reach populations along major highways or trade corridors, in border areas, and 
in remote rural areas with HIV testing opportunities and linkages to HIV care and management. 
Mobile and outreach HIV testing can help to achieve universal HIV testing in sub-Saharan African 
countries. However, despite the efforts being made by the Tanzanian government to address some 
of the challenges to improving HIV testing and subsequent linkage to HIV care and treatment 
services, such as increasing service outlets; available literature and reports in Tanzania show that 
linkage to care is still low.   
Many factors can interfere with or facilitate successful linkage to and continuity of care. This thesis 
describes and compares the populations accessing testing at mobile/outreach versus fixed/facility-
based testing sites, and compares the processes, dynamics, and outcomes of linkage to care 
between these two models of HIV testing.  
The overall aim of the study was to describe and compare rates and determinants of linkage to care 
in the first six months following an HIV-positive test result between mobile and facility-based 
models of HIV testing in Mbeya region, Tanzania.  We reviewed the literature to understand 
linkage to care and to identify challenges in linkage to care from mobile testing sites in contexts 
like South Africa, where treatment is widely available in the public sector. However, to our 
knowledge, there has not been any direct, prospective comparison between mobile and facility-
based models of testing in countries like Tanzania, where treatment is only available in a minority 
of facilities and where overall testing rates remain low. Similarly, a mixed-method approach 
combining a quantitative prospective cohort study, records review, and qualitative research with 
both patients and healthcare providers to explore linkage to care has not been reported in Tanzania 
and East Africa. The empirical findings on rates, timelines, determinants and dynamics of linkage 
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to care in the first six months after testing positive for HIV contribute original knowledge to the 
literature, and to Tanzania’s efforts to control and eliminate HIV/AIDS as a major public health 
problem. Understanding strengths and weaknesses in each approach to testing, in relation to client 
characteristics and preferences, and the capacities of the overall health system, will help strengthen 
the provision of universal testing and linkage to care for HIV positive individuals.  
 
7.2 Summary of findings 
Results reported in Chapter 4 showed that, at the end of six months since diagnosis, 793 (78%) out 
of 1012 participants enrolled in the cohort had linked into care. This is a dramatic increase in 
overall linkage to care since 2009 and 2012 (Nsigaye et al., 2009; Simmelink, 2014; MRACP, 
2014). However, the study also found, in line with studies done elsewhere  (such as Bassett et al., 
2014), that linkage to care was higher from facility-based than from mobile/outreach sites:  84% 
(CI= 81% -87%, n= 512) of individuals tested at facility-based were linked to care, compared to 
69% (CI= 65% -74%, n=281) of individuals tested at mobile/outreach in the same period. This 
paper also reported that individuals tested at facility-based sites entered HIV care sooner than the 
individuals tested at the mobile/outreach sites, but that overall, newly diagnosed clients linked to 
care soon in both models. This also is an important and novel finding. The median time to linkage 
was 1 day (IQR: 1-7.5) for facility-based and 6 days (IQR: 3-11) for mobile/outreach sites. While 
the higher rates of timely linkage to care from both models of testing are encouraging, this study 
nevertheless found that participants tested at the facility-based sites were 78% more likely to link 
than those tested at mobile/outreach sites, when other variables were controlled (AHR=1.78; 
95%CI: 1.52-2.07). The study revealed that disclosure of HIV status was a significant factor 
associated with timely linkage to care: participants who disclosed their HIV status had a 35% 
earlier rate of linkage to care compared to participants who did not disclose their HIV status. 
Clients who reported that they tested because they wanted to get treatment for HIV (suspecting 
that they were HIV-positive) were 25% more likely to link to care. The difference between the two 
models of testing and the subsequent linkage to care appears in large part to reflect a more 
“treatment ready” population testing at facility-based sites, than the population testing at the 
mobile sites. Nevertheless, the study also confirmed that mobile/outreach testing models bring 
HIV testing services closer to people, but that more efforts and strategies are needed to improve 
linkage from mobile/outreach models. 
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Results reported in Chapter 5 (Paper Two) showed that a total of 11,733 individuals received HIV 
testing services at either mobile or facility-based testing study sites during the study period. More 
people (56%) tested at the mobile/outreach site compared to the facility based sites (44%), more 
women (55%) attended HIV testing services than males and the mean age was 33 years. Most 
clients were married and self-employed in small-scale businesses. The difference was seen in the 
HIV testing sites: the mobile sites were actively following people up in their homes, and HIV 
testing was predominantly done out of hospital premises, with some activities that attracted more 
people to come for testing, while at the facility-based sites testing was passive on the part of the 
staff, or routine through a PITC approach. Despite having more people testing at the 
mobile/outreach sites than the facility-based sites, HIV prevalence was higher in the facility testing 
group (21.5%) compared to the mobile/outreach group’s 7.9%.  After post-test counselling, the 
care providers explained the available options for linkage to care and provided the clients with 
referral letters to show in the HIV care section. Processes and procedures in the HIV care section 
were similar for all clients, regardless of where they had tested, but even once they reached a CTC, 
clients who had tested at mobile/outreach sites showed statistically significant delays in nearly 
every step of the process, from registration to the clinician’s decision to start or not start ART. 
These likely reflect a combination of having to return to the facility repeatedly and being 
unfamiliar with the facility procedures and routines. Nevertheless, the proactive, client-centred 
care at the mobile/outreach sites and respondents’ appreciation of the confidentiality and privacy 
at these sites do not translate into linkage to care equal to that of clients who tested at facility-
based sites. 
In Chapter 6 (Paper Three), we sought to explore the multiple factors identified as influencing 
linkage to care. The study showed that the factors that facilitated linkage to care at the individual 
level were: disclosure of HIV status to someone (spouse, family member, relative or friend), 
support from family/relatives, and having symptoms of disease at the time of diagnosis. On the 
other hand, fear of stigma, lack of disclosure, denial, being asymptomatic, and belief in witchcraft 
were barriers identified at the level of individuals. At the provider level, support and good patient-
staff relationships facilitated linkage, while negative provider attitudes and use of abusive 
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language to patients were reported barriers to successful linkage. Clear referral procedures and 
well-organized clinic procedures were system-level facilitators of linkage, whereas poorly-
organized clinic procedures and visit schedules, overcrowding, long waiting times, and lack of 
resources (including human resources and equipment) were reported barriers. Distance and 
transport costs to HIV care centres were important contextual factors influencing linkage to care. 
It was noted that access and linkage to care are influenced positively and negatively at all levels, 
but the individual-level and health system-level factors were most prominent in this setting, rather 
than healthcare provider and contextual factors. 
 
7.3. Discussion of findings 
This section discusses the study findings in relation to the literature and to the policy aims of the 
Ministry of Health in Tanzania. The discussion is structured according to the objectives of the 
study and concludes with the conceptual framework. 
7.3.1 Uptake of HIV testing at mobile/outreach vs. facility sites 
As part of government’s response to HIV/AIDS in Tanzania, mobile and outreach HIV testing 
services were instituted to complement existing approaches of HIV testing in hospital settings in 
the country, and to expand services to remote areas and hard-to-reach communities. In this study, 
it was found that HIV testing was higher in the mobile/outreach sites compared to the facility-
based sites. In the mobile sites, services are provided by care providers who are not from within 
the community, and due to this anonymity, people felt their results will remain confidential, 
echoing similar findings and reasons for choosing to test at outreach services reported in other 
studies conducted in sub-Saharan African countries (MRACP, 2012; Bassett et al., 2015;  Meehan 
et al. 2014). This underlines the importance of using combined approaches, recommended by the 
WHO (2012), to increase knowledge of HIV status in people who may not otherwise have tested.  
The study showed that the proportion of clients who tested HIV positive was significantly higher 
amongst those who tested in fixed facilities compared to those who tested in the mobile/outreach 
sites. A reason for this may be that individuals who tested at the facility had a medical condition 
that pushed them to seek health care and eventually resulted in an HIV diagnosis. At the mobile 
site, some clients were passing by or heard an announcement for free HIV testing, and tested just 
http://etd.uwc.ac.za/
121 
 
because there was an opportunity (Ostermann et al., 2011; Meehan et al., 2014). The significantly 
lower rates of positive HIV test results in the mobile testing group suggests that more people may 
be hoping for and expecting confirmation that they are HIV negative, in contrast to both the higher 
HIV rates and the respondent reports of testing because they felt sick at the facility-based sites. 
HIV-positive individuals in this group may need very high-quality post-testing counseling and 
further assistance and support with linkage to care. Studies conducted in Uganda, Lesotho and 
South Africa showed that assisted or facilitated linkage increased rates of linkage among newly 
HIV diagnosed clients (Labhardt et al., 2014; Sharma et al., 2015; Ware et al., 2016). 
 
7.3.2. Linkage to care and time to linkage 
Timely HIV diagnosis and effective linkage into care and treatment are key to improved HIV 
management outcomes (Kranzer et al., 2010; Suthar et al., 2013). All individuals diagnosed as 
HIV positive must be linked to HIV care and treatment, even if local treatment guidelines do not 
indicate that a person should be started on anti-retroviral therapy immediately (MOH, 2013; Suthar 
et al., 2013). This study showed an overall improvement in linkage to care compared to earlier 
studies on linkage to care in rural areas and hard-to-reach populations (Nsigaye et al., 2009; 
MRACP, 2014; Simmelink, 2014), likely due in part to increased community knowledge about 
HIV/AIDS and the importance of using ART, following the ongoing educational programs in the 
country. The overall linkage to care has increased significantly since a low rate of 14% was 
reported in a study published in 2009 (Nsigaye et al., 2009) and 23% in a second study published 
in 2014 (Simmelink, 2014). The data for the first study was collected in 2006-2008, and for the 
second study in 2012-2013. Data for the study reported in this thesis was collected between August 
2014 and July 2015. The overall retention for this cohort was 83%, which is a very high retention 
rate for a field cohort study in rural areas. The increase in linkage to care probably reflects a 
combination of major efforts by government and partners to increase community knowledge about 
HIV/AIDS and the importance of ART, and significant efforts to improve and standardize the 
procedures for testing, counselling, referral, registration, and evaluation of need for care across all 
facilities in Tanzania, including government and NGO programmes. For example, a campaign has 
been in place since 2013 advocating for people to know their HIV status and educating people 
about the benefits of using ART. These efforts at outreach to communities and improvement of 
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clinical and organizational practice have been translated into policies and guidelines that are being 
implemented in the region. This is discussed further in section 7.3.3. below. 
 Based on the evolution of HIV testing and treatment across Eastern and Southern Africa between 
2006 and 2015 and the increases in access to anti-retroviral therapy reported across the region, we 
believe that it is indeed possible and even likely that linkage to care has increased significantly. 
Our study found that linkage to care in the group of people tested through the facility-based 
approach was significantly higher compared to the group tested through the mobile/outreach 
services. More people were linked to care, and they linked modestly sooner, in the health facility 
than mobile clinic arm. The study supports findings elsewhere that outreach testing methods are 
effective in improving the uptake of HIV testing, but linkage to care after testing positive is lower 
in the outreach testing approaches (Bassett et al., 2014; Hatcher et al., 2013).    
We found that the majority of participants who reported, “Wanting to receive treatment in case 
they are infected with HIV” as one of the reasons for testing for HIV, tested at facility-based sites 
(Paper I). The reasons for seeking to test, particularly being symptomatic or suspecting infection, 
are not only important in deciding where to test, but also strongly influence linkage to care after 
testing. These findings align with earlier studies in Kenya and South Africa, and systematic 
reviews and meta-analysis of community and facility-based HIV testing (Hatcher et al., 2013; 
Bassett et al., 2014; Genberg et al., 2015; Sharma et al., 2015). Studies conducted in South Africa 
found that delay in seeking medical attention for newly-diagnosed individuals was associated with 
being asymptomatic, not expecting to get an HIV positive test result, and having difficulty in 
disclosing their status to others (Medley et al., 2013; Naik et al., 2015). Our findings and their 
interpretation are in line with these recent studies.  
Our study compared not only the proportions of linkage to care, but also looked at the reasons for 
testing and determinants for linkage into care. Sharma et al. (2015) reviewed different HIV testing 
modalities, assessing their relative impact in covering the gap of low HIV testing uptake, especially 
among men, in sub-Saharan Africa. Their study highlighted the importance of expanding HIV 
testing services, suggesting follow up and support to help HIV-positive clients link to care. It was 
pointed out that immediate initiation of ART leads to better outcomes and improves the quality of 
life in people living with HIV.   
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Disclosure of HIV serostatus to partners and/or family members was strongly associated with 
earlier linkage to care, compared to those who did not disclose to partners and/or family 
members/relatives (Hodgson et al., 2014; Ostermann et al., 2015). These findings deepen our 
understanding of determinants of linkage to HIV care and underline the continued importance of 
facilitating disclosure and social support. Despite progress in “normalizing” HIV, and increases in 
testing and linkage in Tanzania and other African countries over a few years, disclosure, stigma 
and perceived or real lack of support are still very important barriers for linkage and engagement 
to HIV care (Mbonu et al., 2009; Aransiola et al., 2014).   
 
7.3.3 Processes and dynamics of linkage to care  
Both mobile and facility-based HIV testing sites and HIV care and treatment centres attended to 
the clients in accordance with the National guidelines for HIV testing and HIV management 
(MOH, 2013; MOHsw, 2015). Recently, the WHO released new guidelines for ART programs, 
encouraging immediate initiation of treatment for all individuals who are HIV-positive,  towards 
the achievement of the 90-90-90 goal by 2020 (Olney et al., 2016; WHO, 2016). Tanzania is 
among the countries that have adopted this recommendation, but the rapid changes in management 
of HIV/AIDS may pose challenges for all facilities trying to follow current guidelines 
immediately. The fact that the facilities in our study, from districts purposely chosen because they 
are remote with hard-to-reach populations, were following guidelines is a significant and 
encouraging finding, associated with dramatic increase in linkage to care outcomes compared to 
studies done some years ago (Nsigaye et al., 2009; MRACP, 2014; Simmelink, 2014). 
The processes and procedures for linkage at the HIV care and treatment centres were similar for 
all clients, regardless of the site of testing. Since HIV care services such as CD4 count testing, 
HIV staging, and ART initiation are not available in the mobile /outreach sites, referral procedures, 
client follow-up and decreasing barriers to access at all levels where linkage can be interrupted is 
very important. The study showed that after HIV positive diagnosis and post-test counselling, the 
care providers explained the available options for further care, and provided the clients with 
referral letters for them to go on their own to the CTCs of their choice. However, there are an 
increasing number of individuals testing at the mobile sites who may be asymptomatic at the time 
of diagnosis and are probably not expecting positive test results, meaning that they are less likely 
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to link with further HIV care. Thus, more efforts, such as client follow-up and assisted linkage 
(active referral), need to be done, rather than just giving a referral letter and leaving the client to 
go on their own. A systematic review of HIV testing and linkage to care in sub-Saharan Africa, 
published after the data collection for this study was completed, pointed out the potential impacts 
of supporting and following-up HIV-positive clients to ensure they link into care and benefit from 
ARTs (Sharma et al., 2015).  Studies have suggested that the use of combined interventions, like 
voluntary counselling and testing with point-of-care CD4, active referral system and outreach 
activities to improve linkage and engagement in the HIV care cascade, may contribute to high 
impact and success in universal test and treat strategies (Gardner et al., 2011; Rio, 2011; Olney et 
al., 2016;). 
The processes in the two models examined in this study differed. However, one of the important 
findings is that despite a more proactive and “client-centred” approach in the mobile sites, linkage 
to care was faster and at higher rates from the facility-based sites. This reflects both the advantages 
of system-level integration at the sites in this study, as well as the particular challenges faced by 
clients who are unlikely to come to a facility to test, and who are also unready to receive and act 
on a positive test result.  These findings can inform the development and adaptation of strategies 
to respond to the challenges of newly HIV diagnosed individuals and can be responsive to the 
health system challenges to successful linkage to care. 
 
7.3.4 Facilitators and barriers for successful linkage to care at the patient, provider, health 
system and contextual levels 
Available literature on linkage to care indicates that while studies are increasingly exploring 
barriers to linkage to HIV treatment and in various settings (Bhatia & Giordano, 2011; Gardner et 
al., 2011; Rosen & Fox, 2011; Bogart et al., 2013; Wachira et al., 2014; Sharma et al., 2015;), 
fewer studies have looked at the facilitating factors, and even fewer have explored both together 
(Hatcher et al., 2013; Layer et al., 2014; Ware et al., 2016). We therefore sought to add to the 
literature and deepen understanding of linkage to care by exploring the facilitators and barriers to 
linkage into HIV care after testing HIV positive, from both facility-based and mobile/outreach 
HIV testing sites.  
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In this study, we conceptualized a framework of factors reported to inhibit or enhance linkage, 
based on the available literature (Figure 2 page 23, chapter 3). The data collected from this study 
showed that multiple factors influence linkage to care in newly HIV positive diagnosed 
individuals, and we identified these factors under four levels: individual, healthcare provider, 
health system, and contextual levels. The framework was very useful in identifying areas that need 
improvement at different levels of the HIV care continuum. This study found that while access 
and linkage to care are influenced by actors and process at all of the levels in the framework, the 
individual-level and health system-levels barriers were most prominent.  
At the individual level, stigma, denial, lack of disclosure, and being asymptomatic at the time of 
diagnosis were identified as very important barriers to linkage to care. These findings correspond 
with other similar studies in HIV (MacPherson et al., 2012; Hodgson et al., 2014;  Ostermann et 
al., 2015; Fatoki, 2016). Factors such as stigma and problems in disclosure are still persistent, 
despite increased HIV awareness programs and education through radio, television, and posters in 
Tanzania. We suggest the need for more community-level educational programs and community 
HIV-support groups, as these strategies have shown potential in alleviating the problem in other 
recent studies (Hodgson et al., 2014; Ostermann et al., 2015). The fact that some people do not see 
the importance of seeking medical care when they do not have any symptoms also needs more 
attention from the healthcare provider’s side. During post-test counselling, the importance of being 
in HIV care and support should be emphasized, whether the client has symptoms of illness or not. 
The study revealed that the patient-staff relationship was generally good, and staff are well-trained 
in HIV care management, which is consistent with their observed ability to do their duties 
according to the guidelines. In a few sites, clients complained of a poor relationship with staff. 
However, in this study, the healthcare providers in some instances suggested that while negative 
relationships with clients do occur, these are related to a shortage of staff at the site, and consequent 
high workloads. The study findings suggest further research on this aspect is required, and 
emphasize that basic resources, effective management, and supportive supervision issues need to 
be addressed within a health system to improve the interpersonal quality of healthcare (Cowing et 
al., 2009; Lamarche et al., 2011). As years of experience, training and professionalism around 
HIV/AIDS increases, there is more positive attitude and support from service providers, but still 
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not enough to overcome stigma, fear, and structural or organizational barriers and inconvenience 
(Ledda et al., 2017). 
At the health system level, clinic overcrowding, poor organization of the clinics, shortage of 
resources (staff, equipment, reagents), and long waiting times came across strongly from both the 
HIV-positive individuals and the healthcare providers as a hindrance for linkage to care. Well-
organized clinic systems, with HIV testing and HIV care services in one place, and availability of 
a referral system were reported to facilitate linkage, and these findings align with other studies 
conducted in Tanzania, Uganda, Kenya and South Africa (Govindasamyet al., 2012; Hatcher et 
al., 2013; Nakigozi et al., 2013; Layer et al., 2014). Poor linkage and delayed entry into HIV care 
management after positive HIV diagnosis hamper efforts to improve coverage for HIV care and 
treatment services (Macpherson et al., 2012; Gerdts et al., 2014). It is therefore important to 
understand the determinants and factors that may influence successful linkage to care in order to 
inform strategies that will address the problem of low rates of linkage to care comprehensively 
along the entire process. 
Below is the conceptual framework for factors influencing linkage to care, with the study 
findings incorporated into the framework. 
 
Figure 7.1: Conceptualizing the factors influencing linkage to HIV care in Mbeya, Tanzania 
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7.4. Conclusion 
Early HIV diagnosis, timely linkage to care, and immediate initiation of ART are critical 
ingredients to achieving the 90-90-90 goal by 2020 (Rio, 2011; Haber et al., 2017). Individuals 
diagnosed as HIV positive must be linked to HIV care and be initiated onto ART for better 
outcomes of HIV management, and prevention of further transmission to others. There is a need 
for special emphasis to link clients who test outside of clinic setting sites into care because these 
are the people who are more likely not to seek further medical attention. Clients testing at the 
mobile outreach services had a lower probability of testing positive (only 7% of clients who tested 
at the mobile sites tested positive, compared to 21% at facility-based sites), meaning that a positive 
test result may be unexpected for them. This is in comparison to those clients who test in facility-
based sites, as they may suspect that they have HIV based on the symptoms that led them to seek 
or accept testing at a health facility (Paper 1). Since clients testing at mobile sites explicitly 
mentioned privacy and confidentiality as reasons for avoiding local health facilities, these are the 
people who need high-quality post-test counselling and support from the healthcare providers and 
referral system, to ensure that they link into care and benefit from ART. 
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CHAPTER EIGHT 
CONCLUSIONS AND RECOMMENDATIONS 
 
8.1 Conclusions 
 
8.1.1 Study conclusions in relation to the study objectives 
This study sought to document and analyze linkage to care in remote areas and hard-to-reach 
populations in rural Tanzania. At the time of this study, there was limited literature on HIV testing 
and linkage to care, and reported rates of linkage to care in Tanzania in 2009 and 2012 were very 
low. The findings of this study contribute to the limited knowledge on linkage to care, comparing 
two models of HIV testing services through a prospective mixed-method cohort study.  
In response to objective 1, describing and comparing the populations accessing testing at 
mobile/outreach versus fixed/facility-based testing sites, our study found that more people tested 
at the mobile/outreach sites than at the facility based sites, and that more women than men tested 
in both arms. This finding reinforces the importance of expanded HIV testing services in out-of-
hospital settings. 
In response to objective 2, measuring and comparing time to linkage to care and factors associated 
with early linkage in the models of HIV testing, this study showed a substantial overall 
improvement in linkage to care compared to earlier studies in rural areas. Nevertheless, linkage to 
care in the group of people tested through the facility-based approach was significantly higher 
compared to those who tested at mobile/outreach services. Secondly, the disclosure of HIV 
serostatus to someone was strongly associated with earlier linkage to care, and HIV testing being 
sought in order to access treatment was modestly associated with earlier linkage to care. These 
findings suggest the need for increased strategies focused on facilitating linkage to care and the 
continued need for programs to normalize HIV in communities to reduce the stigma attached to 
the disease. 
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In response to objective 3, describing and comparing the processes and dynamics of linkage to 
care in the two models, the study findings suggest that while there are differences in the 
organization of services and the degree of proactive, client-centered care between the two models 
(with mobile/outreach sites being more proactive), there were no major differences in the processes 
and procedures of linkage to care in relation to Tanzanian policy and guidelines. All sites adhered 
well to national guidelines. The qualitative differences observed by the researchers and reported 
by study participants did not explain the differences in linkage to care between the two models. 
Once patients arrive at registration, they are managed roughly the same regardless of the testing 
site, though clients who tested at mobile sites were found to have slight delays at most steps 
between registration and initiating treatment or care.   
In response to objective 4, identification of facilitators and barriers influencing linkage to HIV 
care services, the study revealed that access and linkage to care may be influenced positively and 
negatively at different levels (i.e. individual-level, provider-level, health system-level and 
contextual levels), in line with findings elsewhere. However, individual and health system factors 
were most prominent in this setting.  
 
8.1.2 Overall conclusions 
Overall rates of linkage to care have improved dramatically from the 14% and 28% reported in 
2009 and 2014. However, findings from this study suggest that although mobile/outreach service 
delivery models bring HIV testing services closer to people in remote and resource-constrained 
areas, and do increase testing, there is still a significant gap in timely linkage to HIV care compared 
to sites within established health facilities. This study also found that in this setting, health system 
organizational factors, such as on-site services and well-functioning routine procedures, are of 
particular importance in facilitating linkage to care: these organizational factors, together with the 
individual-level factors related to reasons for testing and readiness or willingness to accept an HIV 
diagnosis and seek care, are powerful determinants of linkage. Even though the long waiting times 
at care and treatment centres could themselves be a significant barrier to the linkage, overcoming 
stigma, fear, and logistical barriers are of primary importance. Strategies that are more effective 
are needed to further improve linkage through the mobile/outreach model of service delivery, 
including increased attention to effectively communicating the importance of linkage to care and 
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adherence to HIV treatment and providing additional support. However, if the highly motivated, 
proactive and supportive health workers identified in the mobile sites are to make a difference, the 
health system challenges to linkage to care must be addressed.  
 
8.2. Recommendations 
In light of the high HIV testing uptake but low linkage to HIV care through the mobile/outreach 
testing models compared to facility-based testing, we recommend further focused action to 
improve linkage to care for the people testing in the mobile/outreach HIV testing sites. This 
should include increased efforts to effectively communicate the importance of linkage to care for 
people who are asymptomatic at the time of diagnosis, and improvement of referral procedures, 
support for disclosure to a trusted friend or relative, and follow-up and support to all newly-
diagnosed clients. We also recommend further research on the use of assisted or facilitated 
linkage, since it has shown potential to improve linkage to care in some studies conducted in 
sub-Saharan African countries.  
Multiple level factors were found to influence individuals’ decisions and actions influencing 
linkage to care, and stigma, denial and lack or failure to disclose were particularly important. We 
echo existing recommendations for improvement in counselling strategies and expansion of 
community-level educational programs to hard-to-reach populations. While our study did not 
directly address communities, the findings are in line with suggestions for the establishment of 
HIV support groups and community interaction programs, to discuss and address HIV stigma-
related matters and lack of disclosure in the community. 
Considering that in this region more people show a preference for receiving HIV testing at 
mobile sites, further research is needed to evaluate the possibilities of offering Mobile ART 
services, as the new WHO guidelines recommend that HIV-positive individuals start ART right 
away, regardless of CD4 count or the stage of HIV. 
Realizing the need to improve HIV care clinics and procedures for the provision of better quality 
of care and treatment services to HIV-positive individuals, and recognizing the very low number 
of facilities offering HIV care and shortage of staff in the study area, we encourage the Ministry 
of Health to accelerate the implementation of policies to address the human resource crisis in the 
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health sector, and specifically to explore possibilities of increasing the number of CTCs and staff 
in Mbeya region. 
 
8.3 Strengths and limitation of the study 
The strength of this study is its longitudinal mixed methods comparative design, with various 
stakeholders (healthcare providers, and HIV positive individuals), different data collection 
methods (structured interviews, observation, FGDs, and IDIs) and multiple sites (16 sites) used to 
elicit information relevant to the study.  However, this study had some limitations: 
Despite a random selection of sites to be included in the study, all eight facility-based sites had 
CTCs on the same campus. This limits the generalizability of the findings, as these sites may not 
be representative of all facility-based testing sites. This selection bias in the study also means that 
the comparison was between mobile/outreach testing sites and facility-based testing sites with 
immediately contiguous care and treatment centres. 
Due to limited resources, we were able to only follow up participants for six months; it is possible 
that other participants entered into care later.   
Although retention in the cohort was good (76% in the mobile arm and 87% in the facility-based 
arm), we were not able to reach all clients during the study period, despite efforts to track them 
through telephone calls by the study team, CTC and community-based healthcare providers in 
their respective areas. It may be that the clients moved to other places due to prevailing trade routes 
with extensive cross-border activities, and it is possible that some of them may have sought care 
elsewhere. This represents a selection bias in the study which may have led to underestimating 
linkage to care from mobile sites, as all clients lost to follow-up were treated as not linked to care.  
In the identification of the challenges and facilitators for linkage to care, the study interviewed 
individuals who were linked to care. We did not have access to those individuals who tested HIV 
positive but were not registered in care.  
The study design included contacting newly-diagnosed individuals who were enrolled in the cohort 
for follow-up questionnaire administration. This follow-up may have influenced their decision to 
http://etd.uwc.ac.za/
132 
 
link to care, thus potentially artificially increasing the rates and timeliness of linkage to care in 
both arms of the study. 
The study was unable to compute a possible clustering effect because we did not have a basis on 
which to estimate clustering/design effects as there were no similar studies conducted in the setting 
at the time; therefore our assumption was that there was no clustering effect and we set the design 
effect at 1. However, we are currently undertaking further analysis to look for any significant 
intraclass correlation coefficient (ICC) and if a significant ICC is found will conduct a further 
multilevel modelling analysis for an additional manuscript beyond the dissertation.    
While we found that the mixed FGDs were rich and gender-specific complementary themes 
emerged from the individual interviews, we did not conduct separate men’s and women’s FGDs 
which may have yielded additional themes. 
This study focused on HIV testing and linkage to care but did not focus on the broader health 
system issues like management and leadership in the sites. This may require further investigation 
to address issues around leadership and health systems management. 
 
 
 
 
 
 
  
http://etd.uwc.ac.za/
133 
 
 
9. Reference List 
AmfAR. (2015). “amfAR-Statistics,” Statistics. World Wide. SUb Saharan Africa, 2015. 
[Online]. http://www.amfar.org/worldwide-aids-stats/. Accessed: 01-Aug-2015. 
AMREF. (2012). African Medical and Research Foundation - Tanzania annual Report 
2011/2012. [Online]. http://doi.org/10.1002/ejoc.201200111. Accessed 02 Jun 2016. 
Aransiola, J., Imoyera, W., Olowookere, S., & Zarowsky, C. (2014). Living well with HIV in 
Nigeria? Stigma and survival challenge preventing optimum benefit from an ART clinic. Global 
Health Promotion, 21(1), 13–22. http://doi.org/10.1177/1757975913507297. 
Arroyo, M. A., Hoelscher, M., Sateren, W., Maboko, L., Hoffmann, O., Kijak, G., Robb, M., 
Birx, D. & Mccutchan, F. E. (2005). HIV-1 diversity and prevalence differ between urban and 
rural areas in the Mbeya region of Tanzania, (February), AIDS, 19:1517–1524. 
AVERT. (2015). HIV and AIDS Tanzania. [Online].https://www.avert.org/infographics/hiv-and-
aids-tanzania-2015. Accessed 20 May 2016. 
AVERT. (2016). HIV and AIDS : East and Southern Africa regional overview. [Online]. 
https://www.avert.org/professionals/hiv-around-world/sub-saharan-africa/overview. Accessed 07 
Jul 2017. 
AVERT (2017). HIV and AIDS in Tanzania. Global statistics. [Online] 
www.avert.org/professionals/hiv-around-world/sub-saharan-africa/tanzania. Accessed 11 March 
2018. 
Bassett, I., Regan, S., Luthuli, P., Mbonambi, H., Bearnot, B., Pendleton, A., Robine, M., 
Mukuvisi, D., Thulare, H., Walensky, RP., Freedberg, KA., Losina E. & Mhlongo, B. (2014). 
Linkage to care following community-based mobile HIV testing compared with clinic-based 
testing in Umlazi Township, Durban, South Africa. HIV Medicine, 15 (6), 367–372. 
http://doi.org/10.1111/hiv.12115 
http://etd.uwc.ac.za/
134 
 
Bassett, I. V., Regan, S., Mbonambi, H., Blossom, J., Bogan, S., Bearnot, B., Robine M., 
Walensky RP., Mhlongo B., Freedberg KA,Thulare H.  & Losina E . (2015). Finding HIV in 
Hard to Reach Populations: Mobile HIV Testing and Geospatial Mapping in Umlazi Township, 
Durban, South Africa. AIDS Behaviour, 19 (10). 
http://doi.org/10.1097/ACI.0000000000000108. 
 
Bassett, I. V. & Walensky, R. P. (2010). Integrating HIV Screening into Routine Health Care in 
Resource-Limited Settings. Clinical Infectious Diseases, 50 (Supplement_3), S77-84. 
http://doi.org/10.1086/651477 
Bhatia, R. & Giordano, T. P. (2011). Persons Newly Diagnosed with HIV Infection are at High 
Risk for Depression and Poor Linkage to Care: Results from the Steps Study. AIDS and 
Behavior, 15 (6), 1161–1170. http://doi.org/10.1007/s10461-010-9778-9. 
Bogart, L. M., Chetty, S., Giddy, J., Sypek, A., Sticklor, L. & Walensky, R. P. (2013). Barriers 
to care among people living with HIV in South Africa : Contrasts between patient and healthcare 
provider perspectives, AIDS Care. 25 (7):843-53. doi: 10.1080/09540121.2012.729808. 
Cabral, H. J., Tobias, C., Rajabiun, S., Sohler, N., Cunningham, C., Wong, M. & Cunningham, 
W. (2007). Outreach Program Contacts: Do They Increase the Likelihood of Engagement and 
Retention in HIV Primary Care for Hard-to-Reach Patients? AIDS Patient Care and STDs, 21 
(s1), S-59-S-67. http://doi.org/10.1089/apc.2007.9986 
Cawley, C., Wringe, A., Todd, J., Gourlay, A., Clark, B., Masesa, C.,  Machemba, R., Reniers, 
G., Urassa, M. & Zaba, B. (2015). Risk factors for service use and trends in coverage of different 
HIV testing and counselling models in northwest Tanzania between 2003 and 2010. Trop Med 
Int Health, 20 (11), 1473–87. http://doi.org/10.1111/tmi.12578 
CDC. (2016). Implementing HIV Testing in Nonclinical Settings A Guide for HIV Testing 
Providers. [Online]. 
https://www.cdc.gov/hiv/.../testing/cdc_hiv_implementing_hiv_testing_in_nonclinical. Accessed 
12 May 2017. 
http://etd.uwc.ac.za/
135 
 
Cowing, M., Davino-Ramaya, C. M., Ramaya, K. & Szmerekovsky, J. (2009). Health care 
delivery performance: service, outcomes, and resource stewardship. The Permanente Journal, 13 
(4), 72–8. 
Creswell JW. A concise introduction to mixed methods research. Los Angeles: Sage Publications 
Inc; 2015. 
 
Cummings, B., Gutin, S. A., Jaiantilal, P., Correia, D., Malimane, I. &  Dawson, R.C. (2014). 
The Role of Social Support Among People Living with HIV in Rural Mozambique. AIDS 
Patient Care & STDs, 28 (11), 602–612. http://doi.org/10.1089/apc.2014.0193 
Dima, A., Stutterheim, S., Lyimo, R. & Marijn de Bruin, M. (2014). Advancing methodology in 
the study of HIV status disclosure:The importance of considering disclosure target and intent. 
Social Science & Medicine, 108.166-174. doi: 10.1016/j.socscimed.2014.02.045 
Dombrowski J. (2013). Linkage to Care Case Study. [Online] 
depts.washington.edu/nwaetc/presentations/uploads/109/linkage_to_care.pdf. Accessed 12 Jun 
2017. 
Elul, B., Ahoua, L., Tomo, M., Horowitz, D. & Mussa, A. (2014). A combination strategy for 
enhancing linkage to and retention in HIV care among adults newly diagnosed with HIV in 
Mozambique : study protocol for a site- randomized implementation science study. 
http://doi.org/10.1186/s12879-014-0549-5 
Evangeli, M., Newell, M.L. & McGrath, N. (2016). Factors associated with pre-ART loss-to-
follow up in adults in rural KwaZulu-Natal, South Africa: a prospective cohort study. BMC 
Public Health, 16 (1), 358. http://doi.org/10.1186/s12889-016-3025-x 
Fatoki, B. (2016). AIDS & Clinical Research Understanding the Causes and Effects of Stigma 
and Discrimination in the Lives of HIV People Living with HIV / AIDS : Qualitative Study, 
AIDS & Clinical Research. 7 (12). http://doi.org/10.4172/2155-6113.1000635 
Friese S. ATLAS. ti 7 User Guide and Reference. 2013. [online] http://atlasti.com/wp-
content/uploads/2014/05/atlasti_v7_manual_201312.pdf?q=/uploads/media/atlasti_v7_manual_2
01312.pdf. Accessed 15 May 2016. 
http://etd.uwc.ac.za/
136 
 
Gardner, E. M., McLees, M. P., Steiner, J. F., Del Rio, C., & Burman, W. J. (2011). The 
spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention 
of HIV infection. Clinical Infectious Diseases, 52 (6), 793–800. 
http://doi.org/10.1093/cid/ciq243 
 
Genberg, B. L., Naanyu, V., Wachira, J., Hogan, J. W., Sang, E., Nyambura, M., Odawa, M., 
Duefield,C.,Ndege, S. & Braitstein, P. (2015). Linkage to and engagement in HIV care in 
western Kenya: an observational study using population-based estimates from home-based 
counselling and testing. The Lancet HIV, 2 (1), e20–e26. http://doi.org/10.1016/S2352-
3018(14)00034-4 
Gerdts, S. E., Wagenaar, B. H., Micek, M. A., Farquhar, C., Kariaganis, M., Amos, J., Gimbel, 
S., Pfeiffer, J., Gloyd, S. & Sherr, K. (2014). Linkage to HIV care and antiretroviral therapy by 
HIV testing service type in Central Mozambique: a retrospective cohort study. Journal of 
Acquired Immune Deficiency Syndromes 66 (2), 37-44. 
http://doi.org/10.1097/QAI.0000000000000081. 
Govindasamy, D., Ford, N. &  Kranzer, K. (2012). Risk factors, barriers and facilitators for 
linkage to antiretroviral therapy care: a systematic review. AIDS, 26 (16):2059-67. doi: 
10.1097/QAD.0b013e3283578b9b 
Govindasamy, D., van Schaik, N., Kranzer, K., Wood, R., Mathews, C. & Bekker, L.G. (2011). 
Linkage to HIV Care From a Mobile Testing Unit in South Africa by Different CD4 Count 
Strata. JAIDS Journal of Acquired Immune Deficiency Syndromes, 58 (3), 344–352. 
http://doi.org/10.1097/QAI.0b013e31822e0c4c 
Grabbe, K., Menzies, N. & Taegtmeyer, M. (2010). Increasing Access to HIV Counselling and 
Testing Through Mobile Services in Kenya: Strategies, Utilization and Cost-Effectiveness. J 
Acquir Immune Defic Syndr., 54(3), 317–323.http://doi.org/10.1097/QAI.0b013e3181ced126. 
Haber, N., Tanser, F., Bor, J., Naidu, K., Mutevedzi, T., Herbst, K., Porter K., Pillay D. & 
Bärnighausen, T. (2017). From HIV infection to therapeutic response: a population-based 
http://etd.uwc.ac.za/
137 
 
longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa. The Lancet HIV, 3018 
(16), 1–8. http://doi.org/10.1016/S2352-3018(16)30224-7 
 Haber N, Tanser F, Naidu K, Muteyedzi T, Pillay D. &, Bärnighausen T. (2015). HIV System 
Assessment with Longitudinal Treatment Cascade in KwaZulu-Natal, South Africa, in 19th 
International Workshop on HIV Observational Databases. [Online] 
https://scholar.harvard.edu/noahhaber/publications/hiv-system-assessment-longitudinal-
treatment-cascade-kwazulu-natal-south. Accessed 13 March 2017. 
Hatcher, A. M., Kwena, Z. & Johnson, M. O. (2013). Counseling and Testing in Rural Kenya. 
AIDS Behavior, 16 (5), 1295–1307. http://doi.org/10.1007/s10461-011-0065-1. 
Hayes, R., Sabapathy, K. & Fidler, S. (2011). Universal Testing and Treatment as an HIV 
Prevention Strategy: Research Questions and Methods. Current HIV Research, 9, 429–445. 
http://doi.org/10.2174/157016211798038515 
Hodgson, I., Plummer, M. L., Konopka, S. N., Colvin, C. J., Jonas, E., Albertini, J., Amzel A. & 
Fogg, K. P. (2014). A systematic review of individual and contextual factors affecting ART 
initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS 
ONE, 9 (11). http://doi.org/10.1371/journal.pone.0111421 
Holzemer, W. L., Uys, L., Makoae, L., Stewart, A., Phetlhu, R., Dlamini, P. S., Greeff, M., Kohi, 
T.W., Chirwa, M., Cuca, Y. &  Naidoo, J. (2007). A conceptual model of HIV/AIDS stigma 
from five African countries. Journal of Advanced Nursing, 58 (6), 541–551. 
http://doi.org/10.1111/j.1365-2648.2007.04244.x 
Hulscher, M. E., Laurant, M. G. & Grol, R. P. (2003). Process evaluation on quality 
improvement interventions. Qual.Saf Health Care, 12 (1475–3898), 40–46. 
Hyle, E. P., Jani, I. V., Lehe, J., Su, A. E., Wood, R., Quevedo, J., Losina E., Bassett I.V., Pei 
PP., Paltiel AD., Resch S., Freedberg KA.,T. & Walensky, R. P. (2014). The Clinical and 
Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited 
Settings: A Cost-Effectiveness Analysis. PLoS Medicine, 11 (9). 
http://doi.org/10.1371/journal.pmed.1001725 
http://etd.uwc.ac.za/
138 
 
Kapologwe, N., Kabengula, J. & Msuya, S. (2011). Perceived barriers and attitudes of health 
care providers towards Provider-Initiated HIV Testing and Counseling in Mbeya region, 
southern highland zone of Tanzania. Pan African Medical Journal, 8 (17). 
Kapp, H., Olivier, D., & Ryan Martin. (2014). Tracking Linkage to care and support of HIV 
postive clients tested on Mobile testing units in South Africa. [Online]. 
http://www.iapac.org/EHNC/presentations/EHNC2014_OA07.pdf. Accessed 17 Jul 2016. 
 
Katz, I. T., & Maughan-Brown, B. (2017). Improved life expectancy of people living with HIV: 
who is left behind? The Lancet HIV, 3018 (17), 17–18. http://doi.org/10.1016/S2352-
3018(17)30086-3 
Keller, S. C., Yehia, B. R., Eberhart, M. G., & Brady, K. A. (2013). Accuracy of definitions for 
linkage to care in persons living with HIV. Journal of Acquired Immune Deficiency Syndromes 
(1999), 63(5), 622–30. http://doi.org/10.1097/QAI.0b013e3182968e87 
Kharsany, A. B. M. & Karim, Q. A. (2016). HIV Infection and AIDS in Sub-Saharan Africa: 
Current Status, Challenges and Opportunities. The Open AIDS Journal, 10 (1), 34–48. 
http://doi.org/10.2174/1874613601610010034 
Kiene, S. M., Kalichman, S. C., Sileo, K. M., Menzies, N. A., Naigino, R., Lin, C., Bateganya 
MH., Lule H. & Wanyenze, R. K. (2017). Efficacy of an enhanced linkage to HIV care 
intervention at improving linkage to HIV care and achieving viral suppression following home-
based HIV testing in rural Uganda : study protocol for the Ekkubo / PATH cluster randomized 
controlled trial. BMC Infect Dis.17 (1):460. doi: 10.1186/s12879-017-2537 
Kok, S., Rutherford, A. R., Gustafson, R., Barrios, R., Montaner, J. S. G. & Vasarhelyi, K. 
(2015). Optimizing an HIV testing program using a system dynamics model of the continuum of 
care. Health Care Management Science, 18 (3), 334–362. http://doi.org/10.1007/s10729-014-
9312-0 
Kranzer, K., Zeinecker, J., Ginsberg, P., Orrell, C., Kalawe, N. N., Lawn, S. D., Bekker, L.G. & 
Wood, R. (2010). Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. 
PLoS ONE, 5 (11), 1–6. http://doi.org/10.1371/journal.pone.0013801 
http://etd.uwc.ac.za/
139 
 
Labhardt, N. D., Motlomelo, M., Cerutti, B., Pfeiffer, K., Kamele, M., Hobbins, M. A. & Ehmer, 
J. (2014). Home-Based Versus Mobile Clinic HIV Testing and Counseling in Rural Lesotho : A 
Cluster-Randomized Trial. PLOS Medicine. 11(12). 
http://doi.org/10.1371/journal.pmed.1001768 
Labhardt, N. D., Ringera, I., Lejone, T. I., Masethothi, P., Thaanyane, T., Kamele, M., Gupta, 
R.S., Thin, K., Cerutti, B., Klimkait, T., Fritz, C3. & Glass, T. R. (2016). Same day ART 
initiation versus clinic-based pre-ART assessment and counselling for individuals newly tested 
HIV-positive during community-based HIV testing in rural Lesotho - a randomized controlled 
trial (CASCADE trial). BMC Public Health, 16. 329. http://doi.org/10.1186/s12889-016-2972-6 
Lamarche, P. A., Pineault, R., Gauthier, J., Hamel, M. & Haggerty, J. (2011). Availability of 
Healthcare Resources, Positive Ratings of the Care Experience and Extent of Service Use: An 
Unexpected Relationship. Healthcare Policy, 6 (3), 46–54. 
Lambert, V. A. & Lambert, C. E. (2013). Qualitative Descriptive Research: An Acceptable 
Design. Pacific Rim International Journal of Nursing Research, 16 (4), 255–256. 
Layer, E. H., Kennedy, C. E., Beckham, S. W., Mbwambo, J. K., Likindikoki, S., Davis, W. W., 
Deanna, L., Kerrigan, D.L. &  Massawe, E. (2014). Multi-level factors affecting entry into and 
engagement in the HIV continuum of care in Iringa, Tanzania. PLoS ONE, 9 (8). 
http://doi.org/10.1371/journal.pone.0104961 
Ledda, C., Cicciù, F., Puglisi, B., Ramaci, T., Nunnari, G. & Rapisarda, V. (2017). Attitude of 
health care workers (HCWs) toward patients affected by HIV/AIDS and drug users: A cross-
sectional study. International Journal of Environmental Research and Public Health, 14(3). 
http://doi.org/10.3390/ijerph14030284 
Leon, N., Mathews, C., Lewin, S., Osler, M., Boulle, A. & Lombard6, C. (2014). A comparison 
of linkage to HIV care after provider-initiated HIV testing and counselling (PITC) versus 
voluntary HIV counselling and testing (VCT) for patients with sexually transmitted infections in 
Cape Town, South Africa. BMC Health Services Research, 14 (350). 
Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic Inquiry (Ist Edition). London: Sage 
Publications. 
http://etd.uwc.ac.za/
140 
 
Losina, E., Bassett, I. V, Giddy, J., Chetty, S., Regan, S., Rochelle, P., Walensky, R.P., Ross, D., 
Scott, C.A., Uhler, L.M., Katz, J.N., Holst, H. &Freedberg, K. A. (2010). The “‘ ART ’” of 
Linkage : Pre-Treatment Loss to Care after HIV Diagnosis at Two PEPFAR Sites in Durban , 
South Africa, PLoS ONE 5 (3). http://doi.org/10.1371/journal.pone.0009538 
Lugada, E., Levin, J., Abang, B., Mermin, J., Mugalanzi, E., Namara, G., Gupta, S., Grosskurth, 
H., Jaffar, S., Coutinho, A. & Bunnel, R. (2010). Comparison of home and clinic-based HIV 
testing among household members of persons taking antiretroviral therapy in Uganda: results 
from a randomized trial. J Acquir Immune Defic Syndr, 55(2). doi: 
10.1097/QAI.0b013e3181e9e069 
Mabuto, T., Latka, M. H., Kuwane, B., Churchyard, G. J., Charalambous, S. & Hoffmann, C. J. 
(2014). Four models of hiv counseling and testing: Utilization and test results in South Africa. 
PLoS ONE, 9 (7). http://doi.org/10.1371/journal.pone.0102267 
Macpherson, P., Corbett, E. L., Makombe, S. D.,  Van-Oosterhout, J. J., Manda, E., Choko, A. 
T., Thindwa, D., Squire, S.B., Mann, G.H. & Lalloo, D. G. (2012). Determinants and 
Consequences of Failure of Linkage to Antiretroviral Therapy at Primary Care Level in Blantyre 
, Malawi : A Prospective Cohort Study, PLoS ONE 7 (9), 1–10. 
http://doi.org/10.1371/journal.pone.0044794 
MacPherson, P., MacPherson, E. E., Mwale, D., Squire, S. B., Makombe, S. D., Corbett, E. L., 
Lalloo, D. G. & Desmond, N. (2012). Barriers and facilitators to linkage to ART in primary care: 
A qualitative study of patients and providers in Blantyre, Malawi. Journal of the International 
AIDS Society, 15 (2), 1–10. http://doi.org/10.7448/IAS.15.2.18020 
Marks, G., Gardner, L. I., Craw, J. & Crepaz, N. (2010). Entry and retention in medical care 
among HIV-diagnosed persons: a meta-analysis. AIDS. 24 (17), 2665–2678. 
http://doi.org/10.1097/QAD.0b013e32833f4b1b 
Matovu, J. K. B. & Makumbi, F. E. (2007). Expanding access to voluntary HIV counselling and 
testing in sub-Saharan Africa: Alternative approaches for improving uptake, 2001-2007. Tropical 
Medicine and International Health, 12 (11), 1315–1322. http://doi.org/10.1111/j.1365-
3156.2007.01923.x 
http://etd.uwc.ac.za/
141 
 
Maulsby, C., Kinsky, S., Jain, K. M., Charles, V. & Holtgrave, D. R. (2015). Unpacking Linkage 
and Reengagement in HIV Care: A Day in the Life of a Posi...: EBSCOhost, 27(5), 405–417. 
http://doi.org/10.1521/aeap.2015.27.5.405 
Mayer, K. H. (2011). Introduction: Linkage, engagement, and retention in HIV care: Essential 
for optimal individual-and community-level outcomes in the era of highly active antiretroviral 
therapy. Clinical Infectious Diseases, 52 (SUPPL. 2), 205–207. http://doi.org/10.1093/cid/ciq043 
Mbonu, N. C., van den Borne, B. & De Vries, N. K. (2009). Stigma of People with HIV/AIDS in 
Sub-Saharan Africa: A Literature Review. Journal of Tropical Medicine, 2009, 1–14. 
http://doi.org/10.1155/2009/145891 
McGrath, N., Glynn, J. R., Saul, J., Kranzer, K., Jahn, A., Mwaungulu, F., Ngwira, M., 
Mvula,H., Munthali, F., Mwinuka, V., Mwaungulu, L., Paul EM Fine P. & Crampin, A. C. 
(2010). What happens to ART-eligible patients who do not start ART? Dropout between 
screening and ART initiation: a cohort study in Karonga, Malawi. BMC Public Health, 10 (1), 
601. http://doi.org/10.1186/1471-2458-10-601 
Medley, A., Ackers, M., Amolloh, M., Owuor, P., Muttai, H., Audi, B., Sewe M. & Laserson, K. 
(2013). Early uptake of HIV clinical care after testing HIV-positive during home-based testing 
and counseling in western Kenya. AIDS and Behavior, 17(1), 224–234. 
http://doi.org/10.1007/s10461-012-0344-5 
Meehan, S.A., Leon, N., Naidoo, P., Jennings, K., Burger, R. & Beyers, N. (2015). Availability 
and acceptability of HIV counselling and testing services. A qualitative study comparing clients’ 
experiences of accessing HIV testing at public sector primary health care facilities or non-
governmental mobile services in Cape Town, South Afr. BMC Public Health, 15 (1), 845. 
http://doi.org/10.1186/s12889-015-2173-8 
Meehan, S.A., Naidoo, P., Claassens, M. M., Lombard, C. & Beyers, N. (2014). Characteristics 
of clients who access mobile compared to clinic HIV counselling and testing services: a matched 
study from Cape Town, South Africa. BMC Health Services Research, 14 (1), 658. 
http://doi.org/10.1186/s12913-014-0658-2 
http://etd.uwc.ac.za/
142 
 
Miles, M., & Huberman, M. (1994). An expanded source book: Qualitative Data Analysis. In 
Sage Publications. 
MOH. (2013). National Comprehensive Guidelines for HIV Testing and Counselling. National 
AIDS Control Program (Vol. 80). [Online]. 
https://aidsfree.usaid.gov/sites/default/files/htc_tanzania_2013.pdf. Accessed 16 October 2017. 
MOHsw. (2014). HUMAN RESOURCE FOR HEALTH AND SOCIAL WELFARE, 
TANZANIA. [Online] https://www.jica.go.jp/project/tanzania/006/materials/ku57pq00001x6jyl-
att/HRHSP_2014-2019.pdf. Accessed at 22 Aug 2017. 
MOHsw. (2015). National Guideline for Management of HIV and AIDS 5th Edition-CIRcular of 
Revised guideline for management of HIV/AIDS. MOHsw.[Online]. 
www.nacp.go.tz/site/download/ nationalguideline2012.pdf . Accessed 15 Jun 2016 
MRACP. (2012). Mbeya Regional AIDS Control Program.-Annual Report. 
MRACP. (2014). Mbeya Regional AIDS Control Program-ANNUAL REPORT. 
MRHR. (2010). Mbeya Regional Hospital Report. Annual Report- Mbeya Region, Tanzania. 
Mugavero, M. J., Norton, W. E. & Saag, M. S. (2011). Health Care System and Policy Factors 
Influencing Engagement in HIV Medical Care : Piecing Together the Fragments of a Fractured 
Health Care Delivery System, Clin Infect Dis.52 (Suppl 2). http://doi.org/10.1093/cid/ciq048 
Mugglin, C., Estill, J., Wandeler, G., Bender, N., Egger, M. & Gsponer, T. (2012). Loss to 
programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan 
Africa : systematic review and meta-analysis, 17 (12), 1509–1520. http://doi.org/10.1111/j.1365-
3156.2012.03089.x 
Muhula, S., Memiah, P., Mbau, L., Oruko, H., Baker, B., Ikiara, G., Mungai, M., Ndirangu, M., 
Achwoka, D. & Ilako, F. (2016). Uptake and linkage into care over one year of providing HIV 
testing and counselling through community and health facility testing modalities in urban 
informal settlement of Kibera, Nairobi Kenya. BMC Public Health, 16 (1), 373. 
http://doi.org/10.1186/s12889-016-3033-x 
http://etd.uwc.ac.za/
143 
 
Musheke, M., Ntalasha, H., Gari, S., Mckenzie, O., Bond, V., Martin-Hilber, A. & Merten, S. 
(2013). A systematic review of qualitative findings on factors enabling and deterring uptake of 
HIV testing in Sub-Saharan Africa. BMC Public Health, 13 (1), 220. 
http://doi.org/10.1186/1471-2458-13-220 
NACP. (2012). National AIDS Control Program in Tanzania. [Online]. 
https://aidsfree.usaid.gov/sites/default/files/hts_policy_tanzania.pdf. Accessed 13 April 2017. 
NACP. (2014a). Global AIDS Response Country Progress Report-The united republic of 
Tanzania. [Online]. 
www.unaids.org/sites/default/files/country/.../TZA_narrative_report_2014.pdf. Accessed 28 Jul 
2016. 
NACP. (2014b). Global Aids Response Country Progress Report-United Republic of 
TANZANIA. Report.[Online]. 
www.unaids.org/sites/default/files/country/.../TZA_narrative_report_2014.pdf. Accesed 05 Aug 
2016. 
Naik, R., Doherty, T., Jackson, D., Tabana, H., Swanevelder, S., Thea, D. M.,  Feeley, F.G. & 
Fox, M. P. (2015). Linkage to care following a home-based HIV counselling and testing 
intervention in rural South Africa. Journal of the International AIDS Society, 18, 19843. 
http://doi.org/10.7448/IAS.18.1.19843 
Nakigozi, G., Atuyambe, L., Kamya, M., Makumbi, F. E., Chang, L. W., Nakyanjo, N., Kigozi, 
G., Nalugoda, F., Kiggundu, V., Serwadda, D., Wawer, M. & Gray, R. (2013). A qualitative 
study of barriers to enrollment into free HIV care: Perspectives of never-in-care HIV-positive 
patients and providers in Rakai, Uganda. BioMed Research International, 2013. 
http://doi.org/10.1155/2013/470245 
National AIDS Control Program. (2015). Tanzania National Guideline for Management of 
HIV/AIDS. Fifth Edition.[Online]. https://aidsfree.usaid.gov/sites/default/files/04_11_2016. 
tanzania_national_guideline_for_management_hiv_and_aids_may_2015._tagged.pdf. Accessed 
20 May 2016 
http://etd.uwc.ac.za/
144 
 
National Bureau of Statistics. (2013). 2012 POPULATION AND HOUSING CENSUS.[Online]. 
www.nbs.go.tz/nbstz/index.php/english/statistics-by.../population-and-housing-census. Accessed 
11 Mar 2017. 
Njau, B., Ostermann, J., Brown, D., Mühlbacher, A., Reddy, E. & Thielman, N. (2014). HIV 
testing preferences in Tanzania: a qualitative exploration of the importance of confidentiality, 
accessibility, and quality of service. BMC Public Health, 14, 838. http://doi.org/10.1186/1471-
2458-14-838 
Nsigaye, R., Wringe, A., Roura, M., Kalluvya, S., Urassa, M., Busza, J., & Zaba, B. (2009). 
From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access 
to antiretroviral therapy in rural Tanzania. Journal of the International AIDS Society, 12 (31). 
Olney, J., Braitstein, P., Eaton, J., Sang, E., Nyambura, M., Kimaiyo, S., McRobie, E., Hogan, 
J.W. & Hallett, T. (2016). Evaluating Strategies to Improve HIV Care Outcomes in Kenya: a 
modelling study. Lancet HIV, 3018 (16), 1–9. http://doi.org/10.1016/S2352-3018(16)30120-5 
Oruga, R., Janson, M., Hu, V., Frye, D., & Sayles, J. N. (2012). Factors Associated with Linkage 
to HIV Care among Recently Diagnosed Persons in Los Angeles County 2012 Estimated 
Number of Persons Living with HIV and AIDS in LAC. [Online]. 
http://publichealth.lacounty.gov/dhsp/Presentations/ScienceSummitLTC7-12.pdf. Accessed 23 
Feb 2014 
Ostermann, J., Pence, B., Whetten, K., Yao, J., Itemba, D., Maro, V., Reddy, E. & Thielman, N. 
(2015). HIV serostatus disclosure in the treatment cascade: evidence from Northern Tanzania. 
AIDS Care, 27 Suppl 1 59–64. http://doi.org/10.1080/09540121.2015.1090534 
Ostermann, J., Reddy, E. A., Shorter, M. M., Muiruri, C., Mtalo, A., Itemba, D. K., Njau, B., 
Bartlett, J.A. Crump, J.A & Thielman, N. M. (2011). Who tests, who doesn’t, and why? Uptake 
of mobile HIV counseling and testing in the kilimanjaro region of Tanzania. PLoS ONE, 6 (1). 
http://doi.org/10.1371/journal.pone.0016488 
Philbin, M. M., Tanne, A. E., DuVal, A., Ellen, J. M., Xu, J., Kapogiannis, B., Bethel, J. & 
Network, T. (2015). Factors Affecting Linkage to Care and Engagement in Care for Newly 
http://etd.uwc.ac.za/
145 
 
Diagnosed HIV-Positive Adolescent medicine clinics in the United States. Aids Behaviour, 
18(8), 1501–1510. http://doi.org/10.1007/s10461-013-0650-6. 
PwP. (2013). HIV Prevention Section Bureau of HIV/AIDS. Comprehensive Prevention with 
Positives. 2013. [Online] from: http://www.floridahealth.gov/diseases-and-
conditions/aids/prevention/_documents/resources_materials/Comp-Preven-with-pos.pdf. 
Accessed 16 May 2015 
 Naik R. (2013). Policy Brief Linkage To Care Following Home-Based Hiv Counseling and 
Testing. Medical Research Council of South Africa. [Online]. 
www.mrc.ac.za/policybriefs/LinkageCare.pdf.Accessed 11 May 2016 
Ramjee, G. & Daniels, B. (2013). Women and HIV in Sub-Saharan Africa. AIDS Research and 
Therapy, 10 (1), 30. http://doi.org/10.1186/1742-6405-10-30 
Rasschaert, F., Decroo, T., Remartinez, D., Telfer, B., Lessitala, F., Biot, M., Candrinho, B. 
&Van Damme, W. (2014). Adapting a community-based ART delivery model to the patients’ 
needs: a mixed methods research in Tete, Mozambique. BMC Public Health, 14 (1), 364. 
http://doi.org/10.1186/1471-2458-14-364 
Rio, C. (2011). Cascade of Care and its relevance to Seek , Test , Treat and Retain Strategy. 
[Online]. http://www.apa.org/about/gr/issues/substance-abuse/del-rio-nida.pdf. 
 Accessed 12 Jun 2016. 
Rizza, S. A., MacGowan, R. J., Purcell, D. W., Branson, B. M. & Temesgen, Z. (2012). HIV 
screening in the health care setting: Status, barriers, and potential solutions. Mayo Clinic 
Proceedings, 87(9), 915–924. http://doi.org/10.1016/j.mayocp.2012.06.021 
Rosen, S. & Fox, M. P. (2011). Retention in HIV Care between Testing and Treatment in Sub-
Saharan Africa : A Systematic Review, PLOS MEDICINE 8 (7). 
http://doi.org/10.1371/journal.pmed.1001056 
Ryan, G. W. & Bernard, H. R. (2003). Techniques to Identify Themes. Field Methods, 15(1), 
85–109. http://doi.org/10.1177/1525822X02239569 
http://etd.uwc.ac.za/
146 
 
Sanga, E. S., Lerebo, W., Mushi, A. K., Clowes, P., Olomi, W., Maboko, L. & Zarowsky, C. 
(2017). Linkage into care among newly diagnosed HIV-positive individuals tested through 
outreach and facility-based HIV testing models in Mbeya, Tanzania: A prospective mixed-
method cohort study. BMJ Open, 7(4). http://doi.org/10.1136/bmjopen-2016-013733 
Sharma, M., Ying, R., Tarr, G. & Barnabas, R. (2015). A systematic review and meta-analysis of 
community and facility-based approaches to address gaps in HIV testing and linkage in sub-
Saharan Africa. HHS Public Access, 2(2), 1–26. http://doi.org/10.14440/jbm.2015.54.A 
Shenton, A. K. (2004). Strategies for ensuring trustworthiness in qualitative research projects. 
Education for Information, 22, 63–75. 
Simmelink, A. (2014). High uptake but low rates of linkage to care following home-based 
integrated HIV voluntary counseling and testing services and non-communicable disease 
screening in Ifakara, Tanzania.[online] 
http://scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2014/SimmelinkAM/. Accessed 05 July 
2017 
Statistics South Africa. (2016). Statistical release- PO 302-Mid year population estimates 2016. 
South Africa. [Online].https://www.statssa.gov.za/publications/P0302/P03022015.pdf. Accessed 
19 Apr 2017 
Staveteig, S., Wang, S., Head, S. K., Bradley, S. E. K. & Nybro, E. (2013). Demographic 
patterns of HIV testing uptake in sub-Saharan Africa. Demographic Patterns of HIV Testing 
Uptake in Sub-Saharan Africa. DHS Comparative Reports [Online]. 
https://dhsprogram.com/pubs/pdf/CR30/CR30.pdf. Accessed  16 Jul 2017. 
Stuart, L., Harkins, J. & Wigley, M. (2005). Establishing referral networks for comprehensive 
HIV care in low-resource settings. Family Healthy International [Online]. 
http://pdf.usaid.gov/pdf_docs/Pnadf677.pdf. Accessed 09 Mar 2017. 
Suthar, A. B., Ford, N., Bachanas, P. J., Wong, V. J., Rajan, J. S., Saltzman, A. K., Ajose, O., 
Fakoya, A.O., Granich, R.M., Negussie, E.K. & Baggaley, R. C. (2013). Towards Universal 
Voluntary HIV Testing and Counselling: A Systematic Review and Meta-Analysis of 
http://etd.uwc.ac.za/
147 
 
Community-Based Approaches. PLoS Medicine, 10 (8), e1001496. 
http://doi.org/10.1371/journal.pmed.1001496 
TACAIDS. (2013). HIV/AIDS and Malaria Indicator Survey 2011–12.[Online] 
http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:HIV/AIDS+and+Malaria+Indi
cator+Survey+2011-12#0%5 Cnhttp://scholar.google.com/scholar?hl=en&btnG= Search& 
=intitle: Tanzania+HIV/AIDS+and+Malaria+Indicator+Survey+2011?12#5. Accessed 05 Mar 
2015 
 
Tong, A., Sainsbury, P. & Craig, J. (2007). Consolidated criterio for reporting qualitative 
research (COREQ): a 32- item checklist for interviews and focus group. International Journal of 
Qualitative in Health Care, 19(6), 349–357. 
Ulett, K. B., Willig, J. H., Lin, H., Ph, D., Routman, J. S., Abroms, S., … Sc, M. H. (2009). The 
Therapeutic Implications of Timely Linkage and Early Retention in HIV Care, AIDS Patient 
Care STDS. 23 (1):41-9. doi: 10.1089/apc.2008.0132 
UNAIDS. (2014a). Fast-Track - Ending the AIDS epidemic by 2030 [Online] 
http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf. 
(Accessed on 22.Nov.2017) 
UNAIDS. (2014b).  The Gap Report. Geneva.[Online]. 
www.unaids.org/en/media/unaids/contentassets/.../UNAIDS_Gap_report_en.pdf . 
 Accessed 04 July 2017 
van Schaik, N., Kranzer, K., Wood, R. & Bekker, L. G. (2010). Earlier HIV diagnosis - are 
mobile services the answer? South African Medical Journal, 100 (10), 671–674. 
Wachira, J., Genberg, B., Ndege, S. & Kimayo, S. (2014). Health facility barriers to HIV linkage 
and retention in Western Kenya. BMC Health Serv Res. 14.646. doi: 10.1186/s12913-014-0646-
6 
http://etd.uwc.ac.za/
148 
 
Wachira, J., Naanyu, V., Genberg, B., Koech, B., Akinyi, J., Kamene, R., Ndege, S., Siika, 
A.M., Kimayo, S. & Braitstein, P. (2014). Health facility barriers to HIV linkage and retention in 
Western Kenya. BMC Health Serv Res, 14, 646. http://doi.org/10.1186/s12913-014-0646-6 
Ware, N. C., Wyatt, M. A., Asiimwe, S., Turyamureeba, B., Tumwesigye, E., Rooyen, H.V., 
Barnabas, R.V. &  Celum, C. L. (2016). How home HIV testing and counselling with follow-up 
support achieves high testing coverage and linkage to treatment and prevention : a qualitative 
analysis from Uganda, J Int AIDS Soc. 19 (1).doi.org/10.7448/IAS.19.1.20929. 
 
WHO. (2012). Service Delivery Approaches to HIV Testing and Counselling (HTC): A Strategic 
HTC Programme Framework. [Online]. www.who.int/hiv/pub/vct/htc_framework/en/ Accessed 
30 Feb 2015. 
Wilton, B. J. & Broeckaert, L. (2013). The HIV treatment cascade – patching the leaks to 
improve HIV prevention. Prevention in Focus, Sprng 2013, 1–7. 
World Health Organization. (2016). Consolidated guidelines on the use of antiretroviral drugs 
for treating and preventing HIV infection: recommendations for a public health approach. World 
Health Organization.[Online]. http://www.who.int/hiv/pub/arv/arv-2016/en/. Accessed 07 Feb 
2017 
World Health Organization. (2017). World Health Statistics 2017 : Monitoring Health for the 
SDGs. World Health Organization. http://doi.org/10.1017/CBO9781107415324.004 
Wynberg, E., Cooke, G., Shroufi, A., Reid, S. D. & Ford, N. (2014). Review article Impact of 
point-of-care CD4 testing on linkage to HIV care : A systematic review. Journal of the 
International AIDS Society, 17:18809 
 
 
 
 
 
http://etd.uwc.ac.za/
149 
 
 
 
10. ANNEXES 
 
10.1 Ethical approvals 
 Ethical approval UWC  
 Ethical approval Tanzanian IRB 
http://etd.uwc.ac.za/
150 
 
 
http://etd.uwc.ac.za/
151 
 
 
http://etd.uwc.ac.za/
152 
 
Private Bag X17, Bellville, 7535 
 South Africa 
 Tel: +27 (0) 21 959 2809/2166 
 Fax: +27 (0) 21 9592872 
            Email:  soph-comm@uwc.ac.za  
Website:  
http://www.uwc.ac.za/faculties/chs/soph    
 
 
 
 
 
10.2. Informed consent-English and Swahili 
 
10.2.1 INFORMATION SHEET -English 
 
Title: Linkage to care after testing HIV positive: a comparative analysis of mobile versus 
health facility based models in rural settings, Mbeya-Tanzania. 
 
What is this study about?  
This is a research project being conducted by Erica Sanga at the University of the Western Cape.  
We are inviting you to participate in this research project because you are a person who can give 
the necessary information to the research on the experiences and challenge to HIV testing and 
linkage to HIV care in Mbeya region  
The purpose of this research project is to describe and compare the processes and dynamics of 
linkage to HIV care and management between mobile and facility based models of HTC service 
delivery in the rural settings of Mbeya   
 
What will I be asked to do if I agree to participate? 
You will be asked to respond to certain question that will be asked by the research with regards 
to linkage to HIV care, you may also be asked to participate in focus group discussions. The 
interviews will be conducted at the beginning, then after three months and the last interview will 
be six, months later. 
This is study is conducted in four districts of Mbeya region, and this site is one of the sites 
selected for the study. In this study Linkage to HIV care means entering/start receiving HIV care 
and treatment after positive HIV results. The duration of study will be six month from time of 
enrolment. The interviews will take about 30-40 minutes, and the focus group discussion may 
take one hour. In the interviews you will be asked of general information like age, marital status, 
and occupation also you will be asked about the choices of HIV testing and HIV care sites, in 
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addition you will be asked about your experience in HIV care at this site and your opinion on 
what should be improved 
 
Would my participation in this study be kept confidential? 
We will do our best to keep your personal information confidential.  To help protect your 
confidentiality The completed interviews will be kept safely by the researcher in a locked cabinet 
at the Mbeya Medical research centre and will only be seen by me and my supervisor. 
I will collect your particulars, name and address, only to simplify tracking you for the second 
and third interviews and will not disclose them to anyone, apart from the research team.  The 
data collected will be used for the research purposes only. Every study participants will be 
allocated a study number which will be used to keep the information not your name, and nobody 
will be able to link the number to your name except the research team. These interviews will not 
affect your medical treatment and support from the Health Facility or referral hospital. 
After study completion if we write a report or article about this research project, your identity 
will be protected to the maximum extent possible.   
 
What are the risks of this research? 
There are no known risks associated with participating in this research however you may 
encounter emotional discomfort due to knowledge of their status and having to talk to the 
researcher about your health and what is happening after testing HIV positive. 
 
What are the benefits of this research? 
This research is not designed to help you personally but the information we get from the clients 
taking part in this study will help the health stake holders and ministry of health in Tanzania to 
improve access and linkage to HIV care and management in the rural setting of Mbeya region by 
formulating strategies to mitigate the challenges identified in this study.  You will not be 
compensated with money or food for participating in this study 
Do I have to be in this research and may I stop participating at any time?   
Your participation in this research is completely voluntary.  You may choose not to take part at 
all.  If you decide to participate in this research, you may stop participating at any time.  If you 
decide not to participate in this study or if you stop participating at any time, you will not be 
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penalized or lose any benefits to which you otherwise qualify. You are free to decline answering 
any questions you feel uncomfortable answering without being penalized 
 
What if I have questions? 
This research is being conducted by Erica Sanga of Mbeya Medical Research Centre who is a 
student at the University of the Western Cape.  If you have any questions about the research 
study itself, please contact the Study Coordinator’s Name: Erica Sanga 
Mbeya Medical Research Centre P.O. Box 2410, Mbeya, Tanzania.                                                
Mobile: + 255 762 577 041; Email: esanga@mmrp.org; ericass80@hotmail.com or  
 The study supervisor Professor Christina Zarowsky (czarowsky@uwc.ac.za, 
czarowsky@gmail.com; tel +27 21 959 2809)  
 
Also you may  contact:   
Director: 
Prof Helene Schneider 
School of Public Health 
University of the Western Cape 
Private Bag X17 
Bellville 7535         
hschneider@uwc.ac.za  
 
Dean of the Faculty of Community and Health Sciences:  
Prof Jose Frantz 
University of the Western Cape 
Private Bag X17 
Bellville 7535         
jfrantz@uwc.ac.za  
 
This research has been approved by the University of the Western Cape’s Senate Research 
Committee and Ethics Committee. 
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10.2.2 INFORMATION SHEET- SWAHILI 
 
TAARIFA ZA UTAFITI  
 
Jina la utafiti:  Kuunganishwa katikahuduma baada ya kugundulika kuwa na VVU: 
Kulinganisha huduma za vituo vya kuhamishwa dhidi ya vituo vya afya vilivyojengwa 
katika maeneo ya vijijini mkoa wa Mbeya nchini Tanzania. 
 
 
Utafiti huu unahusu nini?  
Huu ni utafiti unaofanywa na ndugu Erica Sanga wa chuo kikuu cha Western cape kilichopo 
nchini Africa kusini, tunakualika ushiriki katika utafiti huu kwa sababu wewe ni mmoja wa watu 
walio na taarifa muhimu na sahihi kwa ajili ya utafiti unaoangalia uzoefu na changamoto katika 
upimaji wa virusi vya ukimwi (VVU) na kujiunga na huduma katika mkoa wa Mbeya. 
 
Lengo la utafiti huu ni kuelezea na kulunganisha taratibu, michakato na mipangilio ya kujiunga 
katika huduma na matibabu kati ya vituo vinavyohama hama na huduma zinazotolewa na vituo 
vya afya vilivyojengwa katika maeneo ya mbeya vijijini. 
 
 
Iwapo nitakubali kushiriki katika utafiti nitatakiwa kufanya nini? 
Utaombwa kujibu maswali kadhaa ambayo utaulizwa na  mtafiti juu ya  upimaji wa virusi vya 
ukimwi  na kujiunga na huduma  unaweza pia ukaombwa kushiriki katika kundi dogo la 
majadiliano 
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Mahojiano yatafanyika mwanzoni, kisha baada ya miezi  mitatu na mahojiano ya mwisho 
yatafanyika baada ya miezi sita. Utafiti huu utafanyika katika wilaya nne za mkoa wa Mbeya, na 
kituo hiki kimechaguliwa kama moja ya vituo vya utafiti. Katika utafiti huu kujiunga/kuanza 
kupata huduma baada ya kupata majibu ya VVU. Utafiti huu utadumu kwa miezi sita kuanzia 
utakapoingia rasmi kwenye utafiti. Mahojiano haya yanatarajiwa kuchukua takribani dakika 30-
40 minutes nakatika mahojiano ya kundi dogo yanaweza kuchukua saa moja. 
 
Katika mahojiano haya utaulizwa maswali ya kawaida mfano umri, hali ya ndoa na shughuli 
unazofanya, pia utaulizwa kuhusu uchaguzi wa vituo vya upimaji na huduma za matibabu. Zaidi 
ya  hayo utaulizwa uzoefu wako katika kituo hiki cha huduma ya VVU na mawayo yako juu ya 
kitu gani kiboreshwe. 
 
Je ushiriki wangu katika utafiti huu  utakuw a wa siri? 
Tutafanya kila jitihada kutunza taarifa zako binafsi kwa usiri. Kuhakisha tunatunza usiri, 
mahojiano yaliyokamilika yatawekwasalama  na mtafiti kwenye kabati linalofungwa katika kituo 
cha utafiti wa tiba mkoani mbeya, na yataonwa na mimi na mkaguzi tu. 
 
Nitachukua taarifa zako, jina na anuani ya unapoishi kwa ajili ya urahisi wa kuktafuta kwa ajili 
ya mahojiano ya pili nay a tatu na sitazitoa taarifa hizi kwa mtu yeyote zaidi ya watafiti. Taarifa 
zitakazopatikana zitatumika kwa ajili za utafiti tu. Kila mshiriki atapewa namba ya utambulisho 
ambayo itaumika kutunya taarifa zako na sio kwa jina lako, na hakuna atakayeweaza kunganisha 
numba na jina lako isipokuwa watafiti.  Utafiti huu hautaathiri matibabu yako wala msaada 
kutoka kituo cha afya au hospitali ya rufaa. Baada ya kwisha utafiti huu iwapo tutaandika taarifa 
au machapisho kuhusu utafiti huu utambulisho wako utatunzwa katika kiwango cha juu kwa 
kadri iwezekenavyo. 
 
Kuna athari gani kushiriki katika utafiti? 
Hakuna athari yoyote inayojulikana kwa kushiriki katika utafiti huu, hata hivyo unaweza 
kupatwana mfadhaiko kwa sababu ya kujua afya yako na ukatakiwa kuzungumza na mtafiti 
kuhusu afya yako na nini kinatokea  baada ya kujua unamaambukizi. 
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 Kuna faida gani kushiriki katika utafiti? 
Utafiti huu haukupangwa kumnufaisha mshiriki moja kwa moja, bali matokeo yatakayotokana na 
huu utafiti  yatasaidia watoaji wa huduma afya  pamoja na wizara ya afya nchini Tanzania, 
kuboresha utoaji wa huduma kwa watu wenye virusi vya ukimwi  katika vijiji mkoa wa Mbeya 
kwa kuandaa mikakati ya kupambana na matatizo yatakayopatikana au kugunduliwa baada ya huu 
utafiti. Pia  hutalipwa pesa wakla chakula kama fidia ya kushiriki katika utafiti. 
 
 
 
Ni lazima nishiriki katika utafiti au naweza kuacha ushiriki wakati wowote? 
 Ushiriki wako katika utafiti huu  ni huru na wa hiari kabisa. Unaweza kuamua kutoshiriki kabisa 
na  kama ukiamua kushiriki  katika utafiti huu unaweza pia kuacha kushiriki wakati wowote.  
Kama ukiamua kutoshiriki  kabisa au ukaamua kujitoa wakati wowote  hutapata adhabu wala 
kupoteza faida yoyote unayostahili. Unaruhusu. Uko huru kukataa kujibu maswali ambayo 
hujisikii vizuri kuyajibu bila kupata adhabu yoyote 
 
Itakuwaje kama nikiwa na maswali? 
Utafiti huu unaendeshwa na ndugu Erica Sanga wa kituo cha utafiti wa tiba mkoani Mbeya ambaye 
ni mwanafunzi wa chuo kikuu cha Western Cape kilichopo Afrika yza kusini. Kama una maswali 
yoyote kuhusiana na utafiti wenyewe tafadhali wasiliana na  Mratibu wa utafiti Erica Sanga wa 
Mbeya Medical Research Center P.O. Box 2410, Mbeya , Tanzania.                                                
Simu: + 255 762 577 041; baruapepe: esanga@mmrp.org;  ericass80@hotmail.com au  Mkuu wa 
kituo cha utafiti wa tiba mkoani Mbeya, Dr Leonard Maboko kwa simu namba  2503364 au 
msimamizi wa utafiti Profesa  Christina Zarowsky wa (czarowsky@uwc.ac.za, 
czarowsky@gmail.com; tel +27 21 959 2809. 
 
Utafiti huu umepata kibali kutoka kamati la utafiti  na maadili chuo cha Western Cape, 
pia kamati ya maadili ya mkoa wa Mbeya na taifa la Tanzania. 
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 10.2.3 CONSENT FORM- English 
 
Title: Linkage to care after testing HIV positive: a comparative analysis of mobile versus 
health facility based models in rural settings, Mbeya-Tanzania. 
 
The study has been described to me in language that I understand and I freely and voluntarily agree 
to participate.  
My questions about the study have been answered. I understand that my identity will not be 
disclosed and that I may withdraw from the study without giving a reason at any time and this will 
not negatively affect me in any way.   
 
...............................  ...................................    .......................... 
Participant’s name  Participant’s signature/thumb print  Date 
 
...............................  ...................................    .......................... 
Name of  witness   Signature     Date 
 
...............................  ...................................    .......................... 
Name of researcher   Signature     Date 
 
 
Thank you for your participation 
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10.2.4 FOMU YA KUKUBALI KUSHIRIKI 
 
Jina la utafiti:  Kuunganishwa katikahuduma baada ya kugundulika kuwa na VVU: 
Kulinganisha huduma za vituo vya kuhamishwa dhidi ya vituo vya afya vilivyojengwa 
katika maeneo ya vijijini mkoa wa Mbeya nchini Tanzania. 
 
 
Nimepewa maelezo ya kina kuhusiana na utafiti huu na ninakubali kushiriki 
Nimepata nafasi ya kuuliza maswali yote niliyokuwa nayo na yamejibiwa kiasi cha kuniridhisha 
Naelewa kuwa naweza kujitoa katika utafiti huu wakati wowote bila kutoa sababu na hili 
halitabadilisha huduma ninayostahili kupata mimi au familia yangu katika kliniki au kituo hiki. 
 
 
...............................   ...................................   .......................... 
Jina la mshiriki    Sahihi/dole gumba   Tarehe 
 
...............................   ...................................   .......................... 
Jina la Shahidi   Sahihi     Tarehe 
 
...............................   ...................................   .......................... 
Jina la mtafiti   Sahihi     Tarehe 
 
 
Asante kwa kutusaidia katika utafiti wetu. 
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10.2.5 FOCUS GROUP CONFIDENTIALITY BINDING FORM-English 
 
Title:  Linkage to care after testing HIV positive: a comparative analysis of mobile versus 
health facility based models in rural settings, Mbeya-Tanzania. 
 
The study has been described to me in language that I understand and I freely and voluntarily agree 
to participate. My questions about the study have been answered. I understand that my identity 
will not be disclosed and that I may withdraw from the study without giving a reason at any time 
and this will not negatively affect me in any way. I agree to be audio-taped during my participation 
in the study.  
I also agree not to disclose any information that was discussed during the group discussion.  
...............................  ...................................    .......................... 
Participant’s name  Participant’s signature/thumb print  Date 
 
...............................  ...................................    .......................... 
Name of  witness   Signature     Date 
 
...............................  ...................................    .......................... 
Name of researcher   Signature     Date 
 
 
Thank you for your participation 
FACULTY OF COMMUNITY AND 
HEALTH SCIENCES  
School of Public Health 
http://etd.uwc.ac.za/
161 
 
Private Bag X17, Bellville, 7535 
 South Africa 
 Tel: +27 (0) 21 959 2809/2166 
 Fax: +27 (0) 21 9592872 
            Email:  soph-comm@uwc.ac.za  
Website:  
http://www.uwc.ac.za/faculties/chs/soph    
 
 
 
 
 
 
10.2.6 FOCUS GROUP CONFIDENTIALITY BINDING FORM- Swahili 
 
FOMU YA MAKUBALIANO KUTUNZA SIRI YA MJADALA KATIKA MAKUNDI 
 
Jina la utafiti:  Kuunganishwa katikahuduma baada ya kugundulika kuwa na VVU: 
Kulinganisha huduma za vituo vya kuhamishwa dhidi ya vituo vya afya vilivyojengwa 
katika maeneo ya vijijini mkoa wa Mbeya nchini Tanzania. 
Utafiti umeelezwa kwangu kwa lugha ninayoielewa na kwa uhuru na hiari yangu nakubali 
kushiriki. Maswali yangu kuhusiana na utafiti yamejibiwa. Naelewa kuwa utambulisho wangu 
hautajulikana kwa yeyote na kwamba naweza kujitoa wakati wowote katika utafiti bila kutoa 
sababu yoyote na hili halitaniathiri kwa namna yoyote. 
Nakubali kurekodiwa wakati wa ushiriki katika mjadala huu. 
Pia ninakubali kuwa sitatoa nje taarifa yoyote iliyojadiliwa katika kundi hili la mjadala. 
 
...............................   ...................................   .......................... 
Jina la mshiriki    Sahihi/dole gumba   Tarehe 
 
...............................   ...................................   .......................... 
Jina la Shahidi   Sahihi     Tarehe 
 
...............................   ...................................   .......................... 
Jina la mtafiti   Sahihi     Tarehe 
 
 
Asante kwa kutusaidia katika utafiti wetu. 
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10.3. Questionnaires and interview guides 
 
10.3.1. QUESTIONNAIRE- ROUND ONE-@ ENROLLMENT 
 
Title: Linkage to care after testing HIV positive: A comparative analysis of mobile versus 
health facility based models in rural settings, Mbeya-Tanzania 
 
Study number……………………………………….. Site…………………………………… 
 
 
 READ INFORMATION SHEET AND OBTAIN WRITTEN INFORMED CONSENT  
 
PART I. Health facility information 
1 District  
 
1. Kyela       
2. Mbeya Rural 
3. Mbozi 
4. Chunya 
2 Ward  
 
 
3 Street/ Village  
4 Name of street leader/ten cell  
Leader/ popular person 
 
4 Name of health facility/site  
5 Type of health facility/site 1.Hospital  
2. Health Centre  
3. Dispensary 
4. Stand-alone VCT 
5. Mobile/outreach 
6. Other specify_________________ 
7 Ownership 1. Government    
2. Faith based 
3. NGO 
4. Research center (MDTC) 
5. Other specify____________________ 
8 Date of interview /__/__/   /__/__/    __/__/__/__/ 
  Day      Month         Year 
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Thank you for agreeing to answer a few questions I’d like to begin by asking you some general 
demographic questions.   
 
Part II: Demographic and socio-economic information 
9 Sex of client 1. Male  
 
2. Female  
 
10 
How old are you? 
 
Age in complete years at last birthday............................. 
 
11 What is your highestlevelof 
education? 
(Circle only one) 
1. None 
2. Primary school 
3. Secondary school  
4. Vocational training/college 
5. University 
Other (specify)………………………… 
12 
What is your marital status? 
1. Single 
2. Married 
3. Separated 
4. Divorced 
5. Widower 
13 What is/are your occupation(s)  
(Past twelve months)? 
(circle all applied) 
 
1. Unemployed 
2. Student  
3. Driver/transport 
4. Employed -government ,NGO, Private sector 
5. Self-employed (petty trader, business, peasant) 
6. Other (specify)......................... 
 
 13(a) what is your income per months 
(estimation) 
1. 10,000 -100,000 (T- shillings) 
2. 100,000- 500,000 (T- shillings)  
3. 5000,000- 1,000,000 (T- shillings) 
4. Above 1,000,000 (T- shillings) 
5. N/A 
14 What means of transport did you use to 
come to the clinic 
1. Walking 
2. Bicycle  
3. Motorbike   
4. Vehicle (public transport) 
5. Private car 
15 How long did it take you to reach the 
clinic 
1.less than one hour   
2.More than one hour 
3. two to five hours 
4. More than five hours 
5. Other (specify)……………………..  
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16 How much money did you use for 
transport to get to this place? 
 
1. Amount in Tshs................. 
2. N/A 
17 Why did you choose to come to this 
facility/site and not another site  
(give reasons) 
 
 
 
 
 
Part III: HIV testing and linkage to care 
18 What were the reason for you  
testing for HIV 
(circle all applied) 
1. Want to know my HIV status 
2. Want to get married 
3. I’m pregnant 
4. I believe is a good thing 
5. I want to receive treatment in case am infected 
6. Suspicious of partner’s behaviour 
7. I have been feeling sick 
8. I have  been involved in risk behaviour 
9. My spouse/partner forced me 
10. Other (specify)................................... 
19 When did the healthcare worker give 
you the result?  
 
1. Same day, within one hour 
2. Same day, > one hour                                                                                              
3. At the next visit 
20 What is the name of the site where you 
tested for HIV? (Write the name of site) 
 
 
…………………………. 
 20 (a) when did you go for testing (date 
of testing) 
(If possible check the date in the client’s 
card, or  count exact number of days 
since testing) 
 
 
……………………………………….. 
21 Are you planning/intending to share your 
 results with your sexual partner/spouse? 
1.Yes   
2.No       21 (a) 
 21.(a) Why 
(circle all applied) 
1. Fear for divorce 
2. Fear for stigma from the relative 
3. I don’t have a permanent   
partner/spouse  
4. Other, specify______________ 
22 Do you feel/think that you received all 
the necessary information about your 
status and where to go for care by the 
health care provider? 
1. Yes       23 
 
2. No        22 (a) 
  22 (a) If No; what more information 
would you like to be told or explained 
about? 
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23 Are you planning/intending to 
join/register at the HIV treatment and 
care center 
 (circle only one) 
 
1.  Yes         23 (a)   
2.   No        23 (c ) 
3.   Not sure for now       24 
4.   Have already entered care----            23 (d) 
 
  
23. (a) What is the name of the 
CTC do you intend to register? 
 
…………………….. 
 
  
23.(b)When do you intend to go 
for registration  at the CTC 
(number of days from today) 
…………………. 
  
23.(c) If the answer is No What 
are the reasons 
(Probe for reasons) 
 
 
 
 
 
  
 
23 (d) when did you register 
(confirm date in client’s card) 
 
 
23 (e) Registration number 
 (check in the card for d & e) 
  
Date……………………………… 
 
……………………………………… 
24 What do you think makes it difficult 
for someone from entering or joining 
HIV treatment and care services 
 
(circle all applied) 
1. Not understand the importance of being in 
HIV care 
2. Not feeling sick 
3. Long distance to the CTC 
4. Cost of  transportation 
5. Insufficient number of health care providers 
6. Low motivation of health care providers 
7. Long waiting time at the clinic 
8. Delay of laboratory results ( e.g. CD4) 
9. Fear of stigmatization 
10. Failure of involving the partner 
11. The partner/spouse do not allow 
12. Lack of  privacy at the Clinic 
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Ask if the client has any question and respond accordingly 
 
Thank you so much for your time, as we have seen in the participant information sheet, we are 
going to interview you again after three months, so see you in the next three months. Stay well. 
 
 
Contacts:  for tracing purposes: phone number…………………….. 
 
 If no phone get the Family/trusted persons number………………… 
 
If no phones at all try get the name of a popular neighbor or any identifiable thing near 
his/her home. 
 
 
 
 
 
…………………………  ……………..              …………….. 
Initials of research assistant  Date    Signature 
 
 
 
 
 
 
 
 
 
13.Other:_______________________________ 
25 What do you think makes it easier for 
someone to enter/join HIV treatment 
and care services? 
 
(probe) 
 
 
 
 
 99.  Don’t know 
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10.3.2 QUESTIONNAIRE - ROUND 2   (at three months) 
 
Study number……………………………………….. Site…………………………………… 
 
Title: Linkage to care after testing HIV positive: A comparative analysis of mobile versus 
health facility based models in rural settings, Mbeya-Tanzania 
 
Check/confirm participants study number 
 
Take some minutes to chat to the client on other general issues then remind him/her that we had 
agreed to have another interview with them after three months 
 
PART I. Health facility information 
1 District  
 
5. Kyela       
6. Mbeya Rural 
7. Mbozi 
8. Chunya 
2 Ward  
 
 
3 Street/ Village  
4 Name of street leader/ten cell  
leader 
 
4 Name of health facility/site  
5 Type of health facility/site 1.Hospital  
2. Health Centre  
3. Dispensary 
4. Stand alone VCT 
5. Other specify_________________ 
7 Ownership 1. Government    
2. Faith based 
3. NGO 
4. Other specify____________________ 
8 Date of interview /__/__/   /__/__/    __/__/__/__/ 
  Day      Month         Year 
 
 
Thank you for agreeing to answer a few questions 
I’d like to begin by asking you to tell me about what has happened in relation to your health and 
following up on your HIV status. I will also ask you some questions about your experiences at 
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health facilities and specifically at Care and Treatment Centre (CTC), thinking especially about 
your most recent visit.  
 
 Write the participant’s CTC card number ……………………………. 
 
 Process, time line and procedure at the CTC  
1  
What means of transport did you use to 
come to the clinic 
 
1. Walking 
2.  Bicycle  
3.  Motorbike   
4.  Vehicle (Public transport) 
5.  Private car 
2 How long did it take you to reach the clinic 1.less than one hour   
2.More than one hour 
3. two to five hours 
4. More than five hours  
3 Has someone accompanied you to the clinic? 1. Yes       3.(a) 
2. No         4   
 3.(a) Does this other person 
accompanying you know your status 
1. Yes 
2. No 
 
4 How long (days, weeks, months) did it take 
you to go and register at the CTC? 
 
Fill in exact time, calculate by checking 
dates in the card 
 
 
 
 
More than one month               (4(a) 
 4. (a) If answer is more than one 
month  (ask reasons for delay, do 
not make the client feel she has 
made a mistake) 
 
 
 
 
 
 
 
 
5 What happened on your first day at the CTC 
 (mention all events- if possible in series) 
 
 
 
 
6 How long (hours) did it take to complete 
registration and other procedures on your 
first day 
1. One hour 
2. 2-3 hours 
3. 4-5 hours 
4. More than five hours 
7 Did you give  blood for CD4 count and HIV 
staging on the same day of registration? 
1.Yes        8 
2.NO      7(a) 
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 7(a) How many days later did you 
give blood for the above mentioned 
tests (count exact number of days) 
 
………………..  
 
8 How long did it take to receive your results 1. Same day 
2. Two - seven days later 
3. One  to two weeks later 
4. Two to four weeks later 
5. More than four weeks  later        8 (a) 
 
 
  8.(a) If more than two weeks, ask for 
reasons of delay 
1. Results were not ready 
2. I did not return on time for results 
3. I had no money for transport 
4. I was sick 
5. Other……………….. 
13 What happened after receiving your results 
 
 
 
 
 
14 Have you started ART 1. Yes       15 
2. NO      14 (a) 
 
 14 (a) ask for reasons  
1. Not eligible for now     14(b) 
2. Other…………….. 
 
 14(b) For Pre-ARTs, when is your 
next appointment for follow up? 
 
…………………….. 
 
15 For those on ART, how long did it take for 
you to start ART (from day of registration) 
1. Within one week  
2. One to two weeks 
3. Two to three weeks 
4. One month 
5. One to three months  
6. More than three months 
 
16 How many time/visits did you attend at the 
clinic before starting ART? 
1. 1-2 visits 
2. 3-5 visits 
3. 6-10 visits 
4. More than 10 visits 
 
18 How much was your CD4 count when you 
started CTC (check in the patient’s card) 
 
…………………………… 
19 How much was your CD4 count when you 
started ART (check in the patient’s card) 
 
……………………………… 
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20 Do you feel any improvement on your 
health after being on treatment? 
 
1. Yes 
2. No 
 
 
 
21 What do you think of the services given to 
you by the health care providers from the 
time you went for HIV testing up to now? 
 
 
 21(a). Did you receive a referral letter or 
Memo from provider at HTC to go with to 
the CTC? 
 
21(b). Did the care provider show/tell you 
where to go for your next appointment? 
 
21(c). What do you think needs to be 
improved at the site for you to be more 
comfortable with service provided here? 
 
22 When are you scheduled for next visit at the 
clinic 
 
……    ……..      ………. 
Date,    month     and year 
 
 
  22 (a) What helps you/motivates you to 
abide to your scheduled visit? 
 
 
  22 (b) What hinders/inconveniences you 
willingness or desire to abide to your 
scheduled visits?  
 
23 Do you face any challenges in dealing with 
your status 
1. Yes      23(a)     
2. No      24 
 23(a) what are the most frequent challenges  
 
 
 
  
Disclosure and Support 
24 Have you told anyone about your HIV 
status? 
1. Yes       24 (a) 
2. No       25 
 24 (a) How are you related to the 
people you told 
(circle all applied) 
1. Spouse/partner 
2. Parents 
3. Brother/Sister 
4. Uncle/aunt 
5.  Other (mention) 
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25 If you have  not told anyone so far , are you 
planning to tell someone about your HIV 
status 
1. Yes      26 
2. No       25(a)       
 
  25 (a) If No why  
 
 
26 Do you have any friends or family  who are 
taking ARVs 
1. Yes 
2. No 
 
27 Do you know anyone who his/her health has 
been improved because of using ARVs 
1. Yes 
2. No 
 
28  We are organizing a small group 
discussion, Are you okay discussing these 
challenge in a small group of 6-8 people who 
are HIV positive to find out how others deal 
with same challenges? 
1.Yes 
 
2. No 
 
 
 
 
29 I believe you do remember that we have one 
more last interview with you after three 
months to discuss how you are doing and to 
complete the study, is it still okay if we 
contact you again for this purpose? 
1. Yes 
 
2. No 
 
Ask if the client has any question and respond accordingly 
Thank you for your time, see you next time 
 
Check for change of contacts or place of living 
 
 
 
 
 
 
…………………………      …………… 
Initials of research assistant      Signature 
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10.3.3 QUESTIONNAIRE - ROUND 3 (at six months). 
 
Study number……………………………………….. Site…………………………………… 
 
Title: Linkage to care after testing HIV positive: A comparative analysis of mobile versus 
health facility based models in rural settings, Mbeya-Tanzania 
 
Take some minutes to chat with the client on other general issues then remind him/her that we 
had agreed to have another interview with them after six months 
 
Thank you for agreeing to answer a few questions I’d like to begin by asking you some questions 
on how things went for the past three months and your experience in HIV care services 
 
 
Write the participants Card number…………………………….. 
Confirm if it links with the study number 
 
 
 Experiences at  the CTC  
1 Did you come alone or you are accompanied 
by some one 
3. Yes 
4. No 
 1(a) Does this other person 
accompanying you know your status 
3. Yes 
4. No 
 
2 Are you now on  ART 1. Yes    2(a) 
2. No     2(b) 
 2(a)When did you start ART, after 
registering at the CTC(check in the 
patient’s card) 
1. Within one month 
2. Two months 
3. Three months 
4. Four  months 
5. Five  months 
6. Sixth months 
 
 2(b)when is your next appointment  
……………….. 
3 How much was your CD4 count when you 
started CTC? (check in the patient’s card) 
 
…………………………… 
 3.(a) How much was your CD4 count when 
you started ART(check in the patient’s 
card) 
 
…………………………. 
 3.(b) How much is your CD4 count 
now(check in the patient’s card) 
 
 
…………… 
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4 How are you feeling now 1. Very well 
2. Better 
3. Somehow better 
4. Not much improvement 
5. No improvement at all 
 
 
 
5 How regularly do you check the CD4 count 
in this center 
1. Each month 
2. Every three months 
3. Every six months 
4. Whenever necessary 
5. Other specify…………… 
 
6 How would you rate the care you were 
given with healthcare provider at the 
site/clinic? 
 
 
1. Excellent  
2. Good  
3. Average/fair  
4. Not satisfactory  
5. Poor  
 
7 What do you feel needs to be improved at the 
center for you to be more comfortable with 
service provided here? 
 
 
 
 
8 Do you face any challenges in dealing with 
your status 
1. Yes      8(a) 
2. No          9 
 
 
 
 8.(a) what are the most frequent 
challenges 
1. 
 
2. 
3. 
 8.(b)What you think should be done 
to overcome these challenges 
      1. 
 
      2.  
 
3.  
4. Don’t know 
9 We are organizing a small group discussion, 
Are you okay discussing these challenge in 
a small group of 6-8 people who are HIV 
positive to find out how others deal with 
same challenges? 
1.Yes 
 
2. No 
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Ask if the client has any question and respond accordingly 
 
Thank you for taking part in this study and for making it to the third interview, this is the end of 
this study, however you may still contact me or the study coordinator if you have any question. 
Stay well 
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10.3.4 FOCUS GROUP DISCUSSION- INTERVIEW GUIDE - 
 
 Name of the site:………………………………Number of Particpants………………….. 
 
Date ……………………………                         Time start:……………………………… 
 
1. Do you think there are some people in the community who are reluctant to know their 
HIV status in this area/community 
 
2. If yes what are the reasons? 
 
 
3. Let’s now talk of people who have tested positive for HIV,  are there people  who are 
reluctant to join HIV care in this area or who find it difficult to get care? 
 
4. If yes what are the reasons? 
 
 
5. What do you think about the health care providers – do they give enough information and 
support on joining HIV care and treatment centers? 
 
6. What else/more information would make it easier to get services from a CTC? 
 
 
7. How far (distance) is it for people to get  to the  nearby CTC (in sites without CTC) 
 
8. Is  distance a constraint  in abiding to the scheduled visits at the clinic 
 
 
9. Are the any other factors that interfere or are a setback to stayingin  care? (mention) 
 
10. What are your suggestions to improve the service in the HIV care unit (i.e what would 
you suggest to health care providers, to the government or ministry of health, and to 
patients and communities?) 
 
Thank for participation 
 
Time Finished:…………………………………. 
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10.3.5 IN-DEPTH INTERVIEW- INDEX CASES 
 
Study number………………………………….. Time start………………………………. 
 
Title: Linkage to care after testing HIV positive: A comparative analysis of mobile versus 
health facility based models in rural settings, Mbeya-Tanzania 
 
Explain to her about this interview, let the participant choose a Nick name and ask for 
permission to record the interview. 
 
1. Where did you go for HIV test (name of the site)……………………………………. 
 
2.  When was that (date and month if possible)…………………………………………. 
 
3. Did you get your test results the same day or you had to come on another 
day………………….. 
 
4. Please tell me  on your own words what happened in your life from the day you received 
your results until now   
 
5.  Tell me what have you done or tried to do in order to take care of your health after 
knowing your HIV status  
 
Encourage the participant to talk by showing that you are following his/her story and probe 
whenever necessary 
 
6. How would you rate the care you were given with healthcare provider at the site/clinic? 
1. Excellent  
2. Good  
3. Average/fair  
4. Not satisfactory  
5. Poor  
 
7. Is there anything else you would like to advise or suggest to health care providers, to the 
MOH or the government regarding health services to individuals living with HIV? 
 
8. Do you have any question? If yes respond accordingly 
 
 
 
Thank you so much for taking part in this study to the end 
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10.3.6 SITE REGISTER AND RECORDS 
 
 
Site/Facility information 
1 Name of the facility  
 
 
2 
 
Site/facility status 
   
Public, private, FBO, NGO 
 
3  
 
Level of Facility/site 
 
Hospital, Health centre, dispensary, stand alone 
VCT 
 
4 
 
Services type 
 
HTC / CTC or both 
5 Number of client attended per 
month 
HTC 
CTC 
5 Date   
 
B. Client Information 
1 Sex  
 
2 Age   
 
3 Religion  
 
4 Marital status  
 
5 Education  Level  
 
6 Occupation  
 
7 Ever tested before  
 
8 Results disclosure plan by 
client 
 
 
9 Name of referral site/centre ( if 
referred) 
 
10 Client code number 
 
 
 
 
…………………………      …………… 
Initials of research assistant      Signature 
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10.3.7 HIV LINKAGE TO CARE STUDY –OBSERVATIONAL CHECKLIST 
 
District ………………………..   Name of the site………………………  
Type of facility or site:   Hospital, Health center, dispensary, clinic, stand alone-VCT) 
Site ownership:  Government, Private, NGO) 
Working places/ space:  Building, tents, Van or car), 
 
Date…………………….......     Researcher initials ……………………. 
 
SN Item/activity Yes/No Number  or 
time (if 
Applicable) 
Explanation or 
comments 
 HTC with CTC    
 HTC without CTC    
 Documents 
(Registers/Records/reports) 
   
 Waiting area (chairs/benches, 
television) 
   
 Counseling and registration 
rooms,  (Space, privacy) 
   
  
Estimated number of Clients 
   
 Number of staff on duty and 
qualifications. 
   
  Organization of services and flow of activities 
 Working hours   
 Waiting time  
 Referral processes 
(explanations and letter) 
 
 Waiting time for services  
 Step by step for a client 
coming for HIV testing 
 
 Step by step for a client 
coming for registration 
(linkage). 
 
 Any other on going activity or 
event at the site 
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HEALTH CARE PROVIDER INTERVIEW-English 
Study number……………………………………….. Site…………………………………… 
 
Title: Linkage to care after testing HIV positive: A comparative analysis of mobile versus 
health facility based models in rural settings, Mbeya-Tanzania 
 
 A. Facility/site Information  
1 District 
 
9. Kyela       
10. Mbeya Rural 
11. Mbozi 
12. Chunya 
 
2 Ward 
 
 
............................................................... 
3 Location 
 
1- Highway/Boarder 
2- Remote 
4 Name of health facility/site  
_____________________ 
5 Type of health facility 1.Hospital  
2. Health Centre  
3. Dispensary 
4. Stand-alone VCT 
5. Mobile/outreach 
6. Other specify_________________ 
6 Distance from  referral 
Hospital, centre or CTC 
 
1.  It is a site with CTC 
2. Less than 2 kilometers 
3. 2 - 5 kilometers 
4. 6- 10 kilometers 
5. More than 10 kilometers 
7 Ownership/status 1. Government    
2. Faith based 
3. Private 
4. NGO 
5. Other specify____________________ 
8 Role of health provider in 
 the site 
1. Site manager/in-charge 
2. Nurse counsellor in-charge 
3. Counsellor 
4. Doctor/Clinician 
5. Laboratory personnel 
6. Other specify…………………. 
10  
Date of interview 
 
/__ /__/    /__/__/    __/__/__/__/ 
  Day      Month         Year 
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Thank you for agreeing to take part in this key informant interview, please be free to explain 
to me anything that is important in relation to this study 
 
B. Facility/site operation 
 
1. Please tell me about works of this facility/site what happens to the client from the time 
he/she registers for service (if possible in series) 
 
2.  What are the procedures for referral at this facility/site?  
 
3. Are there official documents on guidelines/processes for referral at the site? 
 
4.  How do you follow up clients after HIV positive results? Pre- ART and  those on ART 
 
5. What works well in following up and retention of clients? 
 
6. What doesn’t work very well in follow up of clients? 
 
7. Are there clients who are reluctant to enter HIV care?  
 
7(a) If yes, what do you think are the reasons? 
 
8. In your opinion what makes it difficult for a client to enter or join HIV care? 
 
8 (a) what makes it easier for a client to enter HIV care? 
 
9. What do you think can be done to improve things at the site with regard to linkage and 
continuity in HV care? 
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 C. Process, time lines and patterns  
1  
What are your operating hours (time in a 
day) 
 
 
2 Does this facility/site offer HIV Testing 
and Counseling (HTC) services? 
1.Yes    
 2. No : Go to 6 
3 Are results for HIV test given to the client 
on the same day 
5. Yes 
6. No        4.(a) 
 4.(a) When does the client come 
back for results 
6. Next day 
7. Two - seven days later 
8. One- two weeks later 
9. More than two weeks later 
4 What is the HIV testing algorithm used at 
this facility/site? 
 
 
 
5 Does this site offer Care and treatment 
services 
1.Yes    
2. No      14 
3. CD4 Count on site       8 
 
6 Do clients give blood samples for CD4 
count and other investigation on the day of 
receiving HIV positive result? 
1. Yes        8 
2. No 
7 Do clients give blood samples for CD4 
count and other investigations on the day 
of registration at the CTC? 
1.Yes       8 
2.No       7(a) 
 
 7 (a) If No when do they  come to provide  
blood samples (number of days) 
 
………………………… 
8 How long (days, week, months) does it 
take for the CD4 count results to be 
available from the day of  sample 
collection 
1. Same day 
2. 2 - 7 days 
3. 1 - 2 weeks 
4. 2 - 4 weeks 
5. More than 1 month 
 
9 Do you have clients who do not return for 
their CD4 or any other results? 
1. Yes      9(a) 
2. No        10 
 9. (a) what do you think are the reasons?  
 
 
 
10 For clients with CD4 above 350 cell, what 
happens (mention the steps) 
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11 For clients with CD4 below 350 cell, what 
happens (mention the steps) 
 
 
 
 
 
12 How many visits are scheduled for the 
client with CD4 less than 350 before 
starting on ART (estimates) 
5. 1-2 visits 
6. 2-5 visits 
7. 5-10 visits 
8. More than 10 visits 
13 How long (days, weeks, months) does it 
take for a client eligible for ART to start 
treatment? (e.g.  CD4 below 350) 
1. Less than one week 
2. 1-2 weeks 
3. 2-3 weeks 
4. One month 
5. More than one month 
14  If the site is not a care and treatment center 
(CTC) where do you refer HIV clients for 
further care? 
 
1. ....................................... 
2. Is the site with CTC services 
 
20 Do you face any challenges as a health care 
provider in dealing with HIV clients at this 
site 
1. Yes 
2. No      21 
 20.(a)What are the most frequent 
challenges 
 
 
 
 
 
Ask if the health provider has any question with regard to the study or interview. 
Thank you for participation and your time. Contacts/ phone number 
 
 
 
 
 
…………………………    ……………..    …………… 
Initials of research assistant  Date      Signature 
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10.4. HIV testing and linkage processes-Scenarios  
 
How do these procedures play out on a typical day? Below are two scenarios explaining what 
happens at the mobile site and at the facility based site from the moment the client comes in to the 
time when all procedures are completed. 
 
  
A day at the research mobile site 
The ABC mobile site offers HIV testing, TB screening, cervical cancer screening and CD4 count 
testing, but does not offer ART, therefore all clients diagnosed HIV-positive must be connected to 
the nearby Care and Treatment Centre sites for registration and further HIV care and treatment.  
 
This mobile site normally stays in one area for about one to two weeks. Normally one week before 
its arrival at the area, the field outreach officer goes to the area for preparations, informing the 
local government authorities, community leaders and the health facility in-charge (where the 
mobile team will refer  HIV positive clients or any other client who may need further medical care. 
The outreach officer explains about the coming team, the duration of stay and the services that will 
be offered.  This field officer has to make an arrangement or liaise with the nearby health facility 
staff where the mobile team will have to refer the HIV diagnosed clients for further care or any 
patient that may need further management in the hospital setting. He will finally fix posters in the 
public places showing the picture of the truck, the services offered and the time and dates of 
services.  
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Sometimes they also do film/video shows in the evenings, showing different events or topics 
related to HIV, TB, and cervical cancer. There is also the distribution of leaflets HIV, TB and 
cervical cancer.  
 
The staff and activities at the research mobile site 
The mobile team has two clinicians, three nurse counselors, two laboratory technicians, the 
receptions or the person who registers everyone coming for services on a particular day, the 
education officer, and a driver. There are two tents around the mobile lab, one for the clinicians 
and the other one for counselors. Usually, the mobile lab parks close to the health facility for easy 
linking of the clients who need further care. This offers an opportunity to use some of the facility 
rooms to offer services. 
 
On the day of observation, the mobile lab parked closer to one of the public health center in Kyela 
district. About 100-150 people were waiting to be attended by the mobile team. There was a queue 
to the registration desk, they registered their names and other basic personal information, and then 
depending on the services they come for they are given a small piece of paper with a number and 
the designated tent for service provision. 
We concentrated on the clients who were going to the HIV testing services. The clients who come 
for HIV testing queued towards the tent of the counselor, one counselor is in a tent and the second 
counselor is in one of the facility rooms, they go in one by one.  Most clients took between 10-
20minutes, though some clients took about 30 minutes, The nurse reported that if someone is 
coming for a repeat test and the results are negative then counselling is short, but for those coming 
for the first time it takes longer, and even longer if the client did not expect the result they got. 
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The clients who are HIV negative are counseled on how to stay negative and are advised to come 
for re-check after three months. 
 
Clients who tested HIV positive were directed to the clinician’s tent, where the doctor/clinician 
expected to examine and assess the need for any medical attention, then a request for CD4 count 
test and sputum for TB screening plus any other test that might be necessary is made.  
 
The client will go to the lab technician, provide the requested specimen and then wait for results. 
In most cases the results are available after 2-3 hours, however, clients who provide the samples 
after 3.00 are advised to come on the next day for their results. 
 
After receiving the results, the clinician will explain to the client the next steps, whether they are 
supposed to start ART or not and other necessary information depending on the clients’ condition. 
The clinician will then refer the client to the health facility, giving them a referral form, with a 
copy of lab results to go with, to the facility that offers further care on HIV/AIDS. If the client is 
also TB reactive, they will be referred to a TB section to continue with treatment. Cervical 
carcinoma screening and TB screening was also ongoing concurrently with HIV testing as well as 
the distribution of health information leaflets. 
 
The day ended at 5.30pm. The team then had to prepare for film show that was starting at 7.00pm. 
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HIV testing and linkage at the facility-based site 
DEF is one of the facility based sites in Mbeya region. The site offers HIV testing services as well 
as HIV care and treatment services. The HIV testing and counseling station has one counselor who 
also assists at the antenatal care clinic when there are no clients for HIV testing.  
The care and treatment centers station has one doctor, two nurses, two nurses’ assistants, one Home 
Based Carer and one treatment expert (these are stable patients on ART).  
 
The weekdays in this hospital are divided into different services and activities. Monday is for 
weekly departmental meeting and report writing of the previous week, and is a treatment initiation 
day for ART-eligible clients who tested for CD4 on Friday and received their results on Monday. 
Tuesday is the day for registration of newly diagnosed clients, Wednesday and Friday are CD4 
count testing days. Thursday is also a treatment initiation day plus other usual CTC procedures 
and a clinic for children although recently they have started having a clinic for children on 
Saturdays. Therefore, the whole week the CTC is quite busy with between 40- 80 clients attended 
every day.  
 
On the day we observed this facility, the HIV testing section was not busy: there were five people 
waiting for services. The nurse counselor came and allows them to enter one by one into her office 
for counseling and then testing.  The testing is done using Rapid tests, therefore each person stays 
with the counselor for about 15-30 minutes, less if it is a repeat test. A client who was diagnosed 
with HIV was given a referral letter and asked to bring it on the day of registration at the care and 
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treatment section which was on the other side across the open space, she showed the client where 
to go. 
 
Tuesday is the day of registration into HIV care, on which all clients diagnosed HIV positive in 
the week or those referred from other testing sites comes to register at this care and treatment 
center (CTC).  
 
At 09.00am, about 40 -60 clients are sitting outside the CTC. There are only four benches where 
people were seating.  Most people are seating on the floor or on the grasses, these people are 
waiting for the healthcare providers to finish a brief morning report before they can be attended. 
 
At 9.30 am the treatment expert came to talk to the clients in the waiting area. He asked for their 
attention and asked those who had come to the clinic for the first time to hand in their referral 
letters. He collected the letters, put them n a tray and took them inside to the CTC nurse who is 
responsible for registration.  While the clients were waiting to be called in for services, the 
treatment expert continued with treatment adherence session.  He explained that HIV is not a death 
sentence, if one adheres well to ART they will live a normal life just like other people who are not 
infected. He explained the procedures at the clinic and allowed questions; he responded to all 
question related to treatment adherence. For the question that needed medical personnel to 
respond, he noted them down and asked the doctor to respond. While the treatment session was 
ongoing, the clients who come for ART pick up and follow up visits were being attended by other 
care providers. The clients who were already in care had a box where everyone who comes to the 
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clinic put their cards in the box in order of their arrival. The nurses attend the clients in the order 
of first in first out.  
 
After completing the session, the new clients are called in to see the nurse who registers them and 
gives the CTC card numbers (the clients are supposed to come with this card every time they come 
for a clinic visit or when they are sick and needs medical attention). She also opens a file for each 
client. The file is used to keep the records and clinical notes from the doctors and laboratory results 
for the client. All clients go for vital signs and weight check, and they are sent to the doctor for 
medical examination and HIV staging, then all new clients a given a laboratory request form for 
CD4 count test to determine their eligibility for ART initiation in the next day (Wednesday, if the 
client cannot make it they may come on Friday it was also a day for CD4 count test as well). 
At around 4.30 pm the waiting area was empty. 
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10.5 Paper published on Linkage to Care at BMJBMJ Open. 2017;7. doi: 
10.1136/bmjopen-2016-013733. 
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